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ABSTRACT OF THE DISSERTATION
Control of Neuroendocrine Cell Physiology by a Single Transcription Factor,
Drosophila Basic Helix Loop Helix Regulator DIMMED
by
Tarik Hadžić
Doctor of Philosophy in Biology & Biomedical Sciences
Molecular Genetics and Genomics
Washington University in St. Louis, 2013
Professor Paul H. Taghert, Chairperson
Neuroendocrine cells feature a large capacity for the processing, accumulation and
regulated release of bioactive peptides and peptide hormones. The ultrastructural correlate of
this regulated secretory pathway is a specialized organelle, called a dense core vesicle (DCV).
DCVs are typically larger than conventional, small synaptic vesicles. Past work has identified
intrinsic DCV proteins (non-cargo proteins, like the processing enzyme, carboxypeptidase) or
ancillary ones that play a role in DCV trafficking and exocytosis (like CAPS, the Ca2+dependent activator protein for secretion). Currently, there is a lack of understanding of the
developmental and physiological mechanisms that permit neurosecretory cells to coordinate and
scale the regulated secretory pathway. In this context, the basic helix-loop-helix transcription
factor dimmed (dimm) is especially important in the fruit fly Drosophila, but it is not involved in
neuroendocrine cell fate determination.
Neuroendocrine cells require DIMM to accumulate, and process large amounts of
secretory peptides, but DIMM does not target individual neuropeptide-encoding genes. Instead,
we show that DIMM supports the complete resolution of NE-specific cellular properties by
organizing the cellular machinery required to support a highly active RSP. The mouse
orthologue Mist1 likewise plays a role in supporting the RSP of serous exocrine cells. This
thesis has three goals. First, I evaluated a set of putative DIMM targets obtained by another
x

scientist in the lab, and ask whether or not these are direct targets of this transcription factor. To
accomplish this, I use in vivo chromatin immunoprecipitation (ChIP) followed by measuring
DIMM binding to putative DIMM enhancers by quantitative Polymerase Chain Reaction (qPCR).
This work is described in Chapter 2. Secondly, I extend DIMM ChIP analysis to identify direct
DIMM transcriptional targets on a genome-wide level in vivo in adult neurons. This was done by
DIMM chromatin immunoprecipitation coupled to tiling microarrays (ChIP-chip), and also
applying Fluorescence Activated Cell Sorting (FACS) and deep sequencing (RNA-seq) to define
the transcriptome of DIMM neuroendocrine cells, as described in Chapter 3.
I then integrate the ChIP-chip and RNA-seq datasets to provide new viewpoints on how
DIMM is used to coordinate and appropriately scale the RSP in NE cells. The intersection of the
RNA-Seq and ChIP-chip data presents a list of genes that is likely to mediate the bulk of the
transcriptional output of DIMM – i.e., its molecular “mechanism”. In order to conduct a functional
assay and thus validate the list of intersected genes, I conducted a behavioral genetic screen.
DIMM-expressing cells have previously been shown to regulate sleep amount in flies. I
conducted an RNA interference-based screen, in which expression of individual DIMM target
genes was knocked down in DIMM neurons and the effects of this manipulation on sleep were
quantified. This in vivo validation provides an important filter with which to ascribe single gene
functions and gives further insights into the general mechanisms by which DIMM operates.

xi
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Neuroendocrine Cells
Neuroendocrine (NE) cells are a specialized class of neurons dedicated to the production,
storage and release of large amounts of peptide hormones (Park and Taghert 2009; Burgoyne
and Morgan 2003). The Polish biologist Kopeć produced the first indication anywhere in the
animal kingdom that the nervous system is capable of producing hormones (Kopeć 1917; Kopec
1922; Scharrer B 1987a). Kopeć found the existence of a “pupation hormone,” which is
produced in the brain of the gypsy moth Lymantria dispar in order for the animal to execute
pupation (Scharrer B 1987a). Speidel was the first to describe NE cells in the spinal cord of
elasmonbranchs and bony fishes as "gland-cells of internal secretion" (Speidel 1919; Scharrer B
1987a). In addition to Kopec, Speidel, and Ernst and Bertha Scharrer, one other report identified
a protein, called "Substance P," extractable from mammalian gut and the nervous tissue
(Scharrer B 1987a; von Euler and Gaddum 1931).
In 1928, Ernst Scharrer reported discovering gland-like nerve cells in the hypothalamus of
teleost fish (Scharrer B 1987a; Scharrer E 1952). At this time, a central dogma of neurobiology
was that neuronal cells communicated strictly through electric signals (Scharrer B 1987a). Ernst
Scharrer’s discovery was striking because this small group of hypothalamic cells contained
impressive amounts of secretory material comparable to that of a pancreatic endocrine cell
(Scharrer B 1987a; Scharrer E 1952). Therefore, the term NE neuron was coined, denoting the
neural and endocrine capacities of this cell type (Scharrer E 1952; Scharrer B 1987a). These
few early reports mark the early days of studying NE cells, before neuroendocrinology was a
formal discipline. Ernst Scharrer was the first to formally propose the concept of neurosecretion
in 1934 (Burbach 2011; Scharrer E and Scharrer B 1937).
One of the first classes of neuroendocrine neurons described were those neurons found in
the supraoptic and paraventricular nuclei of the hypothalamus (Zupanc 1996). These neurons,
also known as magnocellular neurons synthesize the posterior pituitary hormones oxytocin and
2
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vasopressin (Zupanc 1996; Leng and Ludwig 2008). Oxytocin and vasopressin are transported
along the axons of the hypothalamic-hypophysial tract, and end up stored in nerve endings in
the posterior lobe of the pituitary gland, where they are finally exocytosed in response to stimuli
(Zupanc 1996; Leng and Ludwig 2008).
The idea that neurons may be capable of dispatching blood-borne signals was initially met
with great resistance (Scharrer B 1987a). In 1921, Loewi proposed the theory of the chemical
transmission of the nervous impulse, which provided no tangible support for the concept of
neurosecretion (Scharrer B 1987a; Loewi 1921). In the early studies, neurohormones appeared
to be distinct from classic neurotransmitters in their proteinaceous character, the large amount
of material produced and the extracellular pathway from site of release to site of action
(Scharrer B 1987a).
Founding work by Ernst and Berta Scharrer in vertebrates and invertebrates, respectively,
has showed the virtually universal occurrence of distinctive peptide-producing NE cell groups
throughout the animal kingdom (Scharrer B 1987a). This work established that the vertebrate
hypothalamic-hypophysial system was remarkably analogous to the insect brain-corpus
cardiacum-corpus allatum system (Scharrer B 1987a; Scharrer B and Scharrer E 1944). The
workhorse of both of these types of systems is the NE cell. NE cells, while they may express
different neuropeptides, and control completely different physiologic processes, are
nevertheless “wired” in the same way to accommodate a large secretory capacity.
Within the technical limitations of their time, extensive cytophysiologic studies by Ernst
and Berta Scharrer provided the first evidence for a functional role of NE products in the control
of developmental, reproductive, and metabolic functions in animals (Scharrer B 1987a). The age
of electron microscopy allowed Palay, Bargmann, Bodian and the Scharrers to precisely
characterize the sites of synthesis and release of peptidergic NE products (Scharrer B 1987a).
This work showed that the NE material consisted of strikingly electron-dense, membrane3
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bounded granules that were easily identified and localized (Scharrer B 1987a). Further
demonstration that the Golgi apparatus was the site of dense core granule formation in
packaged form, as well as findings of their axonal release by exocytosis provided evidence in
support of a close similarity with the products of other protein-secreting gland cells (Scharrer B
1987a; Scharrer E and Brown 1961).
Protein secretion systems
Cells deliver proteins to the cell membrane or secrete them to the extracellular
environment in two general ways: classic secretory systems and non-conventional systems that
traffic proteins with special characteristics (Nickel 2010). The common entry point for proteins
meant for extracellular release is the endoplasmic reticulum (ER) (Arvan and Castle 1998).
Proteins destined for secretion are folded and processed in the ER and the Golgi apparatus,
similar to all other proteins (Burgess and Kelly 1987; Mellman and Simons 1992; Zupanc 1996).
After the initial processing in the cis-Golgi apparatus, secretory proteins enter the trans-Golgi
network (TGN), where they are segregated from lysosomal enzymes and trafficked to the cell
membrane in various types of organelles (Burgess and Kelly 1987; Zupanc 1996).
The TGN portion of the Golgi has come to be recognized as a major branch point from
which distinct classic anterograde membrane traffic pathways emanate (Arvan and Castle 1998;
De Matteis and Luini 2008; Tooze et al. 2001). These classic pathways include constitutive
traffic via small vesicles to the plasma membrane, lysosomal biogenesis via the endosomal
system and the regulated secretory pathway (RSP) via large dense core granules (LDCVs),
used by specialized cell types (Arvan and Castle 1998; Morvan and Tooze 2008). Amongst
classic anterograde secretory systems, the most commonly employed is the constitutive
secretory pathway, believed to be utilized by all cells (Schmidt and Stephens 2010; Thiele and
Huttner 1998; Tooze and Stinchcombe 1992). Constitutive secretion is the ubiquitous process
by which proteins of general importance, such as those of the extracellular matrix, are
4
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continuously released from the cell (Meldolesi et al. 2004). In addition to constitutive secretion,
various specialized secretory systems have been described: constitutive-like secretion,
regulated secretion, secretion of small permeable mediators by diffusion (nitric oxide,
endocannabinoids) as well as non-conventional secretion (Arvan and Castle 1998; Nickel 2010;
Südhof 2007; Vazquez-Martinez et al. 2011).
NE cells package peptide hormones, neuropeptides and specific neurotrophins into
secretory vesicles for release in a regulated manner upon stimulation - also known as the
regulated secretory pathway (RSP) (Park and Loh 2008). Constitutive-like secretion is a
specialized secretory pathway first detected in exocrine tissues as a pathway of protein
discharge attributable to neither constitutive nor regulated exocytosis (Arvan and Castle 1998).
During maturation of the secretory vesicle, the RSP proteins are retained in the maturing vesicle
by binding to a retention receptor (Park and Loh 2008). At the same time, constitutively secreted
proteins are removed from the vesicle by a clathrin-mediated budding mechanism to yield
constitutive-like vesicles for secretion (Park and Loh 2008). Non-conventional secretion
examples include the export of cytoplasmic proteins such as fibroblast growth factor 2 mediated
by direct translocation across plasma membranes, or export involving intracellular transport
intermediates as shown for acyl-CoA binding protein (Nickel 2010). Gases such as nitric oxide
and small lipophilic molecules are also known to diffuse directly out of the cell (Südhof 2007).
The neuroendocrine system
NE cells are capable of storing high concentrations of secretory proteins (Arvan and
Castle 1992; Tooze and Stinchcombe 1992). These proteins are stored in a specialized type of
vesicles with dense cores, the LDCVs (Tooze and Stinchcombe 1992; Scharrer E and Brown
1961). Their cargo is released only upon stimulation by a secretagogue, thereby giving rise to
the name “regulated” secretory pathway (Burgess and Kelly 1987). Like other cells, NE cells
engage in constitutive secretion, but they have also evolved the RSP. The primary function of
5
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this pathway is the secretion of substances (mainly neuropeptides) that produce modulatory
changes in target neurons and other cells (De Camilli and Jahn 1990; Hökfelt et al. 1986). In
most cases these changes appear to involve the generation of intracellular second messengers
(De Camilli and Jahn 1990; Winkler and Fischer-Colbrie 1998).
In order to execute a complicated secretory program that uses the RSP, NE cells have
distinct cell biologic organelles and properties. These individual components, together, have
allowed NE cells to assume important roles in the survival and evolution of metazoan organisms.
NE cells control critical processes such as: growth of cells and organisms, homeostatic
adaptation to environmental changes and stress, reproduction, circadian rhythms and sleep,
metabolism and nutrient storage, defense against predators and other survival mechanisms
(Kalra and Kalra 2010; Tsigos and Chrousos 2002).
Neurosecretory control over these processes is achieved through precise triggers,
controlled modulation with on and off switches and with finely tuned timing. One excellent
example of how precise and cued the neuroendocrine system is comes from insect molting. A
remarkable cascade of endocrine factors regulates this seemingly simple task of shedding the
cuticle called ecdysis (Mesce and Fahrbach 2002). Nevertheless, ecdysis involves a complex
sequence of behaviors, called the ecdysis sequence (Truman 2005). A large body of work by
Riddiford, Truman and others has identified the several hormones implicated in this process:
Ecdysis Triggering Hormone (ETH), Eclosion Hormone (EH), Crustacean Cardioactive Peptide
(CCAP), Bursicon and Corazonin (Truman 2005; Horodyski et al. 1989; Reynolds et al. 1979;
Horodyski et al. 1993; Truman and Riddiford 1970; Taghert and Truman 1982).
Although the ecdysis mechanism is still subject to debate, it is widely accepted that EH
and ETH regulate the timing of ecdysis and that they form an endocrine positive feedback
system (Ewer 2005; Truman 2005). EH released into the circulation causes ETH release, which
in turn feeds back on the CNS, to cause further release of EH (Ewer 2005). The positive
6

Chapter 1.

	
  
feedback between EH and ETH causes a massive surge of both peptides during which the
stores of both are completely exhausted (Truman 2005). This provides an all‐or‐nothing
signal that irreversibly commits the insect to an ecdysis attempt (Truman 2005). Occurrence of
ecdysis behavior is strictly confined to the end of the molt (Ewer 2005). The EH/ETH loop is
non-functional prior to this time, thereby restricting the occurrence of ecdysis behavior to the
appropriate developmental time (Ewer 2005). An early attempt or a delayed attempt at ecdysis
would have major consequences for the animal’s metabolism and its ability to successfully
shed cuticle. This example shows that without sophisticated control over neurosecretion,
species would likely be impaired in their ability to withstand evolutionary pressures.
Similar to insects and other metazoans, human development and survival depend on NE
cells, as judged by the multitude of pediatric and adult endocrine disorders. Diabetes mellitus, a
disease that arises from destruction of the pancreatic beta cell is one of the most rapidly
developing chronic diseases of the twenty-first century and is now one of the main threats to
human health (Naser et al. 2006; Zimmet et al. 2001). The other increasingly common problem
that frequently occurs together with diabetes is central and childhood obesity, both of which are
now of epidemic proportions (Havas et al. 2009; Knecht et al. 2008; Levin 2009).
Neuroendocrine signals originating from hypothalamus in the brain, the gastrointestinal system
and adipose tissue play major roles in the pathogenesis of obesity, as they provide cues for
cessation of meals and the coordination of caloric intake with maintenance of stable body weight
(de Kloet and Woods 2010).
It is now well established that the hypothalamus plays a critical role in the regulation of
energy balance through multiple output pathways (Abizaid and Horvath 2008). NE cells that
respond to hormones leptin, insulin and ghrelin from the periphery and integrate various outputs
into behavioral and neurohumoral cues are required to maintain body weight and adiposity

7
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within relatively narrow limits in many individuals (Levin 2009). While diabetes and obesity are
two of the gravest, there are a multitude of other neuroendocrine disorders with harmful effects
on human health, many of which lack proper treatments. Therefore, to treat neuroendocrine
diseases properly, it is important to understand the molecular basis of neuroendocrine system’s
function.
Invertebrate systems have played a major role in our understanding of how hormones
adjust the functioning of the nervous system (Truman 2005). The episodic events, including the
molting cycle and metamorphic transformations that lead to the emergence of adult insects, are
programmed with greater precision than the developmental steps leading to maturity in most
vertebrates (Scharrer B 1987b). The fruitfly Drosophila melanogaster is an excellent model
organism for the study of NE cells. It is estimated that roughly 75% of fly genes have
homologous sequences in the human genome (Bier 2005). Therefore, conclusions reached in
flies are readily applicable to questions in human biology, as well as disease conditions. Flies
are a workhorse of modern genetics with an experimental history exceeding one hundred years.
Their rapid development, small size, fewer paralogous and redundant genes than humans, and
remarkable functional conservation make Drosophila an excellent model system for the study of
neurosecretion. With regards to NE cells, flies are a great model system for two reasons: i) the
fly neuroendocrine system is highly analogous to the human neuroendocrine system ii) in
addition to the principles on which the NE system is built, the building blocks themselves (genes
encoding processing enzymes, LDCV constituents, RSP factors and neuropeptides) are highly
conserved with human genes (Jiang et al. 2000; Han et al. 2004; Hwang et al. 2000; Kolhekar et
al. 1997; Littleton 2000; Nässel 2002; Rayburn et al. 2003; Sidyelyeva et al. 2006; Siekhaus and
Fuller 1999).
Cell biology of NE cells

8

Chapter 1.

	
  
NE cells possess a robust RSP, which acts through the subcellular compartment
consisting of: i)LDCVs), ii) cellular processing machinery necessary for synthesis, processing
and storage of large amounts of neuropeptides and iii) the ability to release cargos only in
response to precise stimuli (Arvan and Castle 1998; Burgess and Kelly 1987). It is believed that
NE cells, like all other cells, possess a constitutive secretory pathway alongside the RSP (Tooze
and Stinchcombe 1992; Bauerfeind and Huttner 1993). These two pathways, while not mutually
exclusive, are thought to utilize different mechanisms of protein trafficking.
The “two pathway hypothesis” was originally proposed by Kelly in 1985, based on a set
of elegant experiments in a pituitary cell line (Gumbiner and Kelly, 1982). This work showed that
AtT-20 pituitary-derived cells use two remarkably different cellular pathways for the delivery of
two types of cargo: a viral protein versus the mature form of the adrenocorticotropic hormone
(ACTH) (Gumbiner and Kelly, 1982). The viral protein, as well as the ACTH precursor were
delivered to the cell surface and released soon after synthesis in a constitutive-like manner. On
the other hand, the mature form of ACTH was stored in special vesicles and not readily
released. Secretion of the matured ACTH occurred in response to a secretagogue, whereas the
same secretagogue had little effect on the release of the viral protein or the immature form of
ACTH (Gumbiner and Kelly, 1982). These experiments solidified the concept of distinct postGolgi pathways for proteins targeted for constitutive versus regulated secretion (Morvan and
Tooze 2008). It is now known that there are several other types of secretion systems (both
conventional, such as the constitutive-like secretory pathway) and the non-conventional systems
that accomplish protein secretion (Nickel 2010).
LDCVs are the main subcellular compartment used by cells to execute the RSP (Arvan
and Castle 1998; Tooze and Stinchcombe 1992; De Camilli and Jahn 1990). NE cells can
achieve a remarkable concentration and condensation of secretory products into LDCVs (Arvan
and Castle 1992; Tooze and Stinchcombe 1992; Salpeter and Farquhar 1981). NE cells can
9

Chapter 1.

	
  
concentrate secretory proteins from the ER to the LDCVs by a factor as high as 200-fold
(Salpeter and Farquhar, 1981). In contrast, a constitutively releasing cell, such as a plasma cell
shows at most a two-fold concentration factor (Burgess and Kelly 1987; Hearn et al. 1985). This
likely also reflects the temporal dynamics of these two different types of secretory systems. One
(constitutive) is meant for constant trafficking, delivery and release of proteins into the
extracellular environment or the cell membrane, thereby making cargo concentration
unnecessary. The other (regulated) system works over longer time periods and its cargos are
super-concentrated inside LDCVs, awaiting release at a precise moment in time (Arvan and
Castle 1998).
It has been shown that NE cells store neuropeptide-filled LDCVs within their cytoplasm
for long periods of time, thus acquiring large pools of intracellular mature secretory product
(Burgess and Kelly 1987; Zupanc 1996; Burbach 2011). Cells that employ a robust RSP are
therefore designed to synthesize and store one or a few secretory products and to discharge
rapidly a large fraction of these products in response to physiologically specific stimulation, even
in the absence of new protein synthesis (Burgess and Kelly 1987; Arvan and Castle 1998;
Zupanc 1996).
LDCVs
LDCVs are membrane-enclosed spherical organelles with diameters of up to several
hundred nanometers (Borgonovo et al. 2006). LDCVs have electron-opaque content that forms
the “dense core” seen on electron microscopy (EM, Morvan and Tooze 2008; De Camilli and
Jahn 1990; Peters et al. 1991). In NE cells, this core is separated from the membrane by a halo
of “space” (Fuller et al. 1985; Geuze et al. 1983; Griffiths et al. 1981; Griffiths et al. 1984; Pothos
et al. 2002). Little is known about the structure or assembly of this material itself (Burgess and
Kelly 1987). The dense cores are stable, since empty unloaded cores have been observed even
after exocytosis (Tooze and Tooze 1986). Additionally, when detergent is used to remove the
10
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LDCV membrane, secretory products remain bound to the dense cores (Zanini et al. 1980).
Therefore, it can be generalized that cells that employ an RSP condense their secretory
products, whereas those lacking an RSP do not (Kelly 1985). Constitutive secretion can also
occur by means of various transport granules, which have distinct appearance and
characteristics compared to LDCVs. Such constitutively secreted granules readily fuse with the
cell membrane. Thus, in constitutively secreting cells, newly synthesized protein is not stored
but leaves the Golgi apparatus in short-lived membrane vesicles that fuse immediately with the
plasma membrane in the absence of any extracellular signal (Moore and Kelly 1985). In
contrast, LDCVs are prevented from fusing with the plasma membrane until an intracellular
messenger, such as calcium, undergoes a significant change in levels (Kelly 1985).
In addition to the rate of exocytosis, NE cells can also concentrate the sites of
exocytosis. Some secretory cells, such as mast cells or neutrophils are not polarized and they
traffic and release their products towards any part of the plasma membrane that is stimulated
(Kelly 1985). NE cells, on the other hand, appear to be highly polarized. Hypothalamic neurons,
for example, release neuropeptides exclusively from terminals located in the posterior pituitary
gland (Kelly 1985; Leng and Ludwig 2008).
Secretory cargo sorting in the TGN
The TGN is the key exit point not only for RSP proteins and cargo, but for all other
proteins that are destined for various locations, such as the plasma membrane, constitutive
secretory vesicles, endosomes and immature secretory granules (Morvan and Tooze 2008).
The mechanism of RSP sorting has been a matter of controversy. Two dominant hypotheses
have been put forth: sorting-at-entry, and sorting-by-retention (Dikeakos and Reudelhuber
2007). There are several lines of evidence supporting both hypotheses, so it is possible that
they are not mutually exclusive. In the sorting-at-entry mechanism, cargo proteins aggregate
together in the acidic, calcium-enriched environment of the TGN (Park and Loh 2008). Certain
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RSP cargoes such as the secretogranins are thought to be more prone to aggregation, and they
in turn “seed” precipitation of other regulated cargoes (Borgonovo et al. 2006). Further support
for this hypothesis comes from results showing complete spatial segregation of different pituitary
hormones inside LDCVs found in single acidophilic bovine pituitary cells (Hashimoto et al.
1987). Thus, this study demonstrates the sorting of three different hormones to distinct LDCVs
with separate storage within distinct granule types.
In the sorting-by-retention model, on the other hand, immature granules contain proteins
meant for both constitutive and regulated secretion (Arvan and Castle 1998). As vesicles
mature, proteins destined for constitutive secretion are extruded in low-density vesicles,
ultimately leaving only the “correct” RSP cargo in the mature LDCV (Dikeakos and Reudelhuber
2007). Thus, in this model, non-secretory proteins are removed due to receptor-mediated
sorting and/or their inefficient retention properties such as the inability to form aggregates
(Vazquez-Martinez et al. 2011).
Enzymatic processing of neuropeptide precursors
Certain molecular characteristics are hallmarks of neuropeptides. Although
neuropeptides are small protein molecules, they are still about 50 times larger than lowmolecular-weight classical neurotransmitters (Salio et al. 2006). As a consequence,
neuropeptides possess several more recognition sites for receptors than smaller
neurotransmitter molecules and are capable of eliciting a biological effect when released in
lower quantities (Salio et al. 2006). There are three commonly used criteria to denote
neuropeptides: gene expression and biosynthesis by neurons, storage and regulated release
upon demand, and the ability to modulate neural functioning directly through neural receptors
(Burbach 2011).
Neuropeptides are generally synthesized as proteins with a pre and a pro region at the
N-terminal (Docherty and Steiner 1982). The pre-region signal peptide is the 15-30 amino acid
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long amino acid extension at the N-terminal of the precursor, the pre-propeptide (Zimmermann
et al. 2011; Burbach 2011). The pre-region signal is required for import into the ER, and
therefore is key for entry into secretion routes (Zimmermann et al. 2011; Burbach 2011). After
ER entry, the pre-region is cleaved and the proneuropeptide can undergo appropriate
biochemical processing. Since peptide precursors contain basic amino acids separating the
various bioactive or spacer regions, it was hypothesized that a trypsin-like endopeptidase
initially cleaved the precursors, thereby generating intermediates with C-terminal basic residues
(Fricker 2005; Docherty and Steiner 1982). These basic residues would then be removed by a
carboxypeptidase B-like enzyme, in many cases producing the final peptide (Fricker 2005).
Indeed, two such trypsin-like endopeptidases, prohormone convertase 1 and 2 (PC1 and
PC2) are involved in the production of neuropeptides (Fricker 2005; Zhou et al. 1999; Seidah
and Prat 2002). PC1 and PC2 were identified based on their similarity to the yeast enzyme
Kex2p, the endoprotease responsible for cleaving pro-alpha-mating factor at paired basic amino
acid sites (Eipper et al. 1993; Seidah and Chrétien 1999; Seidah et al. 1991; Smeekens and
Steiner 1990). PCs cleave at the C-terminal side of dibasic residues, leaving peptides with a pair
of basic amino acid residues (Lysine (K) and Arginine (R)) extending from their C-terminus
(Perello and Nillni 2007; Fricker 2005).
The intermediates produced by PC1 and PC2 are subsequently cleaved by
exopeptidases, such as carboxipeptidase E, which removes the C-terminal basic amino acids
(Perello and Nillni 2007; Fricker and Snyder 1982). Cleavage of the neuropeptide precursor
leads to the generation of specific peptides with different activities and functions, as well as nonfunctional byproducts (Burbach 2011). Cell-specific differences in PCs lead to different sets of
peptides from the same precursor (Burbach 2011). While immature LDCVs are initially formed at
the TGN, subsequent maturation steps occur beyond this compartment (Burgoyne and Morgan
2003; Tooze and Huttner 1990; Arvan and Castle 1987).
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Peptide amidation
In addition to cleavage, many neuropeptides undergo additional posttranslational
processing steps such as C-terminal amidation, N-terminal acetylation, or other modifications
such as glycosylation, sulfation, and phosphorylation (Fricker 2005; Eipper et al. 1992; Burbach
2011). These extra steps may provide longer stability and stronger activity. C-terminal amidation
is especially common (Eipper et al. 1993). At least 50% of all examined neuropeptides
regardless of species have an alpha-amide moiety at their carboxyl end (Eipper et al. 1992).
More than 90% of Drosophila neuropeptides are predicted to be amidated (Park and Taghert
2009). For many neuropeptides, the presence of the alpha-amide moiety is essential for biologic
activity (Eipper et al. 1992; Tazi et al. 1987). Other speculations about the role of amidation
have included a role in protecting peptides from enzymatic degradation (half-life) and increasing
binding affinity (Fuhlendorff et al. 1990; Kreil 1985).
Peptide amidation is carried out by a bifunctional enzyme that can only act after PCs and
carboxypeptidases have acted (Eipper et al. 1993). The precursors to alpha-amidated peptides
always contain a Gly residue to the COOH-terminal side of the residue to be alpha-amidated
(Eipper et al. 1992). The first step of the two-part amidation reaction is carried out by a
peptidylglycine alpha-hydroxylating monooxygenase (PHM), which catalyzes the copper,
ascorbate, and molecular oxygen dependent conversion of peptidylglycine substrates into an
alpha-hydroxyglycine intermediate (Eipper et al. 1991; Eipper et al. 1992; Eipper et al. 1993). A
peptidyl-alpha-hydroxyglycine alpha-amidating lyase (PAL) activity catalyzes the conversion of
these intermediates into alpha-amidated products along with the production of glyoxylate
(Eipper et al. 1993; Katopodis et al. 1991; Kato et al. 1990). PAL and PHM are contained within
a single bifunctional enzyme in mammals, whereas in Drosophila, these enzymes are encoded
by one or more separate genes (Kolhekar et al. 1997; Jiang et al. 2000; Han et al. 2004).
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Newly synthesized neuropeptides move through the RSP while the various endoproteolytic
cleavages are occur (Eipper et al. 1993). The subcellular location in which each enzyme
functions is not fully clear, but it is known that although the TGN marks the beginning of
processing, the majority of the cleavages occur in LDCVs (Eipper et al. 1993; Schnabel et al.
1989; Glembotski 1981). Finally, neuropeptides can undergo various other chemical
modifications including N- and O-glycosylation, phosphorylation, sulfation, and acetylation, all of
which have various biological effects (Burbach 2011).
While Work by Kelly and subsequent work established the basis for the RSP, the
mechanism by which the RSP operates from cargo’s entry into the pathway to its delivery to the
extracellular environment is still largely unknown. Furthermore, we currently lack extensive
knowledge of the mechanism that establishes the RSP inside developing NE cells, and then
maintains it in mature NE cells. What is clearly known is that the RSP appears to be conserved
across species and genera. NE cells are commonly studied in worms, flies and other insects,
frogs, fish and various mammalian species.
Fast neurotransmission versus slow neuropeptide-mediated neurotransmission
Although neuroendocrine signaling is very important for the nervous system,
quantitatively, synaptic vesicle-mediated synaptic transmission is the dominant form of
communication between neurons (Südhof 2007). Nevertheless, this does not mean that synaptic
transmission is more important than the other types of neurotransmission: the two principally
different signaling pathways play distinct roles in information processing by the brain, and both
are essential for brain function (Südhof 2007).
Synaptic vesicles (SVs) have a characteristic cross-sectional diameter of 30-40
nanometers, appear clear by EM and contain classical neurotransmitters, such as acetylcholine,
gamma-amino-butyric acid (GABA) or glutamate (Craige et al. 2004; Edwards 1998; Südhof
2007). SVs and LDCVs can be readily distinguished by EM: unlike LDCVs, SVs have a clearly
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electron-lucent appearance, which is due to the absence of protein or peptides in their lumen
(Craige et al. 2004). LDCVs and SVs are further distinguished by the mode of stimulation
required for release, the type of calcium channels involved in the exocytotic process, and the
time course of recovery after stimulation (Zupanc 1996).
In addition to morphology and composition, the two vesicle types are also quite different
functionally: SVs cluster over synaptic active zones, respond to high micromolar calcium
concentrations and release their contents rapidly, within a millisecond (Edwards 1998; Katz
1969; Südhof 2007). In addition to the rapid pace of release, neurons release SVs in a highly
localized manner, restricted to an area of less than a square micrometer (Südhof 2004; Südhof
2007). SV release occurs mainly at the presynaptic terminal into the synaptic cleft (Ludwig and
Leng 2006).
As with all phenomena in biology, there are exceptions to all rules. In most neurons for
any single event, a single vesicle per synapse fuses with the membrane following action
potential invasion, and this exocytotic event is limited to the ultrastructurally defined presynaptic
active zone (Biro et al. 2005; Matsui and Jahr 2006; Sargent et al. 2005; Silver et al. 2003).
Nevertheless, at certain synapses, more than a single vesicle can be released per action
potential, and in rare circumstances neuronal exocytosis can occur from sites that are
unremarkable in electron micrographs (Ceccarelli et al. 1979; Matsui and Jahr 2006; Zenisek et
al. 2000). It is important to note that the above-mentioned example is an exception and not a
rule.
When an action potential depolarizes a terminal, calcium enters into the terminal through
voltage-gated channels at the “active zone” and causes SV exocytosis with resultant release of
classic neurotransmitters into the synapse (Ludwig and Leng 2006; Owald and Sigrist 2009;
Südhof 2004). Calcium concentration upon entry in the vicinity of the channels can be very high,
but it does not penetrate far due to rapid sequestration by high-capacity buffers (Ludwig and
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Leng 2006). SV exocytosis involves sensors with a low affinity for calcium, likely due to high
calcium concentrations found close to the site of calcium entry (Ludwig and Leng 2006). Since
LDCVs are frequently located deeper inside the cell, at sites distant from active zones and are
not exposed to such calcium high concentrations, LDCV exocytotic machinery has a high
calcium affinity and so might be activated by calcium entry when a high rate of entry is induced
by intense activation (Ludwig and Leng 2006; Zupanc 1996).
In contrast to SVs, LDCVs have a diameter of 80–200 nanometers and exhibit a
characteristic electron-dense core that contains neuropeptides (Edwards 1998; Crivellato et al.
2005; Crivellato et al. 2006). SVs have dedicated release sites that are associated mainly with
synapses, but LDCVs are released from all parts of a neuron, including the axon, soma and,
especially, the dendrites (Ludwig and Leng 2006; Morris and Pow 1991; Salio et al. 2006;
Südhof 2007). When LDCVs pool in in neuronal cell bodies, dendrites as well as the axonal
terminals, they await a proper signal that would instruct their release (Arvan and Castle 1998).
Once triggered, LDCVs release their contents relatively slowly, taking more than 50
milliseconds and they do so in response to low micromolar calcium concentrations (Edwards
1998; Martin 2003). Compared to SVs, LDCV exocytosis requires more sustained calcium
transients, but is slower and longer lasting than SV exocytosis (Südhof 2007; Stjarne 2000;
Martin 2003). For example, calcium-initiated chromaffin granule exocytosis is 10-fold slower
than SV exocytosis, but otherwise the two systems are similar (Südhof 2007). Though fast, SVmediated and slow, LDCV-mediated neurotransmission are built on many of the same
principles, NE cells are known to have evolved special adaptations for LDCV-mediated slow
neurotransmission (Fukuda et al. 2004).
Similar to exceptions to the rule seen for SVs, there are such exceptions for LDCVs as
well. Occasionally, LDCVs have been observed undergoing exocytosis at typical active zones of
nerve terminals in stimulated synapses of frog sympathetic ganglia and of rat trigeminal
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subnucleus caudalis (Pécot-Dechavassine and Brouard 1997). In the majority of examined
cases, classic neurotransmitters and peptides are not stored together: the former are stored in
SVs, which are densely clustered in synaptic terminals, whereas peptides reside in LDCVs,
which are more rare in terminals (Ludwig and Leng 2006).
After mature LDCVs are formed by budding from the TGN, they are transported from the
cell body to axons or dendrites or they can remain in the cell body (Südhof 2007). A calciumbased signal triggers the translocation and fusion of LDCVs with the plasma membrane outside
of the active zone (Rutter and Tsuboi 2004; Südhof 2007). There still exists a certain amount of
uncertainty and controversy regarding the precise mechanism of LDCV fusion with the
membrane. After exocytosis, empty LDCVs recycle and refill by transport to the cell body and
recycling via the Golgi complex (Südhof 2007).
The mechanism of coordination and maintenance of NE cell properties
Many cell-intrinsic regulatory mechanisms that help establish specific transmitter
phenotypes have been discovered (Park and Taghert 2009; Ding et al. 2003; Cheng et al.
2004). Nevertheless, what is not known is how NE cells develop their mature properties (Park
and Taghert 2009). A host of transcription factors such as Mash1, Otp, Brn2, Sim1 and Sim2
have been shown to regulate the early differentiation of hypothalamic neuroendocrine centers
by their expression in neuronal progenitors and in pre-migratory neurons (Acampora et al. 1999;
Goshu et al. 2004; Hosoya et al. 2001; Michaud et al. 1998; Nakai et al. 1995; Park and Taghert
2009; Schonemann et al. 1995; Wang and Lufkin 2000).
The above mentioned factors are important early in specification of their corresponding
NE cell lineages, as well as in proliferation and migration of NE precursors (Park and Taghert
2009). Very little is known about factors acting in post-mitotic cells, once they are restricted to
their appropriate lineages. This is a time point in the life of a newly born neuron when the
neuron needs to start developing properties of the mature cell type it is destined to become. In
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the case of NE cells, a central question is: what are the intrinsic regulatory factors that directly
organize the maturation of peptidergic cellular properties (Park and Taghert 2009)? Such
properties involve proper scaling and modulation of the RSP by which peptides and peptides
hormones are packaged and released, as well as active maintenance of the RSP and proper
homeostatic response to various environmental and internal perturbations (Park and Taghert
2009; Mills and Taghert 2011).
Although several groups have reported on identification of individual factors that operate
in the RSP, the genetic basis of RSP establishment, scaling and maintenance is largely
unknown (Arvan and Castle 1998; Beuret et al. 2004; Kim et al. 2001; Park and Taghert 2009).
Clonal isolates of particular cell lines (AtT-20 and PC12) have been identified as lacking
particular molecular or subcellular features of the RSP (Day et al. 1995; Malosio et al. 1999).
Various groups have reported several independently derived neuroendocrine cell variants that
lacked regulated secretory organelles or failed to express genes known to be functionally
important for secretory cells (Pance et al. 2006; Matsuuchi and Kelly 1991; Borgonovo et al.
1998; Leoni et al. 1999; Pance et al. 1999).
The transcription factor RE1-silencing transcription factor (REST), is the only known
transcription factor known to play a role in the mammalian RSP (Pance et al. 2006). For
example, the A35C PC12 clone lacks markers for both SVs and LDCVs at the protein and
mRNA level (Pance et al. 1999). Hybrid cells created by fusing A35C with normal PC12 also
failed to accumulate LDCVs, suggesting the existence of a transcriptional repressor that blocks
the existence of a functional RSP (Pance et al. 1999; Pance et al. 2006). This further indicates
that neurosecretion could perhaps be controlled in a modular way (Borgonovo et al. 1998;
Pance et al. 2006). REST is necessary but not sufficient to suppress the NE phenotype in A35C
cells, which implies that other transcription factors or signaling proteins may need to act
together with REST to repress the RSP (Pance et al. 2006). It is therefore possible that RSP
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regulation in other systems also requires factors acting transcriptionally, as well as posttranscriptionally.
Work in Drosophila has suggested that there is a genetic basis underlying development
and maintenance of the NE cell fate (Park and Taghert 2009). A single transcription factor
named dimmed (DIMM) has been shown to act as a dedicated pro-secretory factor (Hewes et
al. 2003; Park and Taghert 2009). The orthologue of DIMM, named Mist1 in mammals, has
been shown to be a dedicated pro-secretory factor in the serous exocrine cells (Johnson et al.
2004; Moore et al. 2000; Pin et al. 2000; Ramsey et al. 2007). As in hypothalamic and pituitary
development in mammals, there is a whole cascade of transcription factors implicated in the
specification of Drosophila neuroblasts and their transition to post-mitotic NE cells destined to
give rise to mature peptidergic cells (Allan et al. 2005; Benveniste et al. 1998; Baumgardt et al.
2009; Kohwi and Doe 2009; Park et al. 2004). These factors include the transcription factors
apterous, squeeze, eyes absent, grainyhead, collier and other early factors. By employing
transcription factor cascades and loops, Drosophila neural stem cells generate many distinct
neuronal and glial subtypes over time (Kohwi and Doe 2009). Nevertheless, there are only two
known Drosophila transcription factors involved in development of the mature phenotype of a
CNS cell type: the neuroendocrine-specific factor dimmed and the pan-glial factor repo (Hewes
et al. 2003; Freeman et al. 2003).
Past work has demonstrated the existence of transcription factors acting to set up
specialized intracellular circuits and pathways that distinguish one cell type over another (Mills
and Taghert 2011). Two known cases of transcriptional organizers of the developmental
programs of neuronal cell subtypes are factors PET-1 and AST-1 (Park and Taghert 2009;
Hendricks et al. 1999; Flames and Hobert 2009). AST-1 is an ETS transcription factor that
controls expression of all dopamine pathway genes in all dopaminergic cell types in
Caenorhabditis elegans (Flames and Hobert 2009). PET-1 is another ETS domain transcription
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factor that appears to control expression of serotonin pathway genes in mammalian
serotonergic neurons (Hendricks et al. 1999). Both of these factors control major elements of
the biosynthetic machinery known to distinguish their respective neuronal subtypes from
neurons expressing other biogenic amines or classic neurotransmitters. Neither factor, however,
is necessary for the initial fate specification or survival of the respective neuron type that they
control (Park and Taghert 2009). There is also no evidence as of yet that either of these factors
controls a whole subcellular compartment, such as LDCVs, endosomes or synaptic vesicles.
One known factor that controls a whole subcellular compartment is Transcription Factor
EB (TFEB) (Sardiello et al. 2009). TFEB exerts coordinated transcriptional control over most
mammalian lysosomal genes (Sardiello et al. 2009). In vitro, TFEB induces lysosomal
biogenesis and increases degradation of lysosomal complex molecules (Sardiello et al. 2009).
Another factor, Peroxisome proliferator–activated receptor Gamma Coactivator-1 (PGC-1), has
been shown to control the number of mitochondria inside heart cells, as well as their function in
response to energy demands (Finck and Kelly 2007; Lehman et al. 2000). Though it has been
convincingly shown that PGC-1 is a master regulator of myocardial energy metabolism, this
protein is a not a sequence-specific transcription factor, but rather a co-activator for such factors
(Finck and Kelly 2007). The above examples demonstrate master regulators / scaling factors
that control the biogenesis, maintenance and homeostasis of lysosomes and mitochondria
(Lehman et al. 2000; Sardiello et al. 2009). Based on previous and current work, evidence
points to DIMM acting as a scaling factor on the RSP of NE cells, through the morphological
correlate of the RSP, the LDCV compartment (Mills and Taghert 2011; Park et al. 2011).
Overview of DIMM biology
DIMM was identified by Hewes et al. in 2003 as a neuroendocrine-specific basic helix
loop helix (bHLH) transcription factor in Drosophila. The original dimmed loss-of-function
phenotype was a severe reduction of neuropeptide staining intensity, with normal survival of NE
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neurons (Hewes et al. 2003). These early results pointed to a role of DIMM in regulating the
differentiation of neuroendocrine lineages (Hewes et al. 2003; Park et al. 2004). Furthermore,
DIMM was proposed to be an integral component of a novel mechanism by which diverse
neuroendocrine lineages differentiated and maintained their pro-secretory state (Hewes et al.
2003). DIMM is a member of the Atonal subfamily of transcription factors and its bHLH domain
displays 78% identity with the mouse Mist1 mammalian protein (Moore et al. 2000; Pin et al.
2000). The predicted DIMM protein consists of a single 390 amino acid open-reading frame with
a centrally-positioned bHLH domain (Park and Taghert 2009).
DIMM was originally identified thanks to Drosophila P-element based enhancer trap
screening that yielded a GAL4-containing P-element named c929-GAL4 inserted 13 kilobases
upstream of the DIMM transcription start site (Hewes et al. 2003). c929-GAL4 drives gene
expression in a pattern that overlaps to a large extent with DIMM, based on in situ hybridization
and immunohistochemical analysis (Hewes et al. 2003; Park et al. 2008a). c929-GAL4 and
DIMM expression overlap in many peptidergic cells in the CNS, and in peripheral endocrine
cells of the corpora cardiaca as well as in the Inka cells of the epitracheal endocrine system
(Park and Taghert 2009; Park et al. 2008a). DIMM is essential for survival as dimm null animals
die late in embryonic stages or rarely as first instar larvae (Park and Taghert 2009; Hewes et al.
2003). This phenotype is strikingly similar to that of animals null for the Drosophila PHM gene
(Jiang et al. 2000).
The developmental time course of DIMM expression has been explored in detail (Hewes
et al. 2003; Allan et al. 2005). Except for maternal DIMM expression and a transient embryonic
stage 11 expression, the first time point at which DIMM is stably expressed in the developing
embryonic nervous system is in stage 12 embryos (Allan et al. 2005; Hewes et al. 2003; Park
and Taghert 2009). Interestingly, there are cases of post-mitotic neurons born in the embryo that
do not display characteristics of mature NE cells until metamorphosis (Park et al. 2004). Such
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cells lack DIMM expression preceding metamorphosis, but they acquire DIMM expression
immediately before differentiation (Park et al. 2004; Park and Taghert 2009). Importantly, once
DIMM expression commences in the embryonic CNS, the vast majority of DIMM-expressing
neurons maintain persistently high-level DIMM expression throughout all developmental stages
and from beginning to the end of their adult life (Park et al. 2008a). In late third instar larvae,
there are ~306 DIMM-positive CNS cells, most of which are NE cells (Park et al. 2008a; Park
and Taghert 2009).
The expression of DIMM was surveyed against that of 26 different neuropeptide markers
(Park et al. 2008a). This study found that 64% of DIMM cells within the larval CNS could be
identified by one or more of the 24 CNS peptide gene markers. Furthermore, there was
remarkable overlap between NE neurons expressing high levels of PHM and DIMM (Park and
Taghert 2009). Outside the CNS, 73% of the 53 prominent DIMM-positive cells in the larva are
associated with one or more neuropeptide markers (Park et al. 2008a). Therefore, most (if not
all) DIMM-expressing neurons are peptidergic (Park et al. 2008a). DIMM expression is restricted
to NE neurons of the neuroendocrine, as well as interneuronal subtypes (Park and Taghert
2009). On the other hand, motor and sensory neurons do not express appreciable levels of
DIMM (Park and Taghert 2009).
Although most DIMM+ cells are peptidergic, the corollary is not necessarily true and
varies on a peptide-to-peptide basis (Park and Taghert 2009; Park et al. 2008a). Of the 26
neuropeptide markers, 8 are >90% DIMM-positive, 18 are >40% DIMM-positive and 2 peptide
markers do not overlap with DIMM (Park et al. 2008a). There are ~1,000 NE cells in the larval
brain that express any of the 26 neuropeptide markers, and ~30 - 40% of them are DIMMpositive (Park et al. 2008a). This selective overlap of DIMM with particular subpopulations of NE
cells, even within populations expressing the same neuropeptide, likely provides a clue to DIMM
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function. There are several features that unite the subtypes of cells that express DIMM that will
be further described below.
Work in this thesis aims to show the mechanism by which DIMM operates to ensure
proper development and dynamic maintenance of the NE cell fate. In addition to the
homologous roles of DIMM and Mist1 in LDCV biogenesis and maintenance, conclusions
reached from studying DIMM could be broadly applicable to other systems due to the high
degree of conservation of RSP factors. The majority of processing enzymes, LDCV trafficking,
biogenesis and release-implicated genes, as well many neuropeptides are conserved in
Drosophila and mammals (Han et al. 2004; Hwang et al. 2000; Jiang et al. 2000; Kolhekar et al.
1997; Littleton 2000; Nässel 2002; Rayburn et al. 2003; Sidyelyeva et al. 2006; Siekhaus and
Fuller 1999).
In order to decipher the mechanism of DIMM operation, various genomic techniques can
be employed to examine the role of DIMM on a genome-wide level. A review of literature shows
that there are only a few reports of in vivo transcriptional profiling of particular NE cell
populations. One such example comes from transcriptional profiling of normal and osmotically
stressed rats (Hindmarch et al. 2006; Hindmarch and Murphy 2010). Here, the authors tried to
understand the hypothalamo-neurohypophyseal system’s response to dehydration. The
hypothalamo-neurohypophyseal system is a NE center responsible for the production of the
antidiuretic peptide hormone vasopressin (Hindmarch et al. 2006). Dehydration evokes a
massive release of the vasopressin from magnocellular neuron axon terminals in the posterior
pituitary, which is accompanied by a plethora of changes in the morphology and
electrophysiological properties, as well as biosynthetic and secretory activity of the
hypothalamo-neurohypophyseal system (Hindmarch et al. 2006). The authors employed
microarray technology to globally identify transcripts that were regulated as a consequence of
dehydration as well as RNAs that were enriched in specific hypothalamic nuclei under normal
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conditions (Hindmarch et al. 2006; Hindmarch and Murphy 2010). Similarly, the role of DIMM in
NE cells can probably be best understood with a genome-wide approach aimed at
understanding its genomic targets and the NE cell transcriptome.
DIMM and the concept of LEAP cells
Among peptidergic cells, several attributes set DIMM cells apart (Park and Taghert 2009).
These properties are: i) the relatively large size of DIMM-expressing NE cells compared to other
NE cells (L), ii) their pattern of episodic release of peptides (E), iii) their specific production of
amidated peptides (AP) (Park and Taghert 2009). Therefore, the acronym LEAP was coined
(Park and Taghert 2009).
Among the peptidergic cells of the fly CNS, LEAP cells have relatively large cell bodies,
as well as larger and more complex branching patterns (Park and Taghert 2009). Episodic
release of peptides is a property of LEAP cells that is currently largely speculative or indirect, as
release has not been documented for many LEAP cells (Park and Taghert 2009). During
episodic release, discrete release events have ballistic rising phases and decay phases lasting
many minutes, with the majority of stored peptides released (Reynolds et al. 1979). Such
release has been documented for several subpopulations of LEAP cells that have important
roles in ecdysis (Reynolds et al. 1979). Finally, LEAP cells specialize in the production of
amidated peptides. DIMM expression is highly correlated with C-terminal alpha-amidation of
secretory peptides (Park and Taghert 2009). Several lines of evidence support this notion:
DIMM directly controls the expression of the amidating enzyme PHM and their expression
patterns overlap highly (Hewes et al. 2003; Park et al. 2008b).
Mechanism of DIMM action
DIMM loss-of-function mutants show reduced neuropeptide staining, but also reduced
levels of neuropeptide processing enzymes (Hewes et al. 2003; Park et al. 2008b). On the other
hand, DIMM loss appears to have no effect on the survival or arborization or morphology of NE
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neurons that normally express DIMM (Hewes et al. 2003). Selective DIMM misexpression in the
CNS can increase the steady state peptide accumulation in NE cells (Hewes et al. 2003; Allan
et al. 2005; Miguel-Aliaga et al. 2008). Furthermore, misexpression of DIMM confers high-level
PHM expression onto all neurons (Allan et al. 2005). This suggests that DIMM acts as a “master
regulator” of the peptidergic cell fate. On the other hand, work in the Drosophila embryo and
larvae suggests that DIMM also participates in combinatorial codes with various other
transcriptional regulators to promote unique subtypes of NE cells (Allan et al. 2005; Baumgardt
et al. 2009; Miguel-Aliaga et al. 2008). These two modes of operation are not mutually exclusive
and can be reconciled with each other, even in the same cell.
DIMM is a class 2 bHLH protein in the Atonal superfamily (Moore et al. 2000). Class 2
bHLH transcription factors function mostly as heterodimers with a class 1 ubiquitous bHLH
protein such as E12/E47 in mammals and daughterless in flies (Massari and Murre 2000; Park
and Taghert 2009). DIMM appears to favor functioning as a homodimer as opposed to forming
heterodimers with DAUGHTERLESS, as other members of its superfamily (Allan et al. 2005).
The simplest prediction for how DIMM functions is that as a transcription factor, it binds to
enhancers in the genome and activates expression of target genes (Powell and Jarman 2008).
Prior to work presented in Chapters 2 and 3 of this thesis, there was a single known direct
DIMM target - the Drosophila amidation enzyme PHM (Park et al. 2008b).
The function of DIMM and PHM is tightly linked, both in vitro and in vivo (Park and
Taghert 2009). Careful analysis has identified precise enhancers in the first intron of PHM that
DIMM binds to and transactivates PHM expression (Park et al. 2008b). In vitro, DIMM controls
PHM transcription by binding to each of three adjacent E boxes within the first PHM intron (Park
et al. 2008b; Park and Taghert 2009). The three identified E-boxes also contribute equally to
proper expression of a PHM transgenic reporter (Park et al. 2008b). Therefore, prior to this
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thesis work, PHM was the single bona fide direct DIMM target, in vitro and in vivo (Park et al.
2008b; Park and Taghert 2009).
More recent studies have shown additional evidence in support of DIMM as a master
regulator of peptidergic cell fate (Hamanaka et al. 2010; Park et al. 2011). When DIMM is
misexpressed in non-peptidergic neurons such as photoreceptors, the morphology and
physiology of these neurons changes dramatically (Hamanaka et al. 2010). Normally, nonpeptidergic neurons fail to accumulate ectopically expressed neuropeptides (Hamanaka et al.
2010; Helfrich-Förster et al. 2000; Rao et al. 2001). Nevertheless, when non-peptidergic
neurons are forced to express a neuropeptide and DIMM, they can successfully express high
levels of neuropeptides (Hamanaka et al. 2010). Furthermore, when DIMM is co-misexpressed
with a neuropeptide, photoreceptors can successfully make bioactive peptides, as measured by
mass spectrometry (Hamanaka et al. 2010). Ultrastructural analysis of photoreceptors
misexpressing DIMM and/or neuropeptide showed a dramatic appearance of an LDCVs inside
photoreceptors (Hamanaka et al. 2010). When DIMM and a neuropeptide are co-misexpressed,
the resultant novel LDCVs package PDF inside ectopic LDCVs, as shown by immunogold EM
(Hamanaka et al. 2010). Normally, photoreceptors package histamine inside SVs and do not
produce any LDCVs (Borycz et al. 2005; Hamanaka et al. 2010).
In addition to DIMM causing LDCV biogenesis when expressed ectopically, it also
appears to repress features required for classic histamine neurotramission in photoreceptors,
including T bar ribbons, sites for vesicle exocytosis, and capitate projections, sites for vesicle
endocytosis, as well the normal architecture of the terminal itself (Hamanaka et al. 2010).
Although classic neurotransmitters and neuropeptides coexist in most neurons, these results
suggest the possibility that DIMM effects an extreme peptidergic phenotype with a near
exclusive dedication of the cell to the accumulation and release of neuropeptides (Hamanaka et
al. 2010).
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Exploring DIMM’s mechanism of action
A precise interplay between cis-acting elements and trans-acting factors allows signaling
pathways to activate or repress the expression of specific genes and to maintain these
expression patterns in differentiated tissues (Carrera and Treisman 2008). In the eukaryotic
genome, RNA polymerase II transcribes most genes, which requires assembly of a pre-initiation
complex, consisting of general transcription factors (Carrera and Treisman 2008; Fuda et al.
2009). In addition to general transcription factors, there are many sequence specific
transcription factors that function in cell-specific and tissue-specific ways (Macquarrie et al.
2011). Such transcription factors enable Pol II to gain access to promoters and to initiate RNA
synthesis at transcription start sites (Fuda et al. 2009). This is accomplished by transcription
factor binding in a sequence-specific manner to cis-regulatory modules (enhancers, promoters)
found throughout the non-coding portions of the genome (Biggin and Tjian 2001; Levine and
Tjian 2003; Li et al. 2008).
There are several techniques for studying how transcription factors interact with the
genome (Southall and Brand 2007; Nègre et al. 2006; Sandmann et al. 2007). Chromatin
immunoprecipitation (ChIP) has become the technique of choice to investigate protein–DNA
interactions inside the cell (Collas 2009; Lee et al. 2006; Sandmann et al. 2007). During ChIP, a
protein of interest is selectively immunoprecipitated from a chromatin preparation to determine
the DNA sequences associated with it (Collas 2009; Gilmour and Lis 1984). ChIP was
developed independently by Gilmour and Lis to study the distribution of RNA Polymerase and
histones in bacteria and flies, and by Solomon and Varshavsky to study the binding of
Drosophila heat shock protein 70 to DNA (Gilmour and Lis 1984; Gilmour and Lis 1987;
Solomon et al. 1988). Since then, ChIP has been applied to sequence specific transcription
factors and other chromosome-associated proteins (Collas 2009).
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For ChIP, DNA and proteins are reversibly cross-linked with formaldehyde (which is heatreversible) to covalently attach proteins to target DNA sequences (Collas 2009). A specific
antibody is then used to immunoprecipitate the protein of interest (Nègre et al. 2006).
Formaldehyde crosslinks proteins and DNA molecules within 2 Angstroms of each other, and
thus is suitable for crosslinking proteins which directly bind DNA (Collas 2009; Toth and Biggin
2000). Traditionally, DNA sequences isolated by ChIP were quantified or identified by Southern
blotting or quantitative polymerase chain reaction (qPCR) (Mukhopadhyay et al. 2008; Toth and
Biggin 2000; Nègre et al. 2006).
In the past decade, ChIP has been coupled to microarray hybridization (ChIP-chip) and to
high-throughput sequencing (ChIP-Seq, Park 2009). This has enabled determination of the
precise, genome-wide distribution of transcription factor binding sites (Macquarrie et al. 2011).
These advances have allowed an unbiased detection of protein–DNA interactions without
having to “select” certain candidate binding and control regions for interrogation (Sandmann et
al. 2007).
Although individual genomic data sets are highly informative, integrating them together
with global profiles of transcription or protein interactions offers the exciting potential to answer
many long-standing questions such as how enhancers contribute to gene expression variation
(Hawkins et al. 2010). As with ChIP-chip, microarrays were also the first technology allowing
genome-wide quantification of gene expression (Watson et al. 1998; Epstein and Butow 2000).
High throughput sequencing has improved on microarrays with higher precision, dynamic range
and genome coverage, and lower background (Wang et al. 2009; Ozsolak and Milos 2011).
Transcriptomes produced by RNA-Seq or microarrays can be integrated with genomewide binding information from ChIP-chip or ChIP-Seq studies. Identifying the set of promoters or
enhancers where factor binding correlates with gene expression increases the probability that
the factor binding site is associated with adjacent gene expression (Ren et al. 2000; Simon et al.
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2001; Wyrick and Young 2002). Additionally, this integration helps resolve potential ambiguities
that occur in cases of intergenic ChIP binding in areas containing the promoters for two
divergently transcribed genes (Wyrick and Young 2002). Furthermore, the sets of promoters /
genes found within the intersection of ChIP-chip binding and expression datasets contains fewer
false positives due to a reduction in noise (Wyrick and Young 2002).
Work on this thesis started out with trying to understand the precise mechanism of DIMM
function. The most logical and technically feasible approach was to perform in vivo DIMM ChIP
in adult fly heads. Experimental success was confirmed by testing for DIMM occupancy at its
known enhancers in the first intron of PHM. Additionally, a set of genes whose expression was
upregulated upon DIMM misexpression in embryonic neurons and downregulated in DIMM lossof-function mutants was also tested for direct DIMM binding to putative enhancers. This gene list
was integrated with a list of genes known to be enriched in normal adult DIMM-expressing
neurons (Kula-Eversole et al. 2010). A portion of this work is presented in Chapter 2.
Upon demonstrating DIMM ChIP success, analysis was then extended to a genome-wide
level by in vivo ChIP-chip. This revealed a set of 156 binding peaks that revealed a rich
repertoire of 284 genes. ChIP-chip analysis provided new clues for how DIMM establishes and
maintains the secretory capacity of a NE cell. A way to enhance the ChIP-chip data further was
to obtain a gene expression profile of LEAP cells, which was not unknown. This was done by
purifying normal DIMM+ adult neurons and profiling their transcriptome by deep sequencing.
The two data sets were then intersected: genes enriched in DIMM+ cells compared to DIMMcells were integrated with genes adjacent to or overlapping with DIMM binding peaks.
The resulting data set of 116 genes likely increased the quality of the data set by
decreasing ambiguities behind intergenic binding and its assignment to peaks (Wyrick and
Young 2002). Finally, many of the genes from the intersected list were tested in a functional
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behavioral essay for DIMM-dependent sleep phenotypes, presented in Chapter 4. Due to the
multidisciplinary and diverse nature of analysis, the integrated DIMM transcription network likely
represents one of the first such networks revealed for a “master regulator” gene. This work is
presented in Chapter 3.
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ABSTRACT
In Drosophila the bHLH protein DIMM coordinates the molecular and cellular properties
of all major neuroendocrine cells, irrespective of the secretory peptides they produce. When
expressed by non-neuroendocrine neurons, DIMM confers the major properties of the
Regulated Secretory Pathway and converts such cells away from fast neurotransmission and
towards a neuroendocrine state. We first identified 134 transcripts upregulated by DIMM in
embryos, then evaluated them systematically using diverse assays (including embryo in situ
hybridization, in vivo ChIP, and cell-based transactivation assays). We conclude that of 11
strong candidates, six are strongly and directly controlled by DIMM in vivo. The six targets
include several large dense-core vesicle (LDCV) proteins, but also proteins in non-LDCV
compartments such as the RNA-associated protein MAELSTROM. In addition, a functional in
vivo assay, combining transgenic RNAi with MS-based peptidomics, revealed that three DIMM
targets are especially critical for its action: These include two well-established LDCV proteins,
the amidation enzyme PHM and the ascorbate-regenerating electron transporter Cytochromeb561-1. The third key DIMM target, CAT-4 (CG13248), has not previously been associated with
peptide neurosecretion – it encodes a putative cationic amino acid transporter, closely related to
the SLIMFAST Arginine transporter. Finally, we compared transcripts upregulated by DIMM with
those normally enriched in DIMM neurons of the adult brain and found an intersection of 18
DIMM-regulated genes, which included all six direct DIMM targets. The results provide a
rigorous molecular framework with which to describe the fundamental regulatory organization of
diverse neuroendocrine cells.
INTRODUCTION
Neuroendocrine (NE) cells embody highly dedicated secretory cell states. While different
NE cells express unique arrays of neuropeptide/ neurohormone-encoding genes, all peptidergic
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NE cells nevertheless share many critical cellular functions. These functions reflect a common
need for enzymes that conduct the post-translational processing of numerous neuropeptide
precursors, and a need for the structural and regulatory components that execute large densecore vesicle (LDCV) biogenesis, packaging, maturation and trafficking [1-2]. They also exhibit a
choreographed capacity to modify their cell properties in response to changing physiological
needs [3]. Many proteins are normally enriched in neuroendocrine tissues, and these may be
coordinately regulated under different physiological states [4-5]. Hence, NE programs of cell
differentiation must reflect the operations of complex regulatory circuits, the details of which are
only beginning to emerge. Examining the intracellular regulatory pathways that organize and
modulate these specialized properties is an important question for cell biology, and specifically
is also critical to understanding NE cell physiology.
Important clues to understanding peptidergic cell biology may come from parallel studies
of other neuronal secretory systems. Developmental programs of neurotransmitter expression
are governed by dedicated transcriptional organizers. For example, serotonergic neuron
differentiation (but not fate specification or survival) is substantially controlled by an ETS domain
transcription factor called PET-1 [6]. Likewise, dopaminergic (DA) neuron maturation is
promoted by the ETS transcription factor, AST-1, although it is not necessary for DA neuron
generation or survival [7]. To what extent therefore, do peptidergic secretory cells rely on similar
transcriptional regulatory controls?
In the Drosophila model system, the transcription factor DIMM operates in peptidergic
NE cells in many ways similar to PET-1 and AST-1 in aminergic cells. DIMM is specifically
expressed in peptidergic NE cells [8-12] – termed LEAP cells (Large, Episodically- Releasing,
Amidating Peptide producing [13]. Notably, DIMM acts like a master cell regulator for
professional secretory cell properties. It confers two cardinal features of the Regulated
Secretory Pathway (RSP) [14] onto neurons that otherwise do not display such properties [15].
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The first property is generation and accumulation of large dense core vesicles (LDCV), which
can house neuropeptides if these are available. Second it activates the complete posttranslational processing machinery, which is sufficient to produce biologically active peptides
from neuropeptide precursors. These cell biological observations raise important questions as to
how DIMM, a single transcription factor, can efficiently organize a complete and functional subcellular domain like the RSP. A large part of the answer must lie in the nature of the target
genes that DIMM activates, and this has motivated our current efforts.
We reasoned that direct targets provide the most compelling basis to describe DIMM
action mechanisms. Here we describe a genome-wide screen to define candidate targets for
DIMM regulation and found 11 genes rapidly up-regulated following DIMM over-expression in
the embryo. We then extended the analysis with several independent measures and concluded
that at least six of the 11 genes are authentic direct DIMM targets. Further, we show that three
of these six are essential to the promotion of neuroendocrine cell properties by DIMM. The novel
targets and the molecular details of DIMM transcriptional regulation provide a molecular
foundation to help define the development and physiology of NE cells.
RESULTS
Identification of candidate genes as putative direct DIMM targets. To amass
candidate DIMM targets in addition to Phm [12], we used genome-wide microarray profiling by
over-expressing DIMM throughout the embryonic nervous system. We compared profiles from
experimental (elav>dimm) and control (elav-GAL4) embryos at 22-26 hr and 28-32 hr after egg
laying (AEL). The design was intended to identify transcripts consistently up-regulated shortly
after the induction of DIMM, reasoning that the targets most likely to be directly affected by
DIMM would be the earliest changed. We focused on genes that were up-regulated at least 1.5
fold following DIMM over-expression, at both time points: this process identified 134 candidate
DIMM targets (Table S3). Many genes were also down-regulated (Table S4), but we did not
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study these further.
We used quantitative real time PCR to verify the authenticity of genes affected in the
embryo by DIMM-over-expression: by this method, 22 genes were confirmed to be up-regulated
at least 1.5-fold by DIMM overexpression and of these, 18 genes up-regulated at least 2-fold
(Table S5). Many of the 134 candidates were not tested based on low expression levels, or
were tested but not detected by qPCR at this stage, or had primer sets that failed quality control
tests. Finally, we focused on the 18 most highly-elevated transcripts and reasoned that if these
18 genes were true DIMM targets, they would be expressed in the central nervous system
(CNS), and their RNA levels would decline in a dimm loss-of-function mutant. Using
conventional PCR, we found that transcripts of all 18 genes were in fact expressed in CNS
(Table S5). In addition, in 1st instar larvae of severe dimm hypomorphs (Rev4/Rev8: [8]),
transcript levels for 11 of the 18 genes were significantly decreased. We therefore focused on
these 11 genes: their identities, and GO terms, are listed in Table S6.
Consistent with previous findings, Phm is included in the 11-gene list, providing critical
internal validation to the profiling method just described. In addition, CG1275 is notable because
it encodes a cytochrome (Cyt) trans-membrane electron transporter most related to the b561-1
protein [16]. The Cyt-b561-1 is a specific to dense-core secretory vesicles that contain
catecholamines or amidated peptides, as are found in chromaffin cells and elsewhere. Cyt-b561-1
regenerates ascorbate which is an essential co-factor to support the biosynthetic functions of
peptidylglycine-a-hydroxylating monooxygenase (PHM) [17-18] from within the vesicles. The
remaining nine candidates were not as readily associated with participation in the peptidergic
secretory pathway; however, we have also evaluated them experimentally and discuss that work
below.
Evaluating the 11 candidate DIMM targets. We performed three independent
experiments to evaluate the degree to which the 11 candidate targets are strongly regulated by
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DIMM, and devised a functional screen to determine the potential contributions of the
candidates to DIMM action mechanisms. Figure 1 presents an overview of the work plan. As
summarized in Table 1 and argued in the Discussion, these experiments suggest the 11 targets
are divisible into a “strongly-regulated” set of six genes (direct regulation), two additional ones
that may be directly-targeted, and another set of three likely indirect targets.
Experiment I. Embryonic RNA in situ hybridization. We first analyzed transcript distributions
for each of the 11 candidates in embryos of diverse stages, and of two different genotypes
(control and elav>dimm – see Methods for precise genotypes). Representative specimens are
shown in Figure 2; control specimens are on the left and dimm over-expression specimens are
on the right of each column. By Stage 16-17 in control embryos, we observed a clear cellspecific pattern of dimm transcripts in the CNS ([8]; Figure 2A). Up-regulation of dimm by
elavGAL4 produced the expected pan-neuronal activation of dimm transcripts (Figure 2A’).
Transcripts for the only previously known direct DIMM target, Phm, display a moderate level of
expression in control embryonic tissues (Figure 2B) and clear up-regulation with DIMM overexpression (Figure 2B’), although the up-regulation was not as pronounced as the one shown by
dimm transcripts.
Seven other candidates (CG1275, CG13248, mael (CG11254), CG17293, CG7785,
CG32850 and CG6522) displayed weak-to-moderate expression levels in control embryos
(Figure 2C-H). In the case of CG6522, transcripts were moderately to broadly expressed in
normal tissues, and were modestly increased with dimm over-expression (data not shown).
None of these candidate targets displayed a normal expression pattern exactly matching that of
dimm. CG13248 (Figure 2D) and CG32850 (Figure 2H) were broadly expressed with very
prominent accumulation in paired mid-line cells of the ventral nerve cord. In the cases of Phm
and CG13248, those patterns were present early (~Stage 13) but resolved to stronger staining
in lateral CNS regions later in embryogenesis that resembled that of dimm (Figure S1). mael
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(CG112545) transcripts were not clearly detected in normal CNS (Figure 2E) although we
clearly observed mael in normal germ cells (cf. [19]). CG17293 was weakly expressed
throughout the CNS (Figure 2F), and CG7785 moderately expressed (Figure 2G).
DIMM over-expression resulted in heightened target RNA accumulation for seven of the 11
candidate targets. The dimm-stimulated transcript patterns varied, but did show some
similarities: most prominently, many patterns included heavy accumulation in the paired midline
cells (Figures 2B’, C’, D’, E’, G’ and H’). Such mid-line cells do not normally express high levels
of dimm (Figure 2A). Transcripts for the three other candidate targets (CG14621, CG31346, and
pastrel (CG8588) were not detectable in control CNS (although some were evident in nonneuronal tissues). Likewise, we could not detect them following dimm over-expression (data not
shown).
In summary, seven of the 11 candidate genes are regulated by DIMM according to
embryonic stage in situ hybridization experiments – Phm, Cyt-b561-1, CG13248, mael, CG17293,
CG7785, and CG32850.
Experiment II. In vitro trans-activation assay: Our second test for strength of regulation
measured DIMM’s ability to trans-activate regulatory fragments of the candidate gene targets
using Luciferase levels as a readout. We generated test constructs containing the luciferase
reporter downstream of a mini-SV promoter and the putative DIMM-binding locus of the gene.
Putative DIMM binding sites were selected by the presence and locations of specific E-box
sequences (CATATG or CAGCTG) based on our previous analysis [12]: therefore, we focused
especially on E-boxes within the first intron. Most candidate genes contained either CATATG or
CAGCTG E-box sequences throughout the gene locus (Figure S2). In addition, we also
combined the data from ChIP analysis (see below). Although our earlier work on DIMM
regulation of Phm utilized mammalian hEK-293 cells [12], we wished to approximate a more
homologous cellular context, and so tested a Drosophila neuronal cell line, BG3-c2 [20]. First,
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we confirmed that the positive control (Phm-sv-Luc) displayed the expected responsiveness
(~10 fold induction) when dimm is co-transfected, but not when a mutant dimm isoform was cotransfected, all such results consistent with our previous observations [12]. Next, we measured
dimm-responsiveness for each of the candidate genes. We found that in addition to Phm, five
candidate DIMM targets (CG1275, CG13248, mael, CG17293, and CG6522) all displayed
significant transactivation responses to DIMM (Figure 3).
To evaluate DIMM transactivation in more detail, we constructed a series of sequence
variants of the CG13248 responsive fragment – the ~1 kB fragment that comprises the 1st
intron and which contain three E boxes. We mutated three of the six consensus bases of the E
boxes: we tested each mutated E box in single, double and triple format: the positions of the E
boxes and the results obtained are shown in Figure 3B. Once again, the wild type CG13248
sequence produced an activity level comparable to that of Phm. Of the three single E box
mutations, only E3 proved necessary for full DIMM transactivation. Furthermore, all mutant
combinations containing the E3 mutation were not at all transactivated. Finally, the E1/E2
double mutant showed a diminished level of transactivation. In summary, the evidence points to
the involvement of multiple E boxes in the transactivation of CG13248, with the E3 sequence
playing the largest role.
Experiment III. In vivo Chromatin immunopreciptation (ChIP). To determine the potential
occupancy by DIMM at candidate target gene binding sites in vivo, we used an epitope-tagged
dimm transgene and ChIP methods. The transgene - UAS-dimm-MYC (II) - was selectively
expressed in dimm-containing neurons by using the c929-GAL4 driver. Furthermore, we
restricted GAL4: UAS activities to adult stages using temperature-sensitive GAL80 (tub-gal80ts)
to avoid the lethality that results from dimm over-expression at earlier stages (T Hadzic,
unpublished). After raising the flies at the restrictive temperature (18oC), 1-3 day old adults were
transferred to 29oC for a three-day period to permit expression of DIMM-MYC protein. We
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confirmed DIMM-MYC expression under these conditions by Western blot analysis of fly head
extracts, and an absence of such without transfer to 29oC (data not shown).
In a previous report, we demonstrated that DIMM activates Phm directly via three
palindromic E-boxes located in the Phm 1st intron (having sequences – CATATG and CAGCTG)
[12]. Therefore, as a positive control, we asked whether DIMM is resident at this Phm intron and
took a comparative approach by testing each of two sites in the Phm gene locus for DIMM
occupancy – the E-box-containing test site within the 1st intron, and a control site located about
6 kb upstream (See Figure S2; control sites listed in Table S2). Across two biological replicates,
DIMM-MYC CHIP’ed samples for the Phm gene showed a strong (~32 fold) average enrichment
over samples from the negative control genotype (c929-GAL4; tub-gal80ts). This difference was
significantly different (p < 0.05) from the average enrichment found at its negative control site.
We then asked whether DIMM is resident at the other target genes in vivo and selected test
sites based on inclusion of potential DIMM-binding E-boxes in the immediate 5’ upstream or 1st
intronic regions. Two of these candidates displayed a statistically higher level of enrichment
compared to controls – CG1275 and CG6522. For seven other genes - CG13248, CG11254
(mael), CG17293, CG7785, CG32850, CG14621 and CG31436 - we observed a trend for DIMM
enrichment at the E-box containing site (Figure 4; Table 1). However, these seven other
examples did not achieve statistical significance.
In summary, ChIP analysis suggests that DIMM protein is normally resident in adult
head DIMM cells in vivo in the regulatory DNA of at least three (Phm, CG1275, CG6522) and
likely as many as ten, of the 11 candidate targets. Furthermore, through all three independent
tests of validation, ten of 11 candidate target genes subsequently scored positive in at least one
independent assay for direct DIMM regulation (Summarized in Table 1). Five genes were
responsive in all three (Phm, CG1275, CG13248, mael, and CG17239) and two others, CG7785
and CG6522, were responsive in two of the assays. CG32850, CG14621, CG31436 all showed
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DIMM residency in vivo by ChIP, but of these three candidates, only CG32850 also displayed
mRNA induction by DIMM in embryos. Only the eleventh candidate, pst, failed to show
significant responsiveness in any test.
Experiment IV. Adult in vivo RNAi and LC-MS. To determine if DIMM target genes
contribute to its action mechanisms, we devised a functional screen to extend our analyses of
gene regulation. We previously demonstrated that ectopic expression of DIMM in photoreceptor
neurons confers peptidergic neuroendocrine properties onto them – photoreceptor neurons do
not normally display such properties of the Regulated Secretory Pathway. When such cells are
also forced to express a heterologous neuropeptide precursor (ppMII), the MII peptide is fully
processed [15]. We therefore used the DIMM-dependent accumulation of processed MII peptide
as an end-point assay to measure potential contributions of single candidate targets to the
DIMM-generated secretory pathway. We used transgenic RNAi methods to knock down
individual DIMM targets exclusively within photoreceptor cells and employed quantitative mass
spectrometry to analyze the processing of MII. In the control condition (GMR> UAS-dimm, UASppMII), fully-processed MII peptide is detected at 1710.69 m/z ratio [15]. To normalize the
results of MII peptide accumulation across conditions, we also measured an endogenous
Drosophila brain peptide, not found in photoreceptors, as an internal standard. For this, we
chose the Drm-MT2 peptide derived from the HUGIN neuropeptide precursor (SVPFKPRLamid
e, m/z 942.59: [21], because hugin-expressing neurons do not express the RNAi transgene in
this experimental design. We predicted that levels of MT2 peptide should not change as a
function of condition. An additional negative control in this design tested the effect of an RNAi
transgene for a neuropeptide precursor never found in photoreceptors – ecdysis triggering
hormone (eth); eth is normally expressed in the endocrine Inka glands, which are cells that
normally express DIMM [8].
We used both labeling and label-free quantitative mass spectrometry approaches to
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analyze MII and MT2 peptide levels in Drosophila head extracts using CapLC-MALDI-TOF/TOF
MS. The MS-based labeling method is well validated [22-23] but involves multiple, samplehandling steps and is less effective for samples with low concentrations and small volumes.
While we were able to quantify MT2 with the labeling approach (Figure S3), MII was not
observed after labeling. We therefore turned to label-free quantitation because isolated peak
heights can be directly compared across conditions for the following reasons: the instrument
parameters are kept constant, the chemical environment of the peptide of interest is similar, and
the total ion acquisition is equivalent for each measurement.
Using the label-free quantitation, MT2 levels showed equal intensities in the control
(GMR>dimm;>ppMII) and experimental (GMR>dimm; >ppMII; Phm-RNAi) samples (Figure 5A),
consistent with labeling results (Figure S3) and supporting its use as an internal standard. MII
levels in the experimental sample (GMR>dimm, >ppMII; > Phm-RNAi) were significantly
decreased from those in the control sample (GMR>dimm; >ppMII) (Figure 5B). After
normalization to MT2, relative MII levels were quantified and we then determined if its
production was significantly affected by the RNAi mediated knockdown of ten of the 11
candidate targets. As shown in Figure 5C, MII levels were significantly lower following RNA
interference knockdown of Phm, CG1275 and CG13248 (Figure 5C). CG17293 RNAi displayed
less fully-processed peptide and CG11254 (mael) RNAi showed a trend of up-regulation, but
their final values did not exceed statistical significance. MII levels in the other six RNAi tests
were very similar to control values.
In summary, three of ten candidate DIMM targets (Phm, CG1275 and CG13248) make
critical contributions to DIMM mechanisms, as tested in vivo under conditions in which the
peptide secretory pathway is completely organized by DIMM. Two candidates (Phm and
CG1275) are clearly involved in processing, while CG13248 may as well be involved in overall
organization of the secretory pathway (see Discussion). The functional assay we employed was
56

Chapter 2.

	
  
sensitive to disturbances of processing, but that is not the only interpretation for a reduction in
the level of the secretory peptide. A reduced level could also result from an inability to
accumulate, properly traffic or retain secretory peptides. We did not detect a build up of
intermediates with CG13248 RNAi and this likely indicates a defect at a stage different from
processing.
The CG13248 protein is enriched in DIMM-neurons and dependent on dimm.
CG13248 encodes a putative cationic amino acid transporter, orthologous to mammalian
cationic amino acid transporter 4 (CAT-4; SLC7a4), and closely related to Drosophila slimfast
(CAT-1). CG13248 protein has not previously been associated with NE cells and so to confirm
this prediction, we analyzed its normal expression (anti-CAT-4). We detected immunoreactivity
(IR) for CAT-4 in both the adult brain in the 3rd instar larval brain and evaluated CAT-4-like IR in
the context of DIMM expression.
First, we performed double immunostaining with dimm neurons labeled by anti-GFP (in
c929-GAL4>GFP brains). In both developmental stages, CAT-4-like IR is heavily enriched in
DIMM-positive neurons; Figure 6A shows an example of an adult brain. We also noted
minorities of DIMM-only and CAT-4-only stained neurons. CAT-4-like IR was found mainly in cell
bodies and terminals (not shown), and very little within axonal tracts. CAT-4-like IR was specific
in that it was greatly reduced by the action of a CG13248 RNAi transgenic construct: when
driven by 386y-GAL4 CAT-4-like IR was lost, while DIMM-like-IR was unaffected (Figure 6C and
C’). 386y-GAL4 is an insertion in the prohomone convertase gene dPC2 and its drives
expression in most or all of dimm neurons, as well as in other cells [24].
We next asked whether CAT-4 expression is dependent on DIMM in loss-of-function and
gain-of-function dimm states. We generated UAS-dimm RNAi flies, confirmed the ability of these
transgenes to produce a large-scale reduction of DIMM-like IR (Figure 6D and D’) and observed
a concomitant reduction of CAT-4-like IR (Figure 6D-E). This result indicates that high level
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CAT-4 expression in dimm-positive neurons depends on DIMM. To test the effects of DIMM
over-expression, we turned to the four-cell Tv cluster of the larval CNS. CAT-4-like IR is
normally found in the two of the four Tv cluster neurons – the peptidergic Tv and Tvb, but not in
the Tva or Tvc neurons (Figure 6E, cf., [25]). We used an ap-GAL4 driver to misexpress DIMM
in all four Tv cells and observed ectopic CAT-4-like expression within the Tva and Tvc cells as
well (Figure 6F). These results confirm that in vivo CAT-4 is specifically enriched in DIMMpositive cells and that it is regulated by dimm. The distribution of CAT-4-like immunoreactivity
within DIMM neurons was studied in various identified peptidergic neurons of the adult brain
(Figure S4), including in diverse neurons of the Pars Intercerebralis, HUG-positive neurons of
the sub-esophageal neuromeres, and PDF-positive large LNv. In these neurons, CAT-4-like IR
was strongly expressed by many DIMM neurons and weakly by others. It appeared principally
cytoplasmic, and displayed heterogeneous accumulations.
A computational analysis afforded by prior transcript profiling of mature DIMM
neurons. A recent microarray analysis of identified neurons from the adult Drosophila brain
provided a fortuitous means to independently assess the authenticity of the original 134-gene
list [26]. Importantly it was conducted on wild type brains containing normal DIMM levels, and so
it serves as a useful counterpoint to our study of DIMM over-expression. Kula-Eversole et al.
[26] profiled three types of neurons – the large lateral neuron ventral (l-LNv) and the small
lateral neuron ventral (s-LNv). These two identified neuron groups are similar in that both are
circadian pacemakers and both are neuropeptide PDF-expressing cells [27]. However they are
different in that only the large LNv are DIMM-positive, while the small-LNv are not ([24]; Figure 7,
and see [13]). Kula-Eversole et al. [26] compared l-LNv and s-LNv with a generic (ELAVpositive) brain neuron type for ~19,000 transcripts. Using that primary data set, we identified
579 genes enriched in large over small LNv. By comparing our 134-gene list derived from DIMM
over-expression in embryonic stages to those ~579 transcripts normally enriched in DIMM58
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positive cells from adult stages, we find an intersection of 18 putative DIMM direct target genes
specifically enriched in adult l-LNv versus s-LNv (Figure 7; Table S3). Significantly, the six
DIMM targets we identified by experimental analysis are all included in this intersection – Phm,
CAT-4, mael, CG17293, CG7785, and Cyt-b561-1.
DISCUSSION
The experiments reported here address the mechanisms underlying DIMM’s regulatory
functions within peptidergic neuroendocrine cells in Drosophila. The results from a genome-wide
screening revealed a diverse array of potential DIMM targets and illustrated that the scope of
DIMM actions is likely broad. The actions of its direct targets appear to extend from the nucleus
(CG17293) to regulation of mRNAs (CG11254) to the ER and Golgi (CG13248) to peptidecontaining LDCVs (Phm and CG1254). We found no neuropeptide–encoding genes on any of
our lists, even the larger 134-gene list of transcripts exhibiting up-regulation with DIMM overexpression. We showed previously that DIMM is very inefficient by itself at driving ectopic
neuropeptide gene expression [8-10]. Together these findings are consistent with our previous
speculation that in Drosophila, specific neuropeptide expression is controlled by differing sets of
transcription factors working within complex combinatorial codes [9, 13]. In contrast, DIMM
provides parallel instructions for the cell biological machinery within which neuropeptides can be
made, stored and trafficked [9, 13, 15].
Because we used an over-expression screen to generate a primary list of candidate
targets, it was important to authenticate those results by reference to genes enriched in “normal”
DIMM cells (i.e., cells in which DIMM levels were not artificially manipulated). We were fortunate
to have access such information from the recently published Gene array study of Kula-Eversole
et al. [26], from which we found that 13% of the 134 gene candidates were in fact highlyenriched in DIMM-positive neurons (versus DIMM-negative peptidergic neurons). While several
candidates performed well in many of these tests and exhibit properties of direct DIMM targets,
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most did not score positive in all tests employed (only Phm, CG1275, CG13248, CG11254 and
CG17293 did). The results emphasize the importance of employing multiple tests to fully
evaluate and properly interpret lists of regulated transcripts. Of the 11 genes passing the first
test, we then used diverse experimental criteria to divide them into sets of six direct targets, two
likely-direct targets, and three indirect targets (Table 1). We emphasize that our categorization
of direct targets is based on highly stringent criteria and here discuss the significance of the
findings for neuroendocrine cell biology.
Phm, Cyt-b561-1 and CG13248 are key and direct DIMM mediators. The inclusion of
Phm and Cyt-b561-1 genes in the original list of 11 candidates increased our confidence in the
list’s authenticity because both play well-established roles in LDCVs [18]. Furthermore, we had
previously demonstrated that Phm is a true transcriptional DIMM target both in heterologous
cells and in vivo [12]. Likewise the subsequent strong performance of Phm and Cyt-b561-1 in all
four downstream assays provided further support for the validity of the experimental design to
identify authentic DIMM targets.
CG13248 is a direct DIMM target and encodes a putative arginine transporter,
CAT-4. In addition to Phm and Cyt-b561-1, these studies show that a third bona fide DIMM target
gene, CG13248 is critical to normal regulation of neuroendocrine cell properties. Notably, in
results described by Kula-Eversole et al. [26], Phm, Cyt-b561-1 and CG13248 all ranked near the
top for absolute transcript abundance in DIMM-positive neurons. The identification of CG13248
as an integral component of neuroendocrine physiology is a significant new finding, but its
specific contribution is a mystery because its precise molecular functions are not known. It is the
clear sequence orthologue to mammalian cationic amino acid transporter 4 (CAT-4) and is
therefore a candidate member of the system y+ (Na+ and pH-independent) cationic amino acidpreferring transport activities [28].
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CAT proteins form a branch of the solute carrier family 7 (SLC7) [29]. Murine CAT-1, -2
and -3 all display arginine transporter activity when heterologously expressed, but to date, CAT4 does not [30]. Notably, the Drosophila orthologue of the CAT-1 protein is the transporter
SLIMFAST, which mediates arginine transport in fat body, couples to the mTOR pathway and
helps that tissue function as a nutrient sensor that restricts global growth through a humoral
mechanism [31]. In murine pancreatic acinar cells (which are regulated by the DIMM orthologue
MIST1, [32], CAT-4 is a membrane-associated protein of secretory granules [33]. Future pursuit
of the exact mechanisms and pathways in which CAT-4 operates in DIMM-expressing neurons
will help illuminate fundamental neuroendocrine cell physiology.
Additional direct DIMM targets. Regarding the other direct DIMM targets, we make
special mention of a few for potential novel insights into mechanisms of neuroendocrine cell
regulation. CG11254 (mael): By transcript profiling, Kula-Eversole et al. [26] report that mael is
highly enriched in the DIMM-positive l-LNv’s. It was originally characterized in nuclei and
perinuclear particles of germ cells. MAEL helps localize components of the microRNA pathway
and contributes to cellular polarization [19]. CG17293 encodes a protein highly related to
mammalian WDR82, and CG7785 encodes a protein highly related to CCLD6 – both of which
suggest a connection of DIMM mechanisms to chromatin-modifying properties [34].
There were two genes we concluded likely to be directly targeted (Table 1: “Maybe
Direct”) - CG6522 encodes a member of the Testin/ Prickle family of proteins. Notably, the
Prickle-like protein RILP interacts with REST and acts as a nuclear translocation factor [35]. The
significance of potential Prickle-REST interactions is that REST displays a suppressive effect on
neurosecretory properties of PC12 cells [e.g., 36]. In addition, CG32850 encodes a protein
orthologous to Ring Finger protein 11, which is a membrane-associated E3 ligase that is
expressed widely in brain [37]. Finally, in the larger list of 18 genes representing the intersection
of the embryonic and adult DIMM-regulated transcripts (Figure 1), there was sizable
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representation of genes encoding proteins previously implicated in regulated neuropeptide
secretion (Rph) and probable elements of the secretory pathway (PPADC1, RCN2 and Rabx4).
DIMM directs a core program for neuroendocrine cells. These results define
principal elements of what we anticipate will be a core program for neuroendocrine cell
organization. Among mammalian bHLH proteins, DIMM is most similar to MIST1 [32]. Mills and
colleagues have identified several candidate MIST1 targets, including RAB3D [38]. We note that
five of the six DIMM targets that responded to DIMM in the trans-activation assay contained E
boxes in their first exon-intron regions. The importance of 1st intron E boxes was already
established for the case of Phm [12] and is also true for MIST1 target genes so far identified [38].
Furthermore, studies of Phm and CG13248 suggest they can define a consensus DIMM binding
profile: they both contain three boxes within the first intron, two of which have the sequence
CATATG, all of which contribute synergistically, and one of which appears to have the strongest
contribution to DIMM transactivation. We predict many other DIMM targets will display a similar
E box profile. Furthermore, how individual target gene products contribute to the DIMM program,
and how many more genes are involved, are now pertinent questions that will require additional
studies. We anticipate that further analysis of this core DIMM program will help explain the
regulatory organization of neuroendocrine cells and their evolution in different phyla. Because
DIMM protein persists for the life of neuroendocrine cells in Drosophila, this work may also
inform studies of neuroendocrine cell physiology and plasticity.
Developmental Generation of Peptidergic Phenotypes. In the case of neurons that
utilize fast conventional neurotransmitters, transcriptional regulatory systems typically exert
direct control over genes that encode biosynthetic enzymes, as well as ones for key transporter
proteins that retrieve and recycle transmitters back into the lumen of synaptic vesicles [39]. For
example, PET-1 supports serotonergic differentiation and directly targets genes that encode the
critical biosynthetic enzyme TBH-1 and the serotonin transporter SERT1 [6]. It is striking
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therefore that our limited but highly validated list of DIMM targets similarly includes genes
essential for neuropeptide biosynthesis (Phm and Cyt-b561-1) as well as a transporter that is
specifically expressed by neuroendocrine cells (CAT-4). We propose that there may exist an
unexpected but essential parallelism in the developmental regulation of secretory systems for
small transmitters and for small amidated peptides. This hypothesis can help design
experiments to further illuminate the mechanisms that underlie the developmental generation of
peptidergic phenotypes.
EXPERIMENTAL PROCEDURES
Fly stocks. Details of the fly lines used are provided in Supplemental
Information.
Microarray analysis and quantitative real-time PCR. We combined UASdimm-myc (II) with elav-GAL4; for microarray analysis, these were compared to elav-GAL4.
Crosses were maintained 18oC to minimize lethality. Details of the RNA preparation [40] and
qPCR analysis are provided in Supplemental Information. All primer sets are listed in Table S1.
All microarray data are publically available (GEO accession # GSE31113).
Whole mount in situ hybridizations. We followed general methods previously
described [41]; details are provided in Supplemental Information.
Transactivation. Assays followed the general methods previously described [12];
details are provided in Supplemental Information.
Immunocytochemistry and Imaging. We generated antibodies and used
immunostaining methods as previously described [8]; details are provided in Supplemental
Information.
Chromatin Immunoprecipitation (ChIP). ChIP was performed as described by Menet
et al. [42]. w1118; c929-GAL4;tub-GAL80ts females were crossed to y1w1; UAS-dimm-myc (II)
males at 18oC. Further details are available in Supplemental Information.
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Real-time quantitative PCR (qPCR) following ChIP. The PCR mixture contained
Platinum Taq polymerase (Invitrogen) and optimized concentrations of Sybr-Green (Invitrogen).
The sequences of primers used are listed in Table S2; further details are available in
Supplemental Information.
Quantitative mass spectrometry. Fly heads of the control (GMR>UAS-ppMII; UASdimm) and experimental (GMR>UAS-ppMII; UAS-dimm; UAS-RNAi) transgenic lines were
collected in frozen state. MS-based quantitation was based on prior quantitative measurement
approaches [22-23, 43]. Further technical details are provided in Supplemental Information.
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Figure 1. A schematic overview of the workplan for this study. A genome wide search for
dimm targets performed by Genechip, then evaluated by three downstream analyses of DIMM
regulation, and further evaluated by a functional in vivo assay.
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Figure 2. RNA in situ hybridization in control embryos and embryos that over-express
dimm. Left - control (w1118); Right - elav> dimm; Probes: A, B) dimm; C,D) Phm; E,F) CG13248;
G,H) CG11254 (mael); I,J) CG17293; K,L) CG6522. See also Figure S1.
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Figure 3. Trans-activation by DIMM of genomic fragments of candidate genes in
Drosophila BG3-c2 neuronal cell lines. Fold ratios represent Luciferase levels with dimm cotransfection divided by those without. Histograms represents means and SEMs of at least three
independent replicate assays. (A). Results of testing ten DIMM targets. (B) Results from
analysis of E box sequence requirements within the CG13248 regulatory region. E1, E2 and E3
indicate three separate E boxes, which were mutated singly, doubly or in triple-format. In (A), *
p<0.05; ** p< 0.01 vs empty vector, by student’s T-test. In (B), * p< 0.01 vs CG13248 WT
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sequence, by student’s T-test. See also Figure S3 which illustrates E box positions in and
around these candidate targets.
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Figure 4. ChIP analysis in vivo of putative DIMM binding at E-boxes within dimmdependent candidates genes. Darker histograms show the level of enrichment of the putative
DIMM binding sites defined by the value in experimental versus control genotypes (see
Methods). Lighter histograms show the level of enrichment of arbitrarily chosen sites ~6 kB
upstream of the putative DIMM-binding sites, in the same experimental versus control
genotypes. Histograms represents average and SEMs at least two independent assays (two
biological replicates).
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Figure 5. MS-based label-free quantitative analysis of alterations in MII peptide
accumulation in photoreceptors following RNA interference of candidate DIMM targets.
(A)

Mass spectra of MII in the control (GMR>UAS-ppMII; UAS-dimm, red) and

experimental (GMR>UAS-ppMII; UAS-dimm; UAS-PHM-RNAi, blue) samples. The intensity
ratio of MII in experimental versus control samples in these spectra is 0.54. B) Mass
spectra of MT2 in the control and experimental samples. The intensity ratio of MT2 in
experimental to control in these spectra is 1.02. C) Exogenous MII level in the experimental
samples with RNAi compared to that in the control samples. Histograms represents means
and SEMs, * p<0.05; vs control (GMR>UAS-dimm), by student’s T-test. N, biological
replicates. See also Figure S3 for analysis of MS-based quantitation of the endogenous
peptide Drm-MT2.
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Figure 6. Enrichment of CG13248 (CAT-4) in DIMM neurons and its regulation by dimm in
vivo.
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A) DIMM-like and CAT-4-like IR are extensively co-localized in the adult brain. c929>UAS-GFP
(anti-GFP, green), anti-CAT-4 (red); bottom: merged image. B-D) CAT-4-like IR following RNAi
knock-down of dimm. B, B’) parental control (386Y-GAL4); C, C’) 386Y>UAS-DCR2/UAS-CAT4-RNAi; D, D’) 386Y>DCR2/ dimm-RNAi; (B-D) anti-DIMM (green), (B’-D’) anti-CAT-4 (red). (EF) CAT-4-like IR is normally present in the two DIMM-positive neurons of the four-cell Tv-cluster;
following DIMM mis-expression throughout the cluster, CAT-4 appears in all four cells. E) ap>
GFP, anti-GFP (green), anti-CAT-4 (red), F) ap> dimm, anti-MYC (=DIMM) (green); anti-CAT-4
(red). See also Figure S4 for high power images of cDAT-4-like immunoreactivity in different
adult brain DIMM neurons.
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Figure 7. Comparison of transcripts upregulated by DIMM in embryos with transcripts
enriched in DIMM-positive peptidergic neurons of the adult brain. Top: A Venn diagram
illustrating the identification of 18 genes (13% of 134) of those up-regulated by DIMM overexpression among the 537 normally enriched in DIMM-positive large LNv [29]. Bottom lists the
18-gene intersection, asterisks mark those genes that were shown to be direct DIMM targets by
current experiments.
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Table 1. Summary of Results to Determine the Validity of Eleven Candidate Direct DIMM
Genes
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SUPPLEMENTARY INFORMATION

Figure S1. Similar spatial distribution of RNAs for dimm, Phm and CG13248 in late stage
control embryos. These data support the spatial analysis of DIMM target RNAs illustrated
in Figure 2.
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Figure S2. The distribution of CATATG and CAGCTG E-boxes within and around the
candidate gene loci.
The schematic cartoon shows the putative DIMM binding sites within eleven candidate genes.
Each box represents an E-box, CANNTG; Two nucleotides on the top of box indicate the
sequence of NN. This information supports the study of DIMM trans-activation illustrated in
Figure 3.
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Figure S3. MS-based quantitation results from endogenous peptide Drm-MT2.
MALDI-TOF/TOF mass spectrum of labeled MT2 with light form of succinic anhydride in the
control (GMR>UAS-ppMII; UAS-dimm) and with heavy form of succinic anhydride in the
experimental (GMR>UAS-ppMII; UAS-dimm; UAS-Phm-RNAi) samples. The relative intensity
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ratio of MII in experimental versus control genotypes is 0.95. This data supports the analysis
illustrated in Figure 5.
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Figure S4. DIMM-positive adult brain neurons double stained for c929-GAL4 (green) and dCAT4-like immunoreactivity (red). Note that the latter is primarily cytoplasmic and within individual
cell bodies, appears heterogeneous (spotty). These images support the data presented in
Figure 6.
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Table S1. Information on primers used for analysis of cDNAs identified by genome-wide
microarray screen of embryos following DIMM-over-expression. Please see attached / uploaded
Microsoft Excel spreadsheet file.

Table S2. Information on primers used for ChIP analysis. Please see attached / uploaded
Microsoft Excel spreadsheet file.

Table S3. Probes for 134 genes enriched > 1.5 fold change in DIMM overexpressing samples
(ED34-E34) & (ED12-E12) over controls. Ordered from most to least enriched (average fold
change, both developmental time points). The meaning of limma - calculated parameters is
explained in the spreadsheet. Please see attached / uploaded Microsoft Excel spreadsheet file.
Excel file also available from: http://www.sciencedirect.com/science/MiamiMultiMediaURL/1s2.0-S0960982211008906/1-s2.0-S0960982211008906mmc2.xls/272099/html/S0960982211008906/7502adb188d50fc94acf32597de56d44/mmc2.xls

Table S4. Probes for 23 genes down-regulated < 0.5 fold in DIMM over expressing embryos
(ED34-E34) & (ED12-E12) over controls. Ordered from most to least down-regulated (average
fold change, both developmental time points). The meaning of limma calculated parameters is
explained in the spreadsheet. Please see attached / uploaded Microsoft Excel spreadsheet file.
Excel file also available from: http://www.sciencedirect.com/science/MiamiMultiMediaURL/1s2.0-S0960982211008906/1-s2.0-S0960982211008906mmc2.xls/272099/html/S0960982211008906/7502adb188d50fc94acf32597de56d44/mmc2.xls
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Table S5. qRT-PCR analysis of the 135 genes up-regulated by dimm over-expression in the
embryonic CNS. 53 genes were tested and 18 showed greater than 2-fold levels following DIMM
over-expression. The 11 genes selected for further study are marked in yellow. NT – not tested;
ND – not detected. Please see attached / uploaded Microsoft Excel spreadsheet file.

Table S6. The eleven candidate DIMM-regulated genes – identification, mammalian orthologues
and GO annotations. Please see attached / uploaded Microsoft Excel spreadsheet file.

Table S7. Probes for 535 genes enriched > 1.5 fold change and satisfying a 5% False
Discovery Rate in large LNvs versus small LNvs. Ordered from most to least enriched (average
fold change). The meaning of limma-calculated parameters is explained in the spreadsheet.
Please see attached / uploaded Microsoft Excel spreadsheet file. Excel file also available from:
http://www.sciencedirect.com/science/MiamiMultiMediaURL/1-s2.0-S0960982211008906/1s2.0-S0960982211008906mmc2.xls/272099/html/S0960982211008906/7502adb188d50fc94acf32597de56d44/mmc2.xls

Table S8. Probes for 537 genes enriched > 1.5 fold change and satisfying a 5% False
Discovery Rate in small LNvs versus large LNvs. Ordered from most to least enriched (average
fold change). The meaning of limma-calculated parameters is explained in the spreadsheet.
Please see attached / uploaded Microsoft Excel spreadsheet file. Excel file also available from:
http://www.sciencedirect.com/science/MiamiMultiMediaURL/1-s2.0-S0960982211008906/1s2.0-S0960982211008906mmc2.xls/272099/html/S0960982211008906/7502adb188d50fc94acf32597de56d44/mmc2.xls
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SUPPLEMENTARY EXPERIMENTAL PROCEDURES
Fly stocks. The following fly lines were used: dimm deletion mutant alleles (Rev4 and
Rev8); UAS-dimm-myc (II or III) [1]; UAS-ppMII [2], UAS-2X EGFP and the pan-neuronal driver,
elav-GAL4 (III), GMR-GAL4 (II). For quantitative mass spectrometry, we used UAS-RNAi
transgenic lines obtained from the Vienna RNAi stock center (VDRC) to knockdown target
genes (See Supplemental Information), combined with UAS-DCR2 (obtained from Stefan Thor,
Linkoping Univ., Sweden). The following strains were used for quantitative mass spectrometry:
w, UAS-DCR2;pGMR-GAL4 (II); UAS-ppMII (III)
w; UAS-dimm-myc (II or III);UAS- dsRNAi lines (II or III).
The following strains were used for ChIP analysis:
w1118; c929-GAL4/UAS-dimm-myc (II);;tub-GAL80ts
w1118; c929-GAL4;tub-GAL80ts (as a negative control strain)
Microarrays. We combined UAS-dimm-myc (II) with elav-GAL4; for microarray analysis,
these were compared to elav-GAL4. Crosses were maintained 18oC to minimize lethality. RNA
was prepared from embryos collected at 22-26 hr (~ embryo Stage 14) and at 28-32 hr (~
embryo Stage 16). A pair of GeneChip® Drosophila Genome 2.0 arrays (Affymetrix Co., Santa
Clara, CA) were tested with each RNA sample (two experimental and two control, for each of
two time points). Eight microarrays were used to hybridize cDNAs from experimental
dimm::myc-expressing and control flies, sampled at two different embryonic stages. Four
microarrays were hybridized with cDNA from the dimm::myc-expressing embryos of genotype
w;UAS-dimm-myc (II)/+;elav-GAL4/+; (prefix "ED"). Another four microarrays were hybridized
with cDNAs from the parental control strain: w;;elav-GAL4 (prefix “E”). Samples ED3 and ED4,
E3 and E4 were hybridized with cDNA from stage 14 embryos (24-26hr development). Samples
ED1 and ED2, E1 and E2 were hybridized with cDNA from stage 16 embryos (28-32 hr old
embryos). A pair of GeneChip® Drosophila Genome 2.0 arrays (Affymetrix Co., Santa Clara,
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CA) were tested with each RNA sample (two experimental and two control, for each of two time
points). All microarray data are publically available (GEO accession #GSE31113).
Affymetrix CEL files raw probe intensity data was loaded into the statistical computing
language R v. 2.12.1 for Snow Leopard (32-bit build) with the affy / simpleaffy libraries
(ReadAffy). Microarrays were quality checked with the affyPLM and affycoretools libraries.
Probe intensities were then log2 normalized with the gcrma algorithm version 2.22.0 (default
settings). All eight arrays were gcrma-normalized together as one data set. Gcrma-normalized
data sets were then processed with the limma package (Linear Models for Microarray Data) v.
3.6.9 and default limma settings [3]. Contrast matrices were set up to look for probes that were
differentially expressed in the ED samples compared to E samples for each age: (ED3,ED4)(E3,E4) and (ED1,ED2)-(E1,E2).
Limma comparison results are displayed in terms of linear scale fold changes when ED
probes are compared to E probes. The ED34-E34 comparison yielded 360 probes that were at
least 1.5 fold up-regulated. There were 48 probes that were below 0.5 fold in the ED34-E34
comparison, indicating down-regulation. The ED12-E12 comparison yielded 342 ED probes that
were at least 1.5 fold above E probes and 97 ED probes below 0.5 fold of E probes.
In order to correct for multiple comparisons, Benjamini-Hochberg False Discovery Rate
(FDR) corrections implemented in limma were used. There were 880 and 912 differentially
expressed genes with conventional p-values < 0.05 in the ED34-E34 and ED12-E12
comparisons, respectively. Of these, 21 / 880 and 44 / 912 satisfied a 5% FDR cutoff. Failure to
obtain a higher number of significant hits after Benjamini-Hochberg correction at 5% FDR was
likely related to the relatively small number of replicates (two) in the experiment. Furthermore,
sampling whole embryos as opposed to only elav-positive cells yielded a low signal to noise
ratio.
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We therefore decided to use the 1.5 fold enrichment cutoff in identifying differentially
expressed genes. We first sought to identify overlapping probes that were above 1.5 fold
enriched in both the early and late embryos. To obtain the intersection of these probe sets,
queries were run in Galaxy, an open platform for genomic research [4-5]. Galaxy queries were
setup to find which of the 360 ED34-E34 enriched probes overlapped with the 342 ED12-E12
enriched probes. This intersection yielded a list of 136 probes (135 genes, Supplementary Table
3). We also identified overlap between the 48 probes below 0.5-fold in ED34-E34 and the 98
probes in ED12-E12. This intersection included 22 probes that were downregulated in both early
and late embryos at 0.5-fold level or less (Supplementary Table 4).
We compared the list of DIMM overexpression-enriched genes generated in this study
with the data generated by Kula-Eversole et al. [6] obtained from purified “normal” DIMM
neurons (adult LNv). In order to directly compare our study with theirs, we reanalyzed the raw
data from [6], with the same methods used for the embryo data. Additionally, Kula-Eversole et
al. compared large LNv and small LNv probe data to elav cells sat different circadian time
points. We wanted to compare large LNv neurons directly to small LNv neurons regardless of
circadian time. For these reasons, data from Kula-Eversole et al. were reanalyzed as follows: all
CEL files from the study were obtained from the Gene Expression Omnibus depository under
the accession number GSE22308. The 24 CELs were gcrma-normalized together followed by
limma analysis of probes enriched in Large-Small LNv neurons.
We analyzed all Large LNv (10 samples) and small LNv (4 samples) files regardless of
the circadian time when RNAs from purified LNv neurons were harvested. For this analysis, we
assumed that DIMM is not involved directly in the circadian system and that therefore those
genes that DIMM activates directly should be enriched in Large LNv neurons across circadian
time points. Limma was used to identify differentially expressed probes in the Large LNv-small
LNv comparison at a Benjamini-Hochberg FDR of 5% and a 1.5 fold minimum fold enrichment.
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535 probes were 1.5 fold enriched in Large LNvs over small LNvs with a 5% FDR
(Supplementary Table 7). 537 Large LNv probes were below 0.5 fold of small LNv with a 5%
FDR (Supplementary Table 8).
Next, the goal was to identify overlapping probe sets that are enriched upon embryonic
DIMM overexpression and in normal adult DIMM-positive Large LNv neurons when compared to
DIMM-negative small LNvs. Galaxy queries were run to find the intersection of 136 enriched
probes from the embryo and the 535 Large LNv-enriched probes from the adult. The
intersection of these data sets yielded a set of 18 genes (Figure 7; Supplementary Table 3).
There were no overlapping hits when 22 probes that were <0.5 fold in both embryonic samples
(Supplementary Table 4) were compared to probes that are <0.5 fold and 5% FDR in the Largesmall comparison (Supplementary Table 8). The term DIMM-negative is used as a descriptor
and is not meant to suggest that the small LNv have no DIMM expression.
qPCR analyses. To evaluate candidate genes, quantitative real time-PCR (qPCR) was
performed using RNA derived from 24-32hr embryos collected at 18oC and mis-expressing
either DIMM (UAS-dimm) or CD8-EGFP (UAS-CD8-EGFP) driven by elav-GAL4. To analyze
dimm mutants, first instar larvae trans-heterozygous for two dimm alleles (rev4/rev8 – [1]), or
first instar larvae from the control w1118, were collected at RT. To analyze neural RNAs, one
hundred third instar larval CNS of w1118 were manually dissected. Total RNA was isolated with
Trizol reagent (Sigma, St Louis, MO), digested with RNase-free DNase I, and purified with
RNAeasy columns (Qiagen, Madison, WI). Reverse transcription reactions were performed
following the manufacturer’s protocols (NEB). We measured transcript quantities using SYBRgreen incorporation on an ABI 7000 machine and made genotypic comparisons with the double
delta Ct method [7]. Levels of RP49 RNA were used for normalization control. The primers used
are listed in Supplementary Table 1.
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In situ hybridizations and antibody staining of embryos. We followed general
methods previously described [8]. Clones containing the cDNA of interest were obtained from
the PCR of the cDNA template. For probe synthesis, plasmids were linearized with appropriate
restriction enzymes at the 5’ end of the coding sequence. Transcription reactions used the digU
RNA labeling mix (Roche, final concentrations 1mM each ATP, CTP and GTP, 0.65 mM UTP,
0.35 mM DIG-11-UTP) and the appropriate RNA polymerase (NEB, Roche, or Promega) for 2
hrs at 37oC. Probes were then hydrolyzed in carbonate buffer (final concentration 60 mM
Na2CO3, 40mM NaHCO3, pH 10.2) for 40 minutes at 65oC. The reactions were neutralized with
stop solution (final concentration 0.1 M sodium acetate pH 6.0), and the RNA is precipitated with
LiCl and re-suspended in 150 ml hybridization solution (see below). Typically, between 2 and 4
ul of probe was used in a 100 ml hybridization reaction.
Embryos were collected and aged on yeasted grape plates. Due to embryonic lethality at
room temperature, for the dimm overexpression studies all collections and aging was done at
18oC. Embryos were dechorionated in 50% bleach and fixed in 50:50 heptane: embryo fix buffer
(1xPBS, 50 mM EGTA pH 8.0, 10% formaldehyde) for 25 minutes with vigorous agitation,
followed by devitellinization with MeOH. The embryos were cleared using Xylenes, postfixed in
5% formaldehyde in PBT (1xPBS + 0.1% Tween 20) and then treated with proteinase K (Roche,
4 ug/ml in PBT) for 10 minutes. This was followed by another postfix and prehybridization for 1
hr in hybridization solution (50% de-ionized formamide (American Bioanalytical), 5x SSC, 100
ug/ml sonicated, boiled salmon sperm DNA (Sigma), 50 ug/ml heparin (Sigma), 0.1% Tween 20
(Fisher)) at 55oC. The embryos were then hybridized with antisense RNA probes in hybridization
solution for 18 hrs at 55oC. After washing with hybridization solution at 55oC and PBT at room
temperature, the embryos were incubated with alkaline phosphatase labeled anti-digoxygenin
antibody (Fab fragments, Roche, pre-absorbed, diluted at 1:2,000) overnight at 4oC. After
washing with PBT, the staining was developed with 4-nitro blue tetrazolium (NBT, Roche,
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0.675mg/ml) and X-phosphate (Roche, 0.35mg/ml) in AP staining buffer (100mM NaCl, 50mM
MgCl2, 100mM Tris pH 9.5, 0.1% Tween 20). Embryos were mounted in permount (Fisher) or
70% glycerol in PBS and viewed using a Zeiss Axioplan2 microscope. Images were obtained
with an Olympus DP71 camera and manufacturer’s software.
Transactivation. Assays followed the general methods previously described [9];
Genomic fragments from the loci encoding candidate genes were subcloned into the pGL3
vector (Promega, Madison WI). Drosophila BG3-c2 neuronal cells (1x 106 cells per well) were
transiently transfected with a total 1.5mg of DNA by mixing with 5 ul of FuGENEHD (Roche) and
incubating for two days at RT. Transactivation was measured by a Luciferase assay system
(Promega, Madison, WI). For each experiment, a vector containing pActin-LacZ was cotransfected to normalize the transfection efficiency, and each transfection was performed at
least three times independently. The significance was tested by the student’s T-test (two tailed).
Immunocytochemistry and Imaging. We generated antibodies and used
immunostaining methods as previously described [1, 10, 11]. Affinity purified guinea pig antiDIMM (1:200; [10]), rabbit anti-FMRFa (1:1000; [11]), mouse monoclonal anti-GFP 3E6 (1:800,
Molecular Probes, Carlsbad CA) and rabbit anti-GFP (1:500; rabbit polyclonal, #AB3080
Chemicon, Temecula, CA) were used as primary antibodies. Cy3-conjugated- (Jackson
Immunoresearch, West Grove, PA) or Alex-488-conjugated- (Molecular Probes, Carlsbad CA)
secondary antibodies were used for immunocytochemistry. To generate an antibody against the
CG13248 protein product, we constructed a GST-fusion containing the predicted C-terminal
(cytoplasmic) region of the protein (596-669 A.A.; 75 amino acids) and produced GST-CAT-4 in
E. coli. Guinea pig anti-CAT-4 protein was used for immunostaining, using methods previously
described [1, 10, 11]. Confocal images were acquired on an Olympus FV500 laser scanning
confocal microscope and manipulated by ImageJ and Adobe Photoshop software to adjust
contrast.
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Chromatin Immunoprecipitation (ChIP) analysis. ChIP was performed as described
by Menet et al. [12]. w1118; c929-GAL4;tub-GAL80ts females were crossed to y1w1; UAS-dimmmyc (II) males at 18oC. To control for non-specific antibody binding, non-specific DNA
enrichment (through binding to sepharose beads, reaction surfaces etc. [13]), ChIPs were also
performed on the w1118; c929-GAL4; tub-GAL80ts parental strain that lacks the dimm::myc
transgene. Progeny developed at 18oC through adult eclosion. Two to five day old adults of the
following two genotypes (y1 w1/ +; c929-GAL4/UAS-dimm-myc (II); tub-GAL80ts/+ and w1118;
c929-GAL4; tub-GAL80ts) were shifted to 30oC for 3 days. Flies were collected on dry ice, and
heads were sieved the following day through 25 and 40 micron sieves. One milliliter of fly heads
was homogenized in 7 ml Wheaton-Dounce homogenizers with the type B (tight) pestle in 3 mL
of NEB buffer (10 mM HEPES-Na at pH 8.0, 10 mM NaCl, 0.1 mM EGTA-Na at pH 8.0, 0.5 mM
EDTA-Na at pH 8.0, 1 mM DTT, 0.5% Tergitol NP-10, 0.5 mM Spermidine, 0.15 mM Spermine
plus protease inhibitor cocktail [Roche mini]) for a total of 30 min (2-min homogenization 10
times, 1 min on ice 10 times). Homogenate was dumped into a 70-mm cell strainer placed in a
50-mL falcon tube and centrifuged at 300g for 2 min. Filtered homogenate was split into three
fractions, transferred to microfuge tubes and centrifuged at 6,000 x g for 10 min. The nucleicontaining pellets were resuspended in 1 mL of NEB and centrifuged at 20,000 x g for 20 min on
sucrose gradient (0.65 mL of 1.6 M sucrose in NEB, 0.35 mL of 0.8 M sucrose in NEB). The
pellet was resuspended in 1 mL of NEB and 11% formaldehyde (diluted in Schneider’s media;
Sigma) was added to a final concentration of 1%. Nuclei were cross-linked for 10 min at room
temperature on a rotator before cross-linking was quenched by adding 1/10 vol of 1.375 M
glycine for 5 min. The nuclei were collected by centrifugation at 6,000 x g for 5 min. All
centrifugations steps were carried out at 4oC. Nuclei were washed twice in 1 mL of NEB and
resuspended in 450 mL of Sonication buffer (10 mM HEPES-Na at pH 7.5, 2 mM EDTA at pH
8.0, 1% SDS, 0.2% Trition X-100, 0.5 mM Spermidine, 0.15 mM Spermine plus Roche mini
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protease inhibitor cocktail). Two biological replicates of nuclei were sonicated using a
Fisherbrand Sonic Dismembranator at setting 2 (57 W) five times for 15 sec on and 2 min off
(set on ice). Three other biological replicates were sonicated on a Misonix 3000 sonicator fitted
with a microtip at setting P=5.0 (12-15W) 6 - 12 times for 15 sec on and 1 minute off (set in iceethanol bath). Sonicated nuclei were centrifuged at 15,000 x g for 10 min and frozen at -80°C in
150 μl aliquots. The majority of the sonicated chromatin had a unimodal sequence length
distribution with a peak around 500 base pairs. Twenty-five microliters of sonicated chromatin
were removed for the input sample. The remaining 125μl of chromatin was diluted in 1.1 mL of
IP buffer (50 mM HEPES/KOH at pH 7.6, 2 mM EDTA, 1% Triton, 0.1% NaDeoxycholate in
PBS). Samples were rotated overnight at 4°C after adding antibodies: 15 μl of anti-c-MYC tag
goat antibody (Abcam ab9132). Protein G-Sepharose beads (Zymed) or protein G-sepharose
beads (Sigma, Saint Louis, MO) were blocked overnight in 0.1 mg/mL yeast tRNA and 1 mg/mL
BSA in IP buffer. After overnight incubation, the beads were washed once in IP buffer, added to
the chromatin/antibody mixture, and then incubated for an additional 2 h at 4°C.
Beads were spun down at 10,000 rpm for 20 sec and were washed once in 1.5 mL of
ChIP Wash buffer (50 mM HEPES-KOH at pH 7.6, 1 mM EDTA, 1% Triton, 0.1%
NaDeoxycholate, 0.1% Sarkosyl, 0.1% BSA, 0.5 M KCl in PBS). Beads were resuspended in 1
mL of ChIP Wash buffer and rotated for 30 min at 4°C. Beads were then washed once in Li
Wash Buffer (10 mM Tris-Cl at pH 8.0, 0.25 M LiCl, 0.5% NP40, 0.5% NaDeooxychoalte, 1 mM
EDTA) and once in cold TE (pH 8.0) before being eluted with 150 mL of ChIP Elution buffer (50
mM Tris-HCl at pH 8.0, 10 mM EDTA, 1% SDS, 1 mM DTT, 0.1 mg/mL Proteinase K). ChIP
Elution buffer (150 mL) was also added to the input sample. Both IP and input samples were
incubated for 2 h at 37°C. The sepharose beads were removed from the IP samples and then all
samples were decrosslinked overnight at 65°C. DNA was isolated from the samples using PCR
purification kit (Qiagen).
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Real-time quantitative PCR (qPCR) following ChIP. The PCR mixture contained
Platinum Taq polymerase (Invitrogen) and optimized concentrations of Sybr-Green (Invitrogen).
The sequences of primers used are listed in Table S2qPCR was performed in triplicate on at
least two, in most cases three independent biological replicates of chromatin obtained from
different sets of fly heads on different days. For each primer set, 1:10 dilutions of ChIP and input
DNA from both strains were prepared from the same master mix. Additionally, for each primer
set, one of the inputs was further diluted to make 1:100 and 1:1,000 dilutions. This was
necessary to create calibration curves to ensure reaction linearity. Fluorescence intensities were
plotted versus the number of cycles by using an algorithm provided by Corbett Research
(Qiagen). For each gene, at least two primer sets were designed. Only reactions whose R2
values were > 0.99 were considered valid. Real-time qPCR was performed a Corbett Research
Rotor-Gene 3000 real-time cycler or a RotorGene Q real-time PCR machine with cycling
parameters: 3 min at 95°C, followed by 40 cycles of 30 sec at 95°C, 45 sec at 55°C, and 45 sec
at 72°C. One set amplified regions around or immediately adjacent to CANNTG canonical Eboxes in genes’ first introns or first exons / 5’ UTR. A second set amplified genomic regions
approximately 6 kilobases upstream of E-box primer sets. Each ChIP was normalized to its
input by delta-Ct value. Delta-delta-Ct value was then calculated by subtracting delta-Ct of
negative control from delta-Ct of the tagged strain. The fold-difference between experimental
and control samples was obtained by 2^(-delta-deltaCt). The properties of the primers used are
listed in Supplementary Table 2.
Quantitative Mass Spectrometry. Fly heads of the control (GMR>UAS-ppMII; UASdimm) and experimental (GMR>UAS-ppMII; UAS-dimm; UAS-RNAi) transgenic lines were
collected in frozen state. MS-based quantitation was based on prior quantitative measurement
approaches [14-16]. Frozen heads were homogenized in acidified acetone (40:6:1,
acetone:water:concentrated HCl, v/v/v; 10 ul/head). The homogenate was centrifuged at 12,000
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rpm for 5 min: supernatants were concentrated by drying in a SpeedVac (Thermo Electron Co.),
and then reconstituted with 2% acetonitrile aqueous solution (containing 0.1% FA and 0.01%
TFA) for subsequent analysis. The quantitative analysis on MII fully processed from ppMII was
performed using capillary liquid chromatography coupled to matrix-assisted laser/desorption
ionization time-of-flight mass spectrometry (CapLC-MALDI-TOF/TOF MS). We performed
relative quantitation using two approaches. For the labeling approach, the samples were labeled
with succinic anhydride as previous described [14-15]. Briefly, 2 µl of 2 M light and heavy forms
of succinic anhydride (Sigma Aldrich) in DMSO were used to label the control and experimental
samples, and the sample solutions were adjusted to be basic. After the reaction, the labeled
control and experimental samples were combined before being desalted using spin columns
(Pierce, Rockford, IL). The combined and desalted samples were then analyzed with CapLCMALDI-TOF/TOF MS (Bruker Daltonics, Billerica, MA). 5 µl samples were separated with a
reverse phase column (Alltech Associates Inc., Alltima HP C18, 150 mm × 300 um, 3 µm
particle diameter, 100 Å pore size) at a flow rate of 2 µl/min. Solvent A contains 95% water, 5%
acetonitrile, 0.1% FA, and 0.01% TFA, and Solvent B contains 5% water, 95% acetonitrile, 0.1%
FA, and 0.01% TFA. The 45-min gradient started from 2% B to 20% B over 10 min, to 40% B in
another 15 min, continued to 80% B in 7 min, and stayed at 80% B for 3 min before ramping
back to 2% B. The fraction collection started at 20 min, and a total of 24 one-minute fractions
were collected on a MALDI target for each sample. 1 µl of a-cyano-4-hydroxycinnamic acid
(Sigma Aldrich) in 70/30 (v/v) acetonitrile/ water solution was used as matrix, and MALDITOF/TOF mass spectra were acquired in the mass range of 600-5000 Da. The relative peak
intensities in the peak pair were used to indicate the relative amount of peptides between control
and experimental samples.
In the label-free quantitation approach, Drosophila head extracts were analyzed with
CapLC-MALDI-TOF/TOF MS described earlier just after they were reconstituted. Endogenous
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peptide Drm-MT2 (hugin (CG6371) (m/z 942.59) and exogenous peptide MII (m/z 1710.69)
have been well studied in Drosophila previously [2, 17], and their presence was determined by
mass matching between the theoretical masses and the experimental masses at signal-to-noise
ratio above 3 within 20 ppm. MT2 and MII were respectively isolated with MALDI-TOF/TOF
tandem MS, and the intensity of the isolated parent ion was used to reflect the amount of the
peptide after normalization. Student’s t-test was used for statistics with at least three biological
replicates.
RNAi transgenic lines used in this study.
CG#

GENE

RNAi line

CG13248

CAT-4

GD5384 (VDRC)

CG1275

Cyt-b561-1

GD4103 (VDRC)

CG11254

mael

GD18198 (VDRC)

CG7785

cddl6

GD36650 (VDRC)

CG32850

rnf11

JF01121 (Harvard)

CG6522

GD22500(VDRC)

CG14321

GD29814 (VDRC)

CG17293

wdr82

GD25246 (VDRC)

CG31436

GD21341 (VDRC)

CG14621

GD8661 (VDRC)
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Integrative analysis of the gene regulatory interactome and
transcriptome of the neuroendocrine scaling factor DIMMED

This chapter will be adapted for the manuscript:
T. Hadžić, K.C. Abruzzi, D. Park, J.S. Trigg, M. Rosbash and P. Taghert: Integrative analysis of
the gene regulatory interactome and transcriptome of the neuroendocrine scaling factor
DIMMED. In preparation.

I performed the following experiments presented in this chapter: ChIP-chip (genetic crosses,
collections and temperature shift, Western blots, ChIP, tiling array hybridization (with help from
KCA for the first biological replicate), bioinformatic analysis of ChIP-chip data: MAT and Galaxy
analysis, intersection, conservation, genomic annotation, selection of enhancer fragments for
luciferase testing), RNA-Seq (genetic crosses, dissection (with help from PHT, DP, Laura Duvall
and Seol Hee Im), cell dissociation for FACS, RNA purification, bioinformatics analysis of RNASeq data: enrichment quantification, heat map generation and intersection of ChIP-chip and
RNA-Seq data.)
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INTRODUCTION
Neuroendocrine (NE) cells possess features characteristic of neurons and glandular
tissue (Scharrer B 1987). They have evolved specialized adaptations to synthesize, process
and store large amounts of neuropeptides until they receive an appropriate signal for their
release (Dannies 1999; Kim et al. 2006). To accomplish this, NE cells possess a repertoire of
neuropeptide processing enzymes, as well as a special subcellular compartment, the Large
Dense Core Vesicles (LDCVs, Dannies 1999; Kim et al. 2006). LDCVs house most of the
processing enzymes and the neuropeptide cargo (Dannies 1999; Kim et al. 2006). LDCVs are
also the key intracellular sites for neuropeptide processing, for long-term storage, for transport
and ultimately for the secretion of the biologically active peptides (Burbach et al. 2001). LDCVs
inside NE cells are made, stored, trafficked and exocytosed out of the cell thanks to a large
complement of structural and regulatory components that ensure precisely timed release in
response to stimuli (Crivellato et al. 2010). With the exception of a few proteomic studies, LDCV
components remain largely undefined by high throughput studies (Gauthier et al. 2008; Wegrzyn
et al. 2010). By utilizing this special subcellular compartment, NE cells have developed a unique
mode of protein secretion, the Regulated Secretory Pathway (RSP; Dannies 1999; Kim et al.
2006). The primary function of this pathway is the secretion of substances (mainly
neuropeptides) that produce modulatory changes in target neurons and other cells (De Camilli
and Jahn 1990). NE cells, through the RSP, engage in episodic release of cargo that has the
potential to affect cells located very far away (Burbach et al. 2001). Although fast
neurotransmission is the dominant form of neural signaling, NE cells have evolved in parallel
with neurons (Südhof 2007). NE cells integrate inputs and adapt their responses to various
stimuli in order to maintain long-term homeostasis in living organisms (Burbach et al. 2001).
Thus far, little is known about how LDCVs and the RSP are established and developed
in NE precursor cells during their maturation into professional secretory cells. Only a few groups
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have used microarrays to obtain gene expression profiles of several normal and stimulated NE
tissues in mammals and Drosophila (Yue et al. 2006; Hindmarch et al. 2006; Kula-Eversole et
al. 2010; Nagoshi et al. 2010). Whereas Yue et al. (2006) used laser capture microdissection to
collect individual cells from the hypothalamic supraoptic nucleus, Hindmarch et al. (2006) used
more heterogeneous tissues from whole hypothalamic nuclei. These two studies suggest the
existence of coordinately regulated NE-specific gene batteries whose function is to ensure
proper secretion from NE tissues (Park and Taghert 2009).
In Drosophila, two groups have examined gene expression profiles of purified Drosophila
circadian neurons, some of which are neuroendocrine (Kula-Eversole et al. 2010; Nagoshi et al.
2010). In both papers, manual collection of freshly dissociated cells was used to source the
RNA material (Kula-Eversole et al. 2010; Nagoshi et al. 2010). Both studies focused on the
portion of the transcriptome that cycles with circadian time in clock cells. The advantage that
these studies had over others is that the circadian system in Drosophila is one of the most well
understood systems implicated in the control of behavior (Nitabach and Taghert 2008). On the
other hand, what remains unanswered is how cells such as the hypothalamic thirst-controlling
NE neurons and the Drosophila circadian NE neurons establish those properties required of
professional secretory cells: a robust RSP with an appreciable LDCV subcellular compartment
and an appropriately regulated transcriptome and epigenome.
Generally speaking, the transcriptome of NE cells likely consists of those genes that are
required in all cells, and others that allow NE cells to perform their unique roles. Although the
“house keeping” portion of the transcriptome is likely not identical in all cells, it probably consists
of a core set of genes with some quantitative variations in their expression (Doyle et al. 2008).
On the other hand, each cell type has a unique portion of its transcriptome that orchestrates its
functions. The definition of “unique” changes depending on the reference cell type to which the
cell population of interest is being compared to (Dougherty et al. 2010). Thus, the degree of
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transcriptome uniqueness changes depending on whether a cell type is being compared against
a related cell type (e.g. one type of neuron against another) or against a distantly related cell
type (e.g. neurons against germ line cells). Regardless of the characteristics, there likely exist
specialized intracellular circuits and pathways that set up, amplify and maintain a particular
distinguishing cell feature, such as the RSP in NE cells, synaptic vesicles in neurons or
mitochondria in cardiomyocytes (Mills and Taghert 2011). Furthermore, such master regulators,
transcriptional organizers and scaling factors are likely not static, but must be able to adapt to
the ever changing environment (Mills and Taghert 2011.
Two known transcriptional organizers of the developmental programs of neuronal cell
subtypes are factors PET-1 and AST-1 (Park and Taghert 2009; Hendricks et al. 1999; Flames
and Hobert 2009). AST-1 is an ETS transcription factor that controls expression of all dopamine
pathway genes in all dopaminergic cell types in Caenorhabditis elegans (Flames and Hobert
2009). PET-1 is another ETS domain transcription factor that appears to control expression of
serotonin pathway genes in mammalian serotonergic neurons (Hendricks et al. 1999). Both of
these factors control major elements of the biosynthetic machinery known to distinguish their
respective neuronal subtypes from neurons expressing other biogenic amines or classic
neurotransmitters. Neither factor, however, is necessary for the initial fate specification or
survival of the respective neuron type that they control (Park and Taghert 2009). There is also
no evidence as of yet that either of these factors controls a whole subcellular compartment,
such as LDCVs, endosomes or synaptic vesicles.
One known factor that controls a whole subcellular compartment is Transcription Factor
EB (TFEB, Sardiello et al. 2009). TFEB exerts coordinated transcriptional control over most
mammalian lysosomal genes (Sardiello et al. 2009). In vitro, TFEB induces lysosomal
biogenesis and increases degradation of lysosomal complex molecules (Sardiello et al. 2009).
Another factor, Peroxisome proliferator–activated receptor Gamma Coactivator-1 (PGC-1), has
101

Chapter 3.

	
  
been shown to control the number of mitochondria inside heart cells, as well as their function in
response to energy demands (Lehman et al. 2000; Finck and Kelly 2007). Though it has been
convincingly shown that PGC-1 is a master regulator of myocardial energy metabolism, this
protein is a not a sequence-specific transcription factor, but rather a co-activator for such factors
(Finck and Kelly 2007).
The above examples demonstrate master regulators / scaling factors that control the
biogenesis, maintenance and homeostasis of lysosomes and mitochondria (Sardiello et al.
2009; Lehman et al. 2000). Another subcellular compartment of great consequences for human
health is the LDCV compartment. Peptide hormone insulin is stored in LDCVs of pancreatic beta
cells and any pathologic changes in LDCVs can lead to beta cell disease and diabetes (Liu et al.
2009). In general, LDCVs are found in NE, endocrine, as well as other secretory cells such as
exocrine and hematopoetic mast cells (Crivellato et al. 2010; Kim et al. 2006). A known NEspecific master regulator and scaling factor that is likely responsible for the establishment and
dynamic maintenance of the RSP in NE cells is the Drosophila basic helix loop transcription
(bHLH) factor dimmed (DIMM) (Park and Taghert 2009; Hewes et al. 2003; Park et al. 2008b;
Hamanaka et al. 2010; Park et al. 2011). DIMM coordinates the molecular and cellular
properties of all major NE cells, irrespective of the secretory peptides they produce (Park et al.
2011). DIMM is a well conserved protein, with a mammalian orthologue called Mist1 (Moore et
al. 2000). Mist1 is the transcriptional organizer of serous exocrine cell-specific secretory
features in mammals (Pin et al. 2000; Ramsey et al. 2007; Johnson et al. 2004).
The goal of this thesis was to identify the precise mechanism of DIMM action in vivo.
Since DIMM is a transcription factor, it functions by binding to and activating expression of a set
of genes. Therefore, I took the specific aim of defining all DIMM genomic targets. Chromatin
immunoprecipitation (ChIP) has become the technique of choice to identify direct genomic
targets of a transcription factor (Collas 2009; Lee et al. 2006; Sandmann et al. 2007). DNA
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sequences from DNA-protein adducts isolated by ChIP can be globally analyzed by microarray
hybridization (ChIP-chip, Lee et al. 2006; Southall and Brand 2007). ChIP-chip allows for
unbiased detection of protein–DNA interactions, as it requires no prior knowledge of candidate
binding sites for any particular transcription factor (Sandmann et al. 2007). In a previously
published study, (Chapter 2), I demonstrated the application of in vivo ChIP to analyze
candidate DIMM binding sites in the enhancers of a few genes (Park et al. 2011). In Chapter 2,
a broad multidisciplinary approach was undertaken to validate a small number of candidate
DIMM-dependent genes as bona fide targets with functional consequences for NE cell
physiology (Park et al. 2011). Nevertheless, the study was limited to evaluating a selection of
134 genes that were derived from a DIMM-over-expression paradigm in the embryonic nervous
system (Park et al. 2011).
In this chapter, I extend the ChIP analysis to the whole genome by ChIP-chip. This in
vivo approach allows for identification of the full complement of potential DIMM regulated sites in
the Drosophila genome in an unbiased, systematic fashion. As I will describe, the ChIP-chip
data yielded a stringent DIMM gene regulatory interactome of at least 156 high fidelity cisregulatory modules, which is highly interesting by itself. Although Sardiello et al. (2009) used in
vitro expression profiling to identify many lysosomal genes as TFEB targets, they did not
conduct a genome-wide survey of TFEB binding. There have so far been no reports of scaling
factor regulatory interactomes being revealed by ChIP-chip or ChIP coupled to deep sequencing
(ChIP-Seq).
Once I successfully identified the gene regulatory interactome of DIMM, it became
evident that DIMM’s interactome could be greatly enhanced by integrating it with the
transcriptome of DIMM-expressing LEAP cells. Therefore, I also describe herein how I purified
DIMM+ and DIMM- cells by Fluorescence Activated Cell Sorting (FACS) in order to profile their
gene expression by deep sequencing (RNA-Seq). Once the LEAP transcriptome was
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successfully obtained, I intersected the DIMM gene regulatory interactome with the newly
derived transcriptome of DIMM+ LEAP cells. This yielded a set of genes that are high fidelity
direct DIMM targets.
MATERIALS AND METHODS
ChIP-chip
ChIP was conducted as described previously (Chapter 2, Park et al. 2011; Menet et al. 2010).
Briefly, tagged ChIP was carried out with a DIMM::MYC-tag fusion transgene that can rescue
diminished neuropeptide levels in DIMM null animals (Hewes et al. 2003). This transgene was
expressed in a spatiotemporally controlled manner by using a GAL4 driver that overlaps to a
great extent with DIMM (c929-GAL4; Hewes et al. 2003; Park et al. 2008a). Furthermore, I
restricted GAL4 activity to DIMM-expressing neurons in adult animals by using a temperature
sensitive allele of a ubiquitously expressed GAL80 protein (tub-GAL80ts) – TARGET (McGuire et
al. 2003; Brand and Perrimon 1993). In this system, GAL4 activation of transcription from the
UAS element is inhibited by GAL80 as long as the animal is kept at the restrictive temperature
(18°C, McGuire et al. 2003). Shifting the animals to 30°C (permissive temperature) results in a
derepression of GAL4 activity and transcription from the UAS element. Two sets of animals
were used for this experiment: i) c929-GAL4/UAS-DIMM::MYC; tub-GAL80ts/+ [experimental
group] and ii) c929-GAL4; tub-GAL80ts maternal strain [negative control]. Both sets of animals
were raised at 18°C to allow for normal development, as well as to prevent the lethality that
results from DIMM overexpression in LEAP cells (unpublished results). Freshly eclosed adult
flies were then shifted to 30°C to induce expression of the DIMM::MYC transgene only in adult
DIMM+ cells. Specific induction of the DIMM::MYC protein within 72 hours was confirmed by
Western blotting (Figure 1). I performed tagged ChIP 72 hours later, using methods described in
Chapter 2 (Park et al. 2011).
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One limitation of ChIP is that it requires a high quality antibody that can recognize fixed
antigens in solution (Orlando 2000; Lee et al. 2006; Sandmann et al. 2007). A second limitation
is that ChIP requires at least one million cells for success (Collas 2009). c929-GAL4 is
expressed in about 300 NE cells in the adult brain, which is less than 1% of all CNS cells (D
Park and P Taghert, unpublished observations). As expected from these technical limitations,
ChIP with a native DIMM antibody failed to produce successful results. Therefore, I employed a
“tagged ChIP strategy based on the availability of the MYC-tagged DIMM transgene. Affinity
tags such as MYC are increasingly used in ChIP assays to detect in vivo binding of transcription
factors to their target genes in chromatin (e.g., Kolodziej et al. 2009).
Following crosslink reversal, DNA was processed according to the Affymetrix®
Chromatin Immunoprecipitation Assay Protocol (P/N 702238 Rev. 3). For each sample, 10
microliters of undiluted ChIP DNA or 1:10 diluted input DNA was amplified by linear PCR-based
amplification. Quantitative PCR was used to show that DIMM occupancy at its known binding
site in PHM was preserved after amplification. Identical amounts (6.0 micrograms) of each
amplified sample were then fragmented and biotin-labeled by Terminal Deoxynucleotidyl
Transferase. Labeled samples were then hybridized to Affymetrix GeneChip® Drosophila 2.0
Tiling Arrays and scanned according to Affymetrix protocols at the National Center for
Behavioral Genomics (Brandeis University).
Bioinformatic analysis of ChIP-chip data
To detect statistically significant DIMM binding peaks throughout the genome, an analysis
algorithm titled Model-based Analysis of Tiling-arrays (MAT) was used (Johnson et al. 2006).
MAT considers the 600-basepair window surrounding each tiling array probe and computes a
trimmed mean of all of the t values in the window (Johnson et al. 2006). Additionally, MAT
models baseline probe behavior by considering the 25-mer probe sequence and copy number of
all probes on a single tiling array (Johnson et al. 2006). MAT detects ChIP regions using an
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enrichment measure known as MAT score, which is calculated for each 600 bp window and
assigned to the probe at the center of the window. Essentially, MAT score, which is calculated
from normalized probe intensities, represents a statistical likelihood that a particular genomic
region is enriched in the immunoprecipitated relative to the control sample (Abruzzi et al. 2011).
MAT analysis was carried out with MAT source build 2.11272006 on a 32-bit Linux machine.
Genome visualization .bar files produced by MAT are incompatible with the University of
California in Santa Cruz (UCSC) Genome Browser. Therefore, UCSC Genome Browsercompatible files were obtained by running an implementation of MAT (rMAT) in the statistical
computing language R (Droit et al. 2010). This analysis produces a graphic representation of
MAT scores in sliding windows on a log2 scale. Visual output from all three MAT analyses
performed (DIMM ChIP/Input, NEG ChIP/Input and DIMM ChIP / NEG ChIP) can be directly
compared to each other as long as the window minima and maxima are identical. This is true
because an identical number of arrays was used for experimental and control samples, with the
same number of biological replicates and DNA amounts hybridized to tiling arrays.
Genomic annotation of DIMM binding sites
Annotation of DIMM binding sites with respect to introns (Figure 3A) was performed in the
Galaxy, an open platform for genomic research (Goecks et al. 2010). A data table describing all
Drosophila introns from the UCSC dm3 Drosophila genome build (UCSC Main on D.
melanogaster: flyBaseGene: Introns) was downloaded from the UCSC Genome Browser
database. Galaxy queries were then run to identify the percent of overlap between DIMM-bound
regions and all known introns from the dm3 genome build (Figure 3A). To annotate DIMM
binding sites against exons, introns and promoters, PinkThing was used (Figure 3B). PinkThing
is an open-source software for quick annotation of a set of genomic regions against transcription
start sites and gene features (TSSs, PinkThing.cmbi.ru.nl, F. Nielsen, M. Kooyman and M.
Huynen; Kramer et al. 2011). PinkThing was used under default parameters to annotate DIMM
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binding sites against genomic features defined as: gene body (introns versus exons), as well as
upstream and downstream regions. A DIMM-bound region was classified as: Near Upstream or
Downstream = 5 kb upstream or downstream of a TSS; Far Upstream = 5 – 25 kb from the
closest TSS and Distant Upstream = >25 kb from the closest TSS). Furthermore, precise
distance of ChIP-chip binding sites from transcription start sites was calculated and plotted in
the statistical programming language R v. 2.14.0 with the BioConductor package ChIPpeakAnno
(Zhu et al. 2010). ChIPpeakAnno allows for visual representation of peak distance from
annotated TSSs (Zhu et al. 2010).
Binding motif identification and conservation analysis
Binding motif analysis was carried out in the Cistrome project with the SeqPos motif finding tool
(He et al. 2010; Liu et al. 2011). DIMM binding peaks with 1% - 100% of intron overlap were
analyzed with the following settings: region width = 600 bp; p-value cutoff = 0.05. For
conservation analysis, Galaxy queries were used to extract Multiple Alignment File (MAF) blocks
for the set of 156 DIMM-bound genomic intervals and a 15-way multiZ (dm3) alignment with the
genomes of twelve other Drosophila species, as well as the bee (Apis mellifera) and mosquito
(Anopheles gambiae) genomes (Blankenberg et al. 2011). A query to calculate MAF Coverage
Stats was then run in Galaxy and the resulting coverage reported on a scale from 0 (no
conservation) to 1 (100% conservation).
In vitro luciferase DIMM transactivation assays
Luciferase assays were performed as in Chapter 2 (Park et al. 2011. DIMM-bound genomic
fragments that were tested in these assays were selected based on their MAT scores, and in
some cases based on their intronic location. Assays were performed with at least n=3 biological
replicates with the exception of the crc-F fragment.
Preparation of cells for FACS sorting
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Brains of homozygous w1118,UAS-dcr2; c929-GAL4, UAS-CD8::EGFP; flies were used to
harvest cells for FACS sorting and subsequent RNA-Seq. UAS-dcr2 was included in the genetic
background because of plans to carry out the same type of analysis in a dimm RNAi loss-offunction background. This strain (w1118,UAS-dcr2; c929-GAL4, UAS-CD8::EGFP;) is essentially
wild-type with respect to DIMM physiology, as evidenced by normal neuropeptide staining (data
not shown). Young flies (5-12 days old) of both sexes were grown at 25°C on standard
Drosophila cornmeal media. They were anesthetized with carbon dioxide and collected on ice.
RNA was isolated from brains dissected on two separate occasions, in order to get as much
material as possible, to minimize RNA amplification. Brains of 140 (first experiment) and 180
flies (second experiment) were dissected within a two to three hour time period. Adult heads
were detached from ventral nerve cords and dissected in cold saline as in Nagoshi et al. (2010)
with some modifications. Sterile, ice-cold Modified Dissecting Saline (MDS) was used for
dissection (9.9 mM HEPES-KOH buffer, 137 mM NaCl, 5.4 mM KCl, 0.17 mM NaH2PO4, 0.22
mM KH2PO4, 33 mM glucose, 43.8 mM sucrose, pH 7.4; Jiang et al. 2005). After dissection,
brains were immediately transferred into sterile, chilled modified SMactive medium and pooled
(SMactive medium containing 5 mM Bis-Tris; Küppers-Munther et al. 2004).
At the end of dissection, brains were pooled in a 2 ml Eppendorf DNA LoBind nucleasefree tube and washed with 1 ml of chilled MDS. Fly brains were then centrifuged at 1,000g for
30 seconds in a microcentrifuge. Frozen L-cysteine-activated papain (50 units/ml in dissecting
saline; Worthington) was thawed at the beginning of dissection and activated at 37°C for 20
minutes immediately prior to the end of dissection. Four hundred and fifty microliters of activated
papain were then added to the brains. Fly brains were gently resuspended and incubated with
papain for 20 minutes at room temperature. Papain digestion was quenched by adding 1.5 ml of
Schneider’s medium supplemented with 1% heat inactivated Fetal Calf Serum. The sample was
centrifuged at 500g for 30 seconds at room temperature. Brains were washed two more times
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and were finally resuspended in 600 microliters of Schneider’s medium supplemented with 1%
FCS.
Papain-digested brains were then triturated 30 times with a flame-rounded P1000 filter
tip (medium tip opening), 30 times with a flame-rounded P1000 filter tip (small opening), 30
times with a flame-rounded P200 filter tip (large opening), 40 times with a flame-rounded P200
filter tip (medium tip opening) and 20 times with a flame-rounded P200 filter tip (small opening).
Pipette volumes used for trituration were 500 microliters and 150 microliters for the P1000 and
P200 pipettes, respectively. Trituration efficiency was such that very small pieces of brain tissue
were still visible under a dissection microscope.
Brain homogenate was then strained through a sterile 70 micron cell strainer (Fishersci)
mounted on a 50 ml Falcon, then centrifuged briefly at 400 rpm at 4℃. Flow through containing
filtered dissociated cells was then strained through a 35 micron sterile cell strainer (BD Falcon)
mounted on a 50 ml Falcon, then centrifuged briefly at 200 rpm. Four hundred and fifty
microliters of dissociated single cells were collected in a 6 ml BD Falcon tube. Cells were then
transported on ice to the Washington University Siteman Flow Cytometry Core for FACS sorting.
FACS sorting
Cell sorting was performed on a DAKO-Cytomation MoFlo High Speed Sorter at the Siteman
Flow Cytometry Core, Washington University in St Louis. The Green Fluorescent Protein
(GFP+) gate was set based on established criteria and experience of the Core’s personnel with
the sorter (Figure 5). Sorting GFP+ and GFP- cells was completed within on hour of the start of
sorting. Roughly, 1% - 3% of all cells in the samples were GFP+, which is consistent with the
number of c929+ cells in the adult fly brain (Park and Taghert 2009). In order to establish the
viability of cells after dissociation, a pilot sorting experiment was performed in which cells were
sorted for GFP, as well as their ability to exclude the vitality dye 7-Amino-Actinomycin D. This
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nucleic acid dye allows detection of dying cells by entering such cells thanks to fragmentation of
their membranes. (Schmid et al. 1992). The pilot experiment showed that the majority of gated
GFP+ and GFP- cells were excluding 7-AAD, and were therefore alive at the time of sorting. The
fact that sorted DIMM+ cells were viable shortly before RNA capture increased confidence that
any subsequent expression profiling would faithfully reproduce the transcriptome of live DIMM+
cells. Because double sorting against GFP and 7-Amino-Actinomycin D doubled the amount of
time needed for sorting, sorting experiments for RNA collection were conducted without 7Amino-Actinomycin D. The combined number of cells sorted from the two experiments was 3.0 x
105 GFP+ cells and 1.35 x 106 GFP- cells.
RNA isolation, processing and Illumina HiSeq 2000 sequencing
At the end of sorting, cells were transferred directly into Qiagen’s RLT buffer
supplemented with beta-mercaptoethanol (Qiagen RNA MinElute kit). Most investigators
harvesting nano scale RNA samples for microarray gene expression profiling use the Arcturus
PicoPure kit (Borghese et al. 2006; Nagoshi et al. 2010; Ramsey et al. 2007; Tian et al. 2010).
This kit contains a poly(dI:dC)-based proprietary nucleic carrier embedded in the column. This
carrier does not interfere with microarray applications, but could interfere with deep sequencing
of RNAs isolated this way. Therefore, we decided to use the Qiagen kit for small samples, which
lacks carriers. After transferring cells into RLT buffer, they were vortexed for 6 seconds, and
lysed by passing the suspension five times through a 21.5 gage needle mounted on a 3 ml
syringe. RNA was isolated as recommended by Qiagen’s MinElute protocol, with the exception
of using 65°C-heated water for enhanced RNA recovery. Next, DNA in the sample was digested
with the DNaseI Turbo DNA-free kit (Ambion). After DNA removal, RNAs isolated from GFP+
and GFP- cells from each of the two experiments were pooled.
Samples with pooled GFP+ and GFP- RNAs were then submitted to the Genome
Technology Access Center (Washington University Genetics Department). RNA quality was
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then checked by Qubit (Invitrogen), NanoDrop (GE Health) and Bioanalyzer (Agilent) quality
control assays. Neither sample showed signs of degradation or DNA contamination, and the
samples were moved into the deep sequencing pipeline at the same facility. After taking sample
aliquots for quality control, there were ~35 nanograms of RNA from GFP+ cells left and ~100
nanograms of GFP- RNA. Since the two samples would be directly compared to each other, the
GFP- sample was diluted in order to have equal quantities of both samples. The samples were
sequenced on Illumina’s HiSeq 2000 platform (Han et al. 2011).
Because Illumina’s deep sequencing protocols require 10 micrograms of RNA, the
samples had to be amplified. Although various oligo dT-based RNA amplification protocols have
been used, a new product emerged recently, which foregoes this type of amplification. The
NuGen Ovation RNA-Seq system is a single primer-based RNA amplification product that uses
isothermal amplification (Kurn et al. 2005; Dafforn et al. 2004). In this system, the RNA is
reverse transcribed, then partially degraded in order to synthesize a second DNA strand from
the first-strand cDNA template (Kurn et al. 2005; Dafforn et al. 2004). Double-stranded DNA is
purified and amplified using single primer isothermal amplification. This amplification process
starts with RNase H cleaving RNA in DNA/RNA heteroduplexes located on the ends of doublestranded DNA. Next, the proprietary primer binds to cDNA and polymerase starts replication at
the end of the primer by displacing the existing forward strand. Finally, random hexamers initiate
linear amplification of the second-strand cDNA (Kurn et al. 2005; Dafforn et al. 2004). After
amplification with the NuGen system, samples were prepared for deep sequencing according to
standard Illumina procedures. This included a poly-A selection step with beads, as well as linker
ligation with unique multiplexed ends. Multiplexing allowed each sequenced read to be
distinguished by a 6 basepair (bp) tag at the end of the sequencing adaptor. Sequencing was
performed in a single lane of an Illumina HiSeq 2000 machine. Base calls were made by
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Illumina’s software (Eland). Next, reads were de-multiplexed to allow the GFP+ sample’s reads
to be distinguished from the GFP- sample.
An algorithm called Tophat was then used to align raw sequence reads to the reference
genome and to map splice junctions (Ensembl Drosophila BDGP5.25.62 release; Trapnell et al.
2009). Tophat output was then used as input for the algorithm Cufflinks v. 1.0.3, which
assembled whole transcripts and estimated their abundance (Roberts et al. 2011). Cuffdiff was
then used to test for differential expression in RNA-Seq samples. Cuffdiff identified 4,846 out of
22,872 transcripts that were enriched at 1.5-fold or higher in the GFP+/GFP- sample. Tophatgenerated alignments of RNA-Seq data in BAM format were indexed and sorted for visualization
in the Integrated Genomics Viewer (Robinson et al. 2011). Indexed RNA-Seq reads were
visualized as coverage tracks. In order to be able to compare samples directly, coverage tracks
were always graphed with identical y-axis coordinates. Heat maps were generated in
MultiExperiment Viewer (MeV; Saeed et al. 2006).
ChIP-chip and RNA-Seq data integration
ChIP-chip and RNA-Seq gene lists were integrated using Galaxy (Goecks et al. 2010). In order
to establish whether or not the statistical overlap was due solely to chance, a cumulative
hypergeometric probability was calculated as follows: population size = 22,872 total transcripts;
number of successes in population = 4,846 enriched transcripts; sample size = 597 ChIP-chip
associated transcripts; number of successes in the sample = 170 ChIP-chip transcripts that are
enriched at 1.5-fold or higher in the population. Instead of a simple hypergeometric probability,
the more stringent cumulative probability of obtaining 170 or more hits due to chance alone was
calculated: P(X ≥	
 170) was equal to 1.21 x 10-5.
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RESULTS
Genome-wide identification of direct DIMM targets by in vivo ChIP-chip
detection of genome-wide DIMM binding
To identify in vivo DIMM occupancy at binding sites throughout the genome, a tagged
ChIP-chip strategy was employed (Ezhkova and Tansey 2006; see Materials and Methods).
Success of the tagged ChIP approach was measured by examining DIMM occupancy at its
known binding site in the first intron of PHM and lack of occupancy at a nearby (control) site
(Park et al. 2011). Once I could confirm the specificity of DIMM binding to PHM intron 1, I
initiated ChIP-chip analysis.
I performed anti-MYC ChIPs from both experimental and control Drosophila head
extracts. DIMM-bound DNA fragments were identified using Drosophila Tiling Arrays 2.0
(Affymetrix). For each genotype, arrays were hybridized with ChIPed DNA, as well as pre-ChIP
genomic input DNA (n=2 biological replicates for each genotype and sample type). Thus, I used
a total of eight arrays: two ChIP arrays, two input arrays per genotype. I identified DIMM binding
peaks using the MAT algorithm (Johnson et al. 2006).
In order to identify true DIMM binding in a rigorous way, I employed three different types
of MAT comparative analyses: i) DIMM::MYC ChIP sample was compared against its input
(DIMM ChIP/Input), ii) the control (maternal strain) ChIP sample was compared against its own
input (NEG ChIP/Input), and iii) DIMM ChIP sample was compared against the control ChIP
sample (DIMM ChIP / NEG ChIP). The last comparison (DIMM ChIP / NEG ChIP) was
scientifically valid because an identical amount of DNA was hybridized to each tiling array,
regardless of sample type or genotype. Each of these MAT analyses, including the second
analysis (NEG ChIP/Input) yielded enriched regions at a commonly accepted p-value of 1 x 10-5:
i) DIMM ChIP/Input - 5,644 bound regions ii) NEG ChIP/Input - 3,177 regions and iii) DIMM ChIP
/ NEG ChIP - 258 regions.
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Although ChIP-chip from the NEG ChIP/Input (control) sample was theoretically
supposed to yield no specifically-bound regions by MAT, many regions was detected as
significant (3,177 regions). This likely happened due to the MYC-tag antibody binding nonspecifically to DNA, or due to specific interactions between genomic DNA and agarose beads,
and other reaction vessels (Sandmann et al. 2007). Nevertheless, increasing the statistical
stringency of MAT analysis of both samples by progressively decreasing the p-value eventually
reduces the number of bound regions in the NEG ChIP/Input to a few, while leaving many more
bound regions in the DIMM ChIP/Input sample intact. Based on the need to fairly compare all
three analyses against each other, I left the p-value cutoff unchanged. Instead, after
consultations with the author of MAT (X. Liu, personal communication), I decided that the most
prudent way to analyze the data was to subtract NEG ChIP/Input bound regions from the DIMM
ChIP/Input bound regions, and then intersect the resulting regions with the 258 bound peaks in
the DIMM ChIP / NEG ChIP comparison.
The resulting intersection of the DIMM ChIP/Input bound regions lacking any NEG
ChIP/Input overlap with DIMM ChIP / NEG ChIP bound regions yielded a total of 156 bound
peaks (Table 1). As with ChIP-qPCR in Chapter 2, I again used DIMM occupancy in the first
intron of PHM as an internal positive control. Indeed, by DIMM ChIP / NEG ChIP analysis, the
DIMM binding peak in the first intron of PHM was the fifth highest scoring peak (MAT score
139), and it was the 25th most highly scoring peak in the DIMM ChIP/Input comparison (MAT
score 280.8). Visualization of this previously known bona fide DIMM enhancer in the genome
browser is shown in Figure 2. Lack of any significant binding in the NEG ChIP/Input comparison
is striking. I therefore submit that the subtraction and intersection of the three MAT analyses
yields a high quality data set of DIMM-occupied regions.
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Genomic annotation of DIMM-bound peaks
Having identified DIMM-occupied genomic regions, I then annotated them with respect to
various genomic features such as transcription start sites (TSSs), exons and introns. It has been
well documented that bHLH transcription factors bind not only to promoters, but also to introns,
where they can recruit the basal transcriptional machinery (Cao et al. 2010; Tian et al. 2010;
Menet et al. 2010). DIMM binds to specific palindromic E-boxes (CATATG and CAGCTG) that
are located in introns of target genes in addition to PHM (Park et al. 2008; Park et al. 2011).
Similarly, its mammalian orthologue Mist1 binds to CATATG E-boxes located in the first intron of
6 of its targets (Tian et al. 2010).
Of the 156 high stringency DIMM-bound peaks, 51 (33%) do not overlap with introns,
although some might be in their vicinity. Another 43 peaks (28%) have a degree of intron
overlap ranging between 1% and 50% of their length. 26 more peaks have 50% - 97% overlap
with an intron. Finally, 36 peaks (23%) have 100% overlap with an intron (Figure 3A). Binding
sites were also annotated with respect to introns, exons and promoters by using a gene
structure annotation algorithm (PinkThing, Figure 3B). This analysis showed that the majority of
the peaks overlap with introns (39%) and promoters (23%).
Next, a search for statistically overrepresented sequence binding motifs was conducted
and one E-box motif was isolated. The E-box motif with the consensus sequence
CATATGKTTS was isolated with a z-score -2.6297 and a p-value of 0.004273. Statistical
overrepresentation of a motif containing the CATATG E-box is entirely consistent with the Eboxed that DIMM binds to in the first intron of PHM (Park et al. 2008b). When conservation
status of all 156 DIMM-bound peaks was examined by employing pairwise alignment
comparisons between DIMM-bound regions and homologous regions in 13 insect species, a
high degree of conservation was observed (Figure 3D). Nucleotide scores ranging from 0.956
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for droSec1 genome to 0.513 for the droGri2 Drosophila species, and lower conservation with
bees and mosquitoes (0.11 - 0.15; Figure 3D).
The 156 DIMM-bound peaks that passed the high stringency criteria were annotated by
using tools from the open source Galaxy platform for genomic analysis (Goecks et al. 2010).
Peaks were annotated by fetching the closest non-overlapping genomic features from: all
Drosophila exons, introns, 5 kilobase upstream regions and 5’ untranslated regions (UTRs).
Using this annotation strategy, 156 peaks as input produced a total of 284 DIMM ChIP-chip
binding-associated genes (Table 2). Additionally, the 284 genes that are associated with DIMMbound regions produce a total of 598 transcripts.
DIMM transactivation of enhancers identified by in vivo ChIP-chip
Based on previous evidence, DIMM and Mist1 likely function as transcriptional activators
(Park et al. 2008b; Park et al. 2011; Tian et al. 2010). To support that supposition, we tested
DIMM’s ability to transactivate ChIP-chip-identified-regulatory fragments of the candidate gene
targets, using luciferase levels as a readout. This assay (carried out by Ms. Jennifer Trigg) used
the BG3 Drosophila neuronal cell line as described in Chapter 2 (Park et al. 2011). 39 of 156
DIMM-bound regions were tested in luciferase transactivation assays (Figure 4). DIMM
transactivated 19 out of 39 fragments with reporter induction ranging from 5.9 to 93-fold (p-value
< 0.05). Interestingly, many of the tested enhancers produced inductions that were many fold
higher than the strongest inductions recorded previously (genes PHM, mael and CG6522, Park
et al. 2011). The remaining enhancers showed mild induction or their induction was
indistinguishable from controls. These data suggest that DIMM can indeed directly activate gene
expression from a considerable fraction of enhancers identified by in vivo ChIP-chip.
Deep sequencing the LEAP transcriptome
The usefulness of a gene regulatory interactome can be greatly enhanced with
information about the gene expression landscape operating in the same cells as the
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transcription factor of interest. In order to obtain a transcriptional profile of LEAP cells, DIMM+
cells were labeled with GFP, and GFP+ cells from adult fly brains were FACS sorted. GFP+
cells and a group of randomly chosen GFP- cells of similar size (likely a stochastic mixture of
neurons and glia) were sorted, their RNAs isolated and profiled by deep sequencing (RNA-Seq).
All data analysis was done by comparing the DIMM+/GFP+ transcriptome directly to the DIMM/GFP- transcriptome. This was a fair comparison because the samples were processed
identically, in parallel and yielded similar numbers of RNA-Seq reads: 36.9 million 42-bp reads
from the GFP+ sample and 39.6 million 42-bp reads from the GFP- sample. The majority of the
reads mapped to the Drosophila genome (23.9 million / 36.9 million GFP+ reads and 32.3
million / 39.6 million GFP- reads). Furthermore, 34.8% of GFP+ reads were unique reads (one
alignment in the genome) and 29.99% were multiple alignments (likely to genomic repeat
regions). The GFP- sample had 56.33% uniquely aligned reads and 25.45% multiply aligned
reads. The algorithm for comparing gene expression levels between RNA-Seq data
standardizes all samples in terms of fragments per million base pairs sequenced (Roberts et al.
2011). Despite some differences in the total number of aligned reads between the GFP+ and
GFP- samples, the two samples are directly comparable by Cufflinks.
After determining that the RNA-Seq datasets contained high quality sequence that
aligned to the Drosophila genome, the DIMM+/GFP+ sample’s transcriptome was compared to
the DIMM-/GFP- transcriptome. Initial analysis showed that 4,676 isoform-specific transcripts
out of 22,872 total transcripts were enriched in LEAP cells at a minimum 1.5-fold enrichment.
The first specific measure examined was the enrichment of DIMM transcripts in the GFP+
against the GFP- sample. Indeed, DIMM transcripts were enriched at 138-fold in the
GFP+/GFP- comparison. Next, I examined a group of genes known to be enriched in DIMM
cells compared to other cell types. In all cases, the enrichment prediction matched the real data
(Figure 6). For example: several of the seven Insulin-like peptides (Ilps) are known to be
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enriched in LEAP cells, whereas other family members are expressed outside of the CNS (Park
et al. 2008a; Brogiolo et al. 2001). The known LEAP cell-enriched Ilps were indeed enriched by
RNA-Seq (Ilp5: 1.6-million fold, Ilp3: 688-fold, Ilp2: 489-fold, Ilp6: 26-fold; Figure 6A,C), whereas
Ilps with known lack of CNS expression were not enriched (Ilp1: 0.3-fold enrichment, Ilp4 and
Ilp7: no expression in either sample; Figure 6A,C). While DIMM overlaps with many peptides,
the extent of DIMM overlap depends on the peptide (Park et al. 2008a). A few peptides have low
or almost no overlap with DIMM (Park et al. 2008a). As expected, such peptides did not show
significant RNA-Seq enrichment (Proctolin: 4% of larval LEAP cells and 1.3-fold enrichment;
Ptth: 0% larval LEAP cells and 1.5-fold enrichment, Dh31: 5.3% of larval LEAP cells and 1.6-fold
enrichment; Figure 6A). Half of Pigment dispersing factor (PDF+) neurons overlap with DIMM in
the adult brain, which matches RNA-Seq data (Figure 6B; Park and Taghert 2009). Previous
reports have indicated that while PHM overlaps extensively with DIMM, the overlap is not
exclusive (Park and Taghert 2009). In accordance with this fact, RNA-Seq data showed that
Phm was enriched 3.5-fold in LEAP cells over non-LEAP cells (Figure 7). CAT-4, another DIMM
bona fide target was enriched at 2.77-fold (Park et al. 2011). Overall, these data confirm the
high fidelity and quality of the RNA-Seq data set.
Integration of transcriptome (RNA-Seq) and interactome (ChIP-chip) results
The resolved LEAP cell transcriptome is an excellent resource that can be directly
integrated with the ChIP-chip data set. The basic hypothesis here is that DIMM activates gene
expression. Therefore, those LEAP-cell enriched genes that are adjacent to DIMM binding
peaks likely represent the true targets of DIMM’s transcriptional activity. DIMM binds to 156
regions in the genome, which corresponds to 284 genes and a total of 598 transcripts from
those genes (Table 1). The LEAP transcriptome has 4,676 transcripts out of 22,872 total
transcripts that are enriched at 1.5-fold or higher (Table 2). Of the 598 ChIP-chip-associated
transcripts, 170 transcripts are amongst the 4,676 LEAP-cell-specific transcripts (Table 3,
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Figure 7). This overlap is more than that due to chance alone (hypergeometric probability
P(x≥170)= 1.21 x 10-5. As in previous analyses, PHM is included on the list of intersected genes
and its inclusion could serve as another quality control measure (Park et al. 2011).
DISCUSSION
DIMM gene regulatory network
Scaling factors allow cells to scale subcellular resources (such as organelles) to become
specialists in certain physiological functions or to adapt to changing daily conditions (Mills and
Taghert 2011). These factors are conserved through evolution and once expressed, their
expression persists for the lifetime of the cell (Mills and Taghert 2011). Identifying their mode of
operation is an important task since their dysfunction might contribute to human diseases of
adult onset (Mills and Taghert 2011). Furthermore, up until now, there has been a focus on
understanding transcription factors acting in the early specification of progenitors and lineage
development. While the information gleaned from such studies is beneficial to our understanding
of how cells are constructed, we must also understand how cells acquire their mature
properties. Studying scaling factors such as DIMM provides insight into this process.
Although I could have pursued a variety of biochemical, molecular and genetic
approaches to better understand the mechanism of DIMM action, I felt that the best systematic
approach was to define the full scope of DIMM targets on a genome-wide level. Thus, I
identified sites of DIMM binding in the genome of adult NE cells in vivo. This allowed me to
pursue identification of genes that DIMM targets for transcriptional activation. With the exception
of a recent TFEB study, genome-wide identification of scaling factor direct targets has not been
previously reported in literature (Palmieri et al. 2011). The ChIP-chip gene regulatory
interactome that I identified in this study is one of the first genome-wide studies to identify direct
targets of a scaling factor in vivo. The technical approach I pursued allowed for ChIP-chip to be
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performed in a highly selected cell population (e.g. directed expression of the DIMM::MYC
transgene only in 300 DIMM+ adult NE cells).
In order to focus my attention on DIMM target genes that contribute most highly to
DIMM-dependent NE physiology, I decided to use extra-rigorous binding site identification
methods. I first compared the DIMM ChIP sample and the negative control sample to their
respective input samples. The negative control sample likely contains ‘background’ binding that
is a common artifact of ChIP due to unexpected ‘‘off-target effects’’ of the antibodies, nonspecific enrichment of chromatin through binding to unrelated immunoglobulins, as well as nonspecific binding to agarose beads, reaction surfaces and other reagents (Sandmann et al.
2007). As a first step in data analysis, the coordinates of genomic regions enriched at
statistically significant levels in the negative control were subtracted from the genomic regions
bound by DIMM. This subtraction resulted in 2,914 regions enriched in the DIMM ChIP/Input
sample but not in the NEG ChIP/Input sample (or 6,869 “bits” of regions with no such overlap). It
is possible that a significant fraction of these peaks represent DIMM targets. In order to increase
analysis stringency further, MAT results from DIMM ChIP tiling arrays were directly compared to
results from negative control ChIP tiling arrays. This analysis yielded 258 DIMM-bound regions
that were significantly enriched in the DIMM ChIP condition compared to the negative control
ChIP. Finally, the intersection of the two sets of regions produced a set of 156 genomic regions
that are the most likely enhancers that DIMM binds in vivo in adult NE cells.
By performing this rigorous bioinformatic identification of DIMM ChIP-chip binding sites,
the certainty of uncovering true DIMM targets was raised at the expense of false negatives.
Nevertheless, the estimated number of binding sites for DIMM (156 peaks) closely resembles
the estimated number of lysosomal genes that are controlled by TFEB (on the order of 200
genes; Sardiello et al. 2009). It is unlikely that scaling factors, such as DIMM or TFEB control a
large fraction of the genome. Furthermore, it is plausible that scaling factors, similar to other
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transcription factors, lie at the top of a gene regulatory hierarchy involving multiple transcription
factors acting in loops or cascades (Macquarrie et al. 2011). Therefore, a limited number of
gene targets (on the order of 200) does not necessarily rule out more genes involved in scaling
factor physiology, by means of activation by downstream transcription factors.
The assignment of genes to ChIP-chip peaks (Table 1) is not perfect due to many
factors, including: close packing of genes in the genome, the incomplete annotation of
transcription units, and the ability of enhancers to act over large distances that sometimes skip
intermediate genes (Li et al. 2008). In fact, the c929-GAL4 element that overlaps extensively
with DIMM expression is located 13 kilobases upstream of DIMM, in an alternative intron of
another gene (cryptocephal; Hewes et al. 2003). Despite these caveats, it is believed that most
transcription factors bind their gene targets in stereotypically close association to TSSs and
long-range enhancers appear to be the exception rather than the rule (Arnosti 2003).
LEAP cell transcriptome
To the best of my knowledge, this high quality data set is the first NE transcriptome
obtained by next generation sequencing. Although DIMM-expressing NE cells are highly diverse
with respect to their peptidergic identity, they share in common a high secretory capacity and a
robust RSP (Park and Taghert 2009). In Drosophila, these cells were previously subjected to
limited peptidomic profiling (Yew et al. 2009), and a single identified set of DIMM neurons (the
eight circadian pacemakers called large LNvs) was profiled transcriptionally (Kula-Eversole et
al. 2010; Nagoshi et al. 2010). Nevertheless, there are currently no reports of RNA-Seq-derived
transcriptomes of any known NE cell population. Unlike microarrays, deep sequencing allows for
a more detailed examination of the transcriptome with the ability to distinguish allelic expression
and transcriptional isoforms of genes (Wang et al. 2009). Due to the focus on using RNA-Seq to
interpret ChIP-chip data, a detailed analysis of the RNA-Seq data is out of the scope of this
chapter but will be pursued in detail later.
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NE cells in mammals and insects represent the minority of CNS cells in terms of
absolute numbers (Zupanc 1996; Park and Taghert 2009). Despite low absolute numbers, loss
of DIMM expression from LEAP cells is not compatible with survival past embryonic stages
(Hewes et al. 2003). There are several available methods of profiling gene expression in a cell
population with sparse numbers: manual collection of individual cells, laser capture
microdissection and FACS (Ozsolak and Milos 2011). While each method has advantages and
disadvantages, the primary goal of the current study was to collect a highly purified cell
population and maximize the amount of input material. Therefore, FACS was chosen as the
method of choice due to its high speed and ability discriminate cellular fluorescence levels easily
(Givan 2011).
Interactome – Transcriptome integration
A natural progression in data analysis was to integrate the DIMM gene regulatory
interactome obtained by ChIP-chip and the LEAP cell transcriptome obtained by RNA-Seq of
purified DIMM-expressing cells. When the list of 156 ChIP-chip regions that were mapped to
284 genes and a total of 598 transcripts was intersected with the list of genes enriched in LEAP
cells, 170 transcripts (116 genes) fell into both categories. This likely represents a high quality,
stringent list of direct DIMM targets. The observed overlap was greater than overlap due to
chance, as shown by the cumulative hypergeometric probability. Thus, genes on this crosssectional list are not only direct DIMM targets in LEAP cells by ChIP-chip, but their expression is
enriched in LEAP cells compared to DIMM-negative cells.
The caveat to this intersectional assignment is that it assumes that DIMM acts as a
transcriptional activator in all cases. This assumption is based on previous experiments that
demonstrated that DIMM acts as an activator of PHM transcription (Park et al. 2008b).
Nevertheless, certain bHLH proteins are known to act as repressors (Stevens et al 2008). Such
repressive bHLHs were first identified in Drosophila (Stevens et al. 2008). In accordance with
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this possibility, 50 out of 598 ChIP-chip associated transcripts are expressed in DIMM+/GFP+
cells at 50% of their level in the DIMM-/GFP- cells (and only 3 out of 50 are found at 10% of
their level in DIMM-/GFP- cells). In contrast, 170 out of 598 ChIP-chip transcripts are enriched in
DIMM+/GFP+ cells over DIMM-/GFP- cells, which gives credibility to the hypothesis that DIMM
operates as a transcriptional activator in all cases. A precise answer to this question can be
obtained by pursuing RNA-Seq of DIMM loss-of-function cells, which is one of the planned
follow-up studies.
DIMM, like many transcription factors acts as an activator of transcription (Allan et al.
2005). By this logic, if a DIMM binding site is located in a dense milieu of TSSs and only one of
the surrounding genes is enriched in LEAP cells, then, this increase the likelihood that DIMM is
activating this particular gene and not its neighbors. Overall, transcriptome/interactome
integration reduces the false positives in ChIP-chip gene regulatory data due to a reduction in
gene assignment noise (Wyrick and Young 2002).
Classifying DIMM target genes into functional categories
The integrated data set consists of a variety of genes with certain subsets clustering in a
few categories (Table 4). One such category are neuropeptide processing enzymes: the
peptidylglycine hydroxylating alpha-monooxygenase PHM, the peptidyl-alpha-hydroxyglycine
alpha-amidating lyase PAL1, the prohormone convertase amontillado, and the
carboxypeptidase D silver. All these enzymes reside in LDCVs, where they are indispensible for
the proper processing of neuropeptides. Their appearance on this high quality list confirms and
extends the supposition that DIMM targets peptide biosynthetic enzymes (Park et al. 2008). It
also provides important “quality control” assurance that the procedure is generating targets
expected to be on the list. Slamdance is a Drosophila aminopeptidase with a bang-sensitive
paralytic mutant phenotype (Zhang et al. 2002). Human aminopeptidase N, the mammalian
orthologue of slamdance, is in involved neuropeptide processing and degradation (Montiel et al.
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1997; Solhonne et al. 1987). Thus, the inclusion of slamdance as a likely DIMM target
represents the first indication that it could be involved in neuropeptide processing in Drosophila
as well as mammals.
Slamdance also establishes a link between neuropeptide signaling and epilepsy, which
is a relatively new concept with a seminal paper reporting a knockout mutation of neuropeptide
Y leading to epileptic phenotypes in the mouse (Baraban et al. 1997). Furthermore, expression
of a PHM / Pal1 and a number of amidated neuropeptides increases after seizures induced by
electroconvulsive shock, kainate, or pentylenetetrazole (Ma et al. 2002; Bhat et al. 2003;
Baraban et al. 1997). Additional genes that fall into the endopeptidase/metallopeptidase
category with possible role in neuropeptide processing or degradation are: CG4933, Rpn9 and
Atg4. This work shows that a whole battery of secretory processing enzymes is under
transcriptional control of a single transcription factor, DIMM. Although the fact that DIMM
controls processing enzymes may not be a surprising, it is, nevertheless, a completely novel
finding. No single transcription factor has been revealed to possess the ability to control all or
most neuropeptide processing factors.
Another category of genes under direct DIMM control includes fly orthologues of those
mammalian genes whose protein products have been shown by proteomic studies to be
constituents of LDCVs (Table 4; Gauthier et al. 2008; Wegrzyn et al. 2010). Genes in this
category include: 14-3-3zeta, 14-3-3epsilon, jaguar, Translationally controlled tumor protein and
betaTubulin56D. The two members of the 14-3-3 family of adaptor proteins are a highly
conserved family of acidic molecules present in all eukaryotes (Aitken 2006). Both 14-3-3zeta
and 14-3-3epsilon have been implicated in the response of the hypothalamic-neurohypophyseal
system to osmotic stress (Gouraud et al. 2007). The expression of 14-3-3zeta and 14-33epsilon is increased in the rat supraoptic nucleus, a NE center, after three days of water
deprivation. Furthermore, 14-3-3epsilon has a crucial role in antimicrobial peptide secretion
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(Shandala et al. 2011). Jaguar, a Drosophila myosin VI homologue is another gene with LDCV
localization and known role in secretory vesicle fusion at the plasma membrane (Bond et al.
2011). Jaguar is a unique member of the myosin superfamily of actin-based motor proteins
because it is the only myosin known to move towards the minus or pointed ends of actin
filaments (Kisiel et al. 2011). Drosophila larvae lacking jaguar have altered synaptic vesicle
localization: instead of peripherally located synaptic vesicles, jaguar mutants have diffusely
located vesicle across the entire bouton area (Kisiel et al. 2011). After budding from the transGolgi network, LDCVs are transported to the secretion sites at the plasma membrane via
microtubule-based transport systems (Park and Loh 2008). LDCVs are then loaded onto an
actin/myosin system for distal transport through the actin cortex to just below the plasma
membrane (Park and Loh 2008). Therefore, it is plausible that DIMM would activate the
expression of those genes necessarily for LDCVs to properly traffic to their designated location
at the cell periphery where they await release signals.
Transcription. In addition to secretory enzymes and LDCV constituents, DIMM also
targets transcription factors, in particular members of the Atf/CREB superfamily of basic leucine
zipper (bZIP) genes: the Drosophila Atf-4 orthologue cryptocephal (significant for being
immediately adjacent to DIMM), the pro-secretory transcription factor CrebA, the stressresponse gene Atf-2, as well as the circadian-implicated transcriptional repressor vrille. bZIP
proteins contain a leucine zipper, an alpha-helical coil structure required for dimerization, as well
as a neighboring basic domain needed for direct contact with DNA (Foulkes et al. 1997). Two
non-bZIP transcription factors are the circadian regulator clockwork orange, as well as the
Per/Arnt/Sim-domain containing bHLH similar. Cryptocephal (Atf-4) is important for
metamorphosis and molting in Drosophila, and in oxidative stress, amino acid synthesis,
autophagy, unfolded protein response and long-term memory in mammals (Hewes et al. 2000;
Ameri and Harris 2008). Mammalian Atf-2 and Atf-4 regulate emotional behavior in the nucleus
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accumbens by unknown mechanisms (Green et al. 2008). It is currently unknown how
cryptocephal might play a role in the secretory capacity of NE cells.
CrebA is major and direct regulator of secretory capacity of a variety of cell types at the
level of the Golgi apparatus (Fox et al. 2010). CrebA can upregulate expression of the general
protein machinery required in all cells for secretion, as well as certain secreted proteins that are
cell-type specific (Fox et al. 2010). In Drosophila, CrebA is important for elevated secretory
activity in the salivary gland, as well as in the developing cuticle (Abrams and Andrew 2005).
Thus CrebA is adaptable, in different cellular contexts, to promote a high capacity secretory
state. CrebA appears to activate expression of genes encoding proteins required for ER
targeting and translocation, and proteins that mediate transport between the ER and Golgi
(Abrams and Andrew 2005). Thus, similar to other secretory cell types, it is plausible that NE
cells need high levels of CrebA, which is recruited to the purpose by DIMM as a part of its
general action mechanisms. Interestingly, there is very little overlap between genes thought to
be CrebA targets and DIMM target genes that I have identified.
Furthermore, it may be notable that DIMM activates two factors that are known for the
their potent ability to antagonize bHLH actions: vrille and clockwork orange. Vrille is a bZIP
transcriptional repressor that acts by inhibiting expression of the core circadian bHLH gene
Clock, as well as the circadian blue light photoreceptor cryptochrome (Glossop et al. 2003). As
a part of the circadian system, VRILLE competes with a related bZIP protein PDP1 for binding to
the Clock promoter. Whereas VRILLE represses Clock expression, PDP1 activates expression
of Clock and thereby actively competes with vrille (Cyran et al. 2003). In addition to vrille, DIMM
targets another repressive factor, the basic helix–loop–helix ORANGE family member clockwork
orange. Clockwork orange forms its own negative feedback loop and directly suppresses the
expression of other clock genes through the E-box sequences (Matsumoto et al. 2007; Kadener
et al. 2007). It is possible that by targeting vrille and clockwork orange, DIMM uses complex
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gene regulatory logic, beyond simple transcriptional activation. According to this line of thinking,
the genetic logic of the mechanisms activated by the bHLH DIMM is similar that of the molecular
clockwork instigated by the bHLH proteins Clock and cycle: both may use feedforward and / or
feedback negative regulation by vrille and clockwork orange to modulate the amplitudes of the
target gene expression.
Endocytosis. Genes involved in endocytosis and Notch signaling represent another
category of DIMM targets: nicastrin, Gp150, I’m not dead yet, TRAM and CG31064. Nicastrin is
a part of the gamma-secretase core complex required for cleavage of transmembrane proteins
such as Notch and presenillin (Hass et al. 2009; Steiner et al. 2008). Gp150 is an endosomal
protein that regulates Notch activity (Li et al. 2004). Since the Notch protein itself is high in
LEAP cells, it is possible that Gp150 and nicastrin are performing a role in DIMM-dependent NE
cell physiology in a manner that also involves Notch signaling in mature cells.
RNA-binding proteins. A separate family of DIMM targets includes genes that are
implicated in RNA processing or metabolism: alan shepard, ELL-associated factor, Ef1α48D,
Not1, U4-U6-60K and eIF-4A. Alan shepard is a single-stranded RNA-binding protein isolated
in a genetic screen for gravitaxis mutants (Bjorum and Beckingham 2007). RNA-binding
proteins such as alan shepard engage in pre-mRNA processing, which includes splicing,
editing and polyadenylation of messages (Glisovic et al. 2008). At the structural level, RNAbinding proteins are highly modular, with one or more RNA-binding and auxiliary domains
(Glisovic et al. 2008). DIMM binding frequently occurs in areas that are promoters of certain
isoforms and introns of other isoforms of the same RNA-binding protein. Furthermore, RNASeq data show that only certain isoforms of RNA-binding proteins are enriched in LEAP cells
by RNA-Seq, whereas other isoforms of the same gene are not enriched, or could even be
repressed. Therefore, it is possible that DIMM targets certain isoforms of RNA-binding proteins
with desired sequence-binding specificities for expression in LEAP cells.
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RNA-binding proteins function in every aspect of RNA biology, from transcription, premRNA splicing and polyadenylation to RNA modification, transport, localization, translation and
turnover (Glisovic et al. 2008). Therefore, it is possible that RNA-binding proteins that DIMM
targets play a major role in the ability of LEAP cells to correctly traffic or localize
neuropeptides. Certain RNA-binding proteins are known to be potent repressors of translation
of certain sequence-specific RNA targets (Horisawa et al. 2009). Since neuropeptides are
translated in very large quantities inside NE cells, it is plausible that translation of other RNA
messages needs to be reduced or halted from time to time in order to achieve necessary levels
of neuropeptide translation. RNA-binding proteins could play a role of in translation of such
RNA messages that are perhaps of secondary importance during particular physiologic states.
Alternatively, the splicing of neuropeptide RNAs or their stability might need to be enhanced,
therefore requiring RNA-binding proteins to carry this function out with high selectivity.
Before this work was initiated, Hamanaka et al. (2010) investigated what happened to
photoreceptors, a class of conventional, non-peptidergic neurons, when they are forced to
express DIMM. This work showed DIMM’s remarkable ability to convert non-peptidergic cells
into peptidergic cells possessing LDCVs, the morphologic correlate of the RSP. Therefore, we
had a great insight into the ultrastructural changes that DIMM can set off once activated
ectopically in a cell. What was lacking, however, was the molecular framework of how this
remarkable cellular transformation is achieved. Collectively, therefore the results presented in
this chapter provide a fundamental road map to define exactly how DIMM is able to organize,
scale up and maintain an active RSP in NE cells.
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Figure 1. Detection of DIMM::MYC induction in adult heads by Western blotting. (A) Flies
overexpressing DIMM::MYC (left panel, labeled “DIMM”) or GFP (right panel, labeled “GFP”) in
DIMM+ (c929-GAL4-expressing cells) developed normally at the restrictive temperature (18°C).
Following eclosion, both genotypes were shifted to 30°C for 3-5 days. This allowed for a specific
induction of DIMM::MYC expression in DIMM::MYC-overexpressing heads (top left panel) and
lack thereof in GFP-overexpressing heads (top right panel). In contrast to DIMM::MYC induction,
GFP was induced in GFP-overexpressing heads (middle right panel) but not in DIMM::MYCexpressing heads (middle left panel). Adult head extracts were analyzed by Western blotting
with indicated antibodies. Tubulin was used as a loading control (bottom). Genotype: yw/w;
c929-GAL4/UAS-DIMM::MYC; tub-GAL80ts/+ (left panel) and yw/w; c929-GAL4/UAS-2xEGFP;
tub-GAL80ts/+ (right panel). (B) Time course of DIMM::MYC induction following the shift from
restrictive to permissive temperature. Genotype: yw/w; c929-GAL4/UAS-DIMM::MYC; tubGAL80ts/+. Tubulin was used as a loading control. Hours after shift to 30°C are indicated above
each lane. Adult head extracts were analyzed by Western blotting with indicated antibodies.
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Figure 2. DIMM Binding to its known enhancer in the first intron of PHM by ChIP-chip. MYC
antibody ChIP-chip was performed in flies expressing a DIMM::MYC transgene in normally
DIMM+ cells. The negative control strain, lacked the DIMM::MYC transgene, but was otherwise
identical to the experimental strain. ChIP and input DNA were analyzed using Affymetrix tiling
arrays and MAT. The PHM locus is displayed inside the UCSC Genome Browser. In order to
rigorously identify true DIMM binding, three types of MAT comparisons were used. Genomic
enrichment in the DIMM::MYC ChIP DNA was compared to enrichment in its input (DIMM
ChIP/Input, shown in pink). Negative control ChIP DNA enrichment was compared to
enrichment of its input (NEG CONT ChIP/Input, shown in dark blue). Finally, ChIP DNA
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enrichment in the DIMM::MYC samples was directly compared to DNA enrichment in the
negative control (DIMM ChIP / NEG CONT ChIP, shown in red). In order to identify true DIMM
binding, peaks from NEG CONT/Input were first subtracted from DIMM ChIP/Input peaks.
Secondly, the resulting list of binding regions was then intersected with regions identified in the
DIMM ChIP / NEG CONT ChIP comparison. In order for a peak to pass this cutoff, genomic
regions in the subtracted list had to have at minimum 1 bp overlap with genomic regions in the
DIMM ChIP / NEG CONT ChIP list.
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Figure 3. Genomic annotation, motif identification and conservation of DIMM binding peaks. (A)
Overlap of DIMM ChIP-chip peaks with introns calculated as percentage of their length. (B)
PinkThing software annotation of ChIP-chip peaks against Drosophila gene structural elements
(exons, introns, promoter and downstream elements. (C) CATATG E-box motif enriched in
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DIMM ChIP-chip peaks found in introns (p-value 0.004273). (D) Conservation analysis (Multi
Alignment blocks on 15 insect species) of ChIP-chip peaks between D. melanogaster (dm3,
shown on the bottom ) and 14 other insect species. (E) Distance of ChIP-chip peaks from
transcription start sites.
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Figure 4. DIMM transactivation of 39 genomic fragments with significant DIMM ChIP-chip
binding in a Drosophila BG3-c2 neuronal cell line. Luciferase reporter was placed downstream
of a mini-SV promoter and a ChIP-chip derived enhancer. Fold ratios represent Luciferase
levels with DIMM co-transfection divided by those without. Histograms represents means and
SEMs of at least three independent replicate assays except for the crc-F fragment. *p-val<0.05
student t-test
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Figure 5. FACS sorting of DIMM+ and DIMM- cells. Brains were dissected from UAS-dcr2; c929GAL4, UAS-CD8; flies and dissociated into single cells. DIMM+ cells (as marked by c929>GFP
expression) and randomly selected GFP- cells were FACS sorted. Top left panel shows the
distribution of c929>GFP signal in an adult brain. Examples of GFP+ cells (bottom right panel)
and GFP- cells (bottom left panel) are shown.
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Figure 6. The neuroendocrine transcriptome of LEAP cells revealed by deep
sequencing. (A) Enrichment of known Drosophila neuropeptides by RNA-Seq in the GFP+/GFPsample is depicted as fold change (left) and in the form of a heat map (right). Neuropeptide
names are indicated in the center of the figure. Overlap of DIMM+ cells with some of the
neuropeptides in the larval CNS is given on the right (Park et al. 2008a). (B-D) Integrated
Genomics Viewer was used to visualize RNA-Seq tracks from GFP+ and GFP- cells. (B)
Pigment dispersing factor (PDF) locus. (C) Ilp1, Ilp2 and Ilp3 loci. (D) short Neuropeptide F
(sNPF) locus.
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Figure 7. Intersection of DIMM targets detected by ChIP-chip and transcripts
enriched in DIMM+ LEAP cells. Venn diagram depicts the intersection of DIMM interactome and
LEAP transcriptome genes (top, not drawn to scale). Integrated Genomics Viewer view of the
PHM gene locus (bottom). The top three tracks depict ChIP-chip results (DIMM ChIP/Input, pink;
NEG CONT ChIP/Input, blue; DIMM ChIP / NEG CONT ChIP, red). The bottom two tracks
depict RNA-Seq signal: DIMM+/GFP+ signal is shown in green, and DIMM-/GFP- signal is
shown in gray. PHM gene locus structure is shown at the bottom of the window in blue.
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Table 1. List of 156 DIMM binding sites identified by ChIP-chip. Genomic coordinates given
based on the dm3 genomic scaffold. ChIP-chip sites were obtained by subtracting NEG CONT
ChIP/Input sites from DIMM ChIP/Input sites, and by intersecting the resulting sites with the
DIMM ChIP / NEG CONT ChIP sites. Please see attached / uploaded Microsoft
Excel spreadsheet file.	
  

Table 2. List of 284 DIMM ChIP-chip binding region-associated genes. Please see attached /
uploaded Microsoft Excel spreadsheet file.

Table 3. Intersection of the 598 ChIP-chip-associated transcripts and the 4,676 LEAP-cellspecific transcripts. Each entry is described by: gene symbol, CG#, Flybase Gene ID, Flybase
Transcript ID and enrichment in DIMM+/GFP+ cells compared to DIMM-/GFP- cells (reported as
fold change). Please see attached / uploaded Microsoft Excel spreadsheet file.

Table 4. ChIP-chip / RNA-Seq-derived genes grouped into functional categories based on
known gene function reported in literature. Please see attached / uploaded Microsoft
Excel spreadsheet file.
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Assessing the contribution of individual DIMM targets to
DIMM-dependent LEAP cell physiology by an RNAi-based genetic
screen for sleep defects

I performed the sleep experiments in this chapter: genetic crosses, behavioral monitoring and
data analysis with some technical help from Neely Williams.

166
	
  

Chapter 4
INTRODUCTION
LEAP cells express neuropeptides, many of which function in modulating various
behaviors (Nässel 2002). DIMM-expressing neuropeptides control metabolism and a variety of
behaviors, such as ecdysis and sleep (Park et al. 2008a; Kim and Rulifson 2004; O’Brien and
Taghert 1998; Sheeba et al. 2008; Shang et al. 2008). I have chosen to evaluate the functional
consequences of DIMM target knockdown using sleep as a regulated behavior in Drosophila
that has been an established paradigm (Shaw et al. 2000). A subset of LEAP cells, the large
LNv neurons have been implicated in the control of sleep and light-mediated arousal (Sheeba et
al. 2008; Shang et al. 2008). When DIMM+ large LNv and DIMM- small LNv neurons are
chronically hyperexcited, nocturnal activity is increased (Sheeba et al. 2008). Furthermore,
when the authors hyperexcited LEAP cells but excluded PDF-positive Large and Small LNv
neurons, flies exhibited increased daytime and nighttime locomotor activity with decreased sleep
(Sheeba et al. 2008). Another study showed that activation of DIMM- small LNvs had no effect
on sleep or arousal (Shang et al. 2008). This study provides the best evidence the effect of PDF
neuron hyperexcitation on sleep and arousal is attributed solely to the DIMM+ large LNv
neurons and not to the DIMM- small
A direct connection between DIMM and sleep has not been established in the literature
and is reported for the first time in this chapter. When DIMM expression is reduced in small and
large LNv neurons, this leads to an increase in sleep compared to controls (Figure 1A).
Therefore, a functional genetic screen for sleep defects was conducted by RNAi-mediated gene
knockdown specifically in LEAP cells. This allowed for interrogation of the intersected
interactome / transcriptome data set by evaluating individual gene targets in a functional, RNA
interference (RNAi) based screen. This would be relatively feasible considering the ease of
conducting genetics in Drosophila.
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MATERIALS AND METHODS
Sleep
Sleep assays were performed according to standard procedures (Andretic and Shaw 2005).
Conditions were standardized to avoid any inconsistencies since behavior can be affected by
many factors. Virgin females of genotype w,UAS-dcr2; c929-GAL4; were crossed to males from
the Vienna Drosophila RNAi Center (VDRC; Dietzl et al. 2007). The screen was carried out with
the VDRC KK library, which was made by inserting UAS-RNAi casettes into a single attP
genomic site on chromosome II. As controls, w,UAS-dcr2; c929-GAL4; virgins were crossed to
the yw; attP; males. The yw; attP; stock was originally used to create the VDRC KK RNAi library
and is isogenic with the UAS-RNAi lines. Two or more crosses were done for each genotype in
each biological replicate in order to be able to collect 20 female offspring within 48 hours. For
each cross, 15 virgin females were crossed to 5 males at 25°C in standard Drosophila vials.
Males and females were allowed to mate for 5 days, and were then transferred out of the vials.
Daughters from each cross were collected within 12 hours of eclosion and were in almost all
cases virgins. After collection, virgin flies were housed in regular fly vials with ~20 flies per vial
for three days under 12 hour light / 12 hour dark (LD) conditions. In all cases, flies were raised
and aged on the same food medium (standard Drosophila medium). On day four, flies were
placed in 65 mm x 5 mm glass tubes (VWR glass) containing standard Drosophila medium.
Thus, flies were raised and their sleep tested while being fed the same medium. Flies were then
transferred to behavior incubators, where they spent one day acclimating to LD conditions. Light
emitting diodes (LEDs) were used as a light source. Light intensity was tightly controlled to be in
the range of 40 – 50 Lux for all flies. Locomotor activity was collected with second generation
Drosophila Activity Monitoring (DAM2) System monitors in one-minute bins (Trikinetics,
Waltham, MA). Fly sleep was measured for five days, and analysis was done on the first day of
behavior. Although data consistency from day one to day five is relatively high, a minority of flies
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died during recording (from desiccation due to an accidental breach of the wax plug integrity, or
other unknown factors). Therefore, the first full day of behavior is used for all sleep analyses.
Sleep analysis was done with Excel macros provided by Dr. Paul Shaw (Washington
University). Per convention, sleep was measured as bouts of uninterrupted inactivity lasting 5
minutes (Andretic and Shaw 2005). Daytime sleep is defined as the total amount of sleep during
the first twelve hours of the day (this is the period during which lights are on). Daytime sleep is
defined as the total amount of sleep during the first twelve hours of the day (this is the period
during which lights are on). Sleep data shown in Figure 1A were provided by Dongkook Park
and were obtained by crossing UAS-dcr2; pdf-GAL4; females to UAS-dimm RNAi males. Two
different DIMM RNAi lines from the VDRC library were tested: a KK line with precisely inserted
UAS-RNAi, as well as DIMM RNAi from the GD library, which was created by random insertion
transgenesis (Dietzl et al. 2007).
RESULTS
Functional genetic screen of integrated DIMM targets
The 170 transcripts that were identified by integrating DIMM ChIP-chip targets and the
LEAP transcriptome are encoded by a total of 116 genes (Chapter 3 Table 3). Therefore, this list
of 116 “integrated” genes likely represents true DIMM targets. In addition to in vivo binding and
expression, DIMM can directly transactivate at least 12 of these target genes in luciferase in
vitro transactivation assays (Chapter 3 Figure 4). Nevertheless, it is currently not known how
DIMM target genes might affect the physiology of LEAP cells. Therefore, the role of these genes
in DIMM-dependent LEAP cell functions was tested in a genetic screen for sleep defects. When
DIMM expression is reduced in PDF-expressing LNv neurons, flies exhibit increased daytime
sleep (Figure 1A). This effect can be solely attributed to DIMM+ large LNv neurons, which are a
subset of LEAP cells (Sheeba et al. 2008; Shang et al. 2008). DIMM- small LNv neurons do not
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express DIMM and likely have no role in sleep (Park et al. 2008; Sheeba et al. 2008; Shang et
al. 2008).
In order to test the effect of DIMM target gene knockdown on sleep, RNAi was used to
trigger gene knockdown in LEAP cells and the effect of this manipulation on sleep was
monitored. Of the 116 DIMM target genes identified by integrating ChIP-chip and RNA-Seq data,
62 were available from the VDRC KK RNAi library. These 62 isogenic RNAi lines were created
by precise P-element insertion were tested 2 – 4 times as independent biological replicates in
sleep assays. Results showed that manipulating many of DIMM target genes had an effect on
one or more sleep parameters. Various sleep parameters examined included: sleep latency
(time to the first sleep episode of the night), length of sleep episodes (bouts) during the day and
night, length of the longest sleep episode during the day and night, as well as the number of
sleep episodes during the day and night (Andretic and Shaw 2005). The most obvious effect of
DIMM knockdown in PDF+ neurons is an increase in daytime sleep. Therefore, this was the first
parameter examined in the sleep screen (Figure 1B). Indeed, knockdown of many of the high
confidence DIMM targets in LEAP cells showed a tendency towards increased daytime sleep,
which partially phenocopied DIMM loss-of-function sleep phenotype (Figure 1A). This effect was
not significant by a one-way ANOVA with a Bonferroni correction except in the case of Tango14
knockdown. A third of the crosses tested had daytime sleep changes that were significant by an
unpaired student t-test (p-value 0.05). By visual inspection, RNAi lines clearly cluster in the right
half of the graph, whereas control flies (shown in black) sleep ~100 minutes during the first
twelve hours of the day (Figure 1B, 1C). RNAi manipulations with some of the most extreme
deviations in daytime sleep were: Tango14, CG15394, jaguar (Myosin VI), and Rpn9 (Figure
1C). Additionally, many genes had strong effects on other sleep parameters (data not shown).
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DISCUSSION
When genome-wide studies yield lists of genes implicated in a certain process, it is
commonly useful to evaluate the validity of such genes in a functional screen. Since LEAP cells,
and in particular the large LNv DIMM+ neurons, have been implicated in sleep control, I chose
to conduct an RNAi-based screen for sleep defects induced by loss of DIMM target gene
expression in LEAP cells. The sleep screen showed that knockdown of a significant portion of
the DIMM target genes identified by interactome/transcriptome integration produced sleep
defects. In particular, a third of tested RNAi lines phenocopied DIMM RNAi sleep defects with
statistical significance.
There are several explanations available for explaining why all RNAi lines did not
phenocopy DIMM RNAi sleep defects. Many DIMM target genes could function redundantly with
several other proteins, so it is unlikely that knockdown of any one gene would be able to
phenocopy the DIMM loss-of-function sleep phenotype. Indeed, only a few genes produced a
sleep phenotype across all the various sleep parameters such as daytime and nighttime sleep,
sleep latency, the number and length of sleep episodes. Nevertheless, many genes produced
defects in at least one of these categories compared to controls. Furthermore, due to the
inherent variability in sleep time results that exists even after the most rigorous controls, it is
entirely possible that finishing the screen with 4 biological replicates for each tested genotype
could lead to increased ability to determine statistical significance (Andretic and Shaw 2005).
Another potential reason for why some of the tested 62 lines failed to show statistically
significant sleep changes could be due to the GAL4 line used in the sleep study. Although c929GAL4 overlaps greatly with DIMM-expressing neurons, this collection of cells is highly
heterogeneous with respect to neuropeptide expression. C929-GAL4 cells express at least 17
different neuropeptides, and likely more (Park et al. 2008). It is possible that some
neuropeptides could be sleep-promoting, whereas others, such as PDF, could be wake171
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promoting (Parisky et al. 2008). Therefore, interfering with synthesis, accumulation, storage or
trafficking of sleep-promoting and wake-promoting neuropeptides could have neutralizing effects
on sleep. In other words, sleep defects induced by RNAi-based knockdown of DIMM target
genes in one subgroup of c929-GAL4 cells could be cancelled out by another subgroup of c929GAL4 cells. This could be correct by perhaps using pdf-GAL4 for a repeat sleep screen. This
GAL4 line is only expressed by ~20 PDF-expressing peptidergic neurons that have clearly been
implicated in wake-promoting activity (Sheeba et al. 2008; Shang et al. 2008).
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Figure 1. Genetic screen for sleep defects induced by RNAi of DIMM targets derived from
integrated interactome / transcriptome analysis (A) DIMM RNAi in PDF-expressing LNv cells
increased daytime sleep compared to w1118 controls. Pdf-GAL4 was used to knock down DIMM
expression with two different dimm RNAi constructs from the Vienna Drosophila RNAi Center
(VDRC). (B and C) DIMM targets were knocked down by RNAi expressed in DIMM+ cells. UASdcr2; c929-GAL4; females were crossed to UAS-RNAi males from the VDRC attP-based KK
Library or the UAS-attP empty vector controls. (B) Knockdown of many of the integrated DIMM
targets in DIMM-expressing cells shows a tendency towards increased daytime sleep, which
partially phenocopies DIMM loss-of-function sleep phenotype. Daytime sleep values are
displayed for 62 tested KK VDRC RNAi lines (blue) and the attP control progeny (shown in black
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color). Histograms represents means and SEMs of at least two and in most cases three or four
independent biological replicate assays (C) Sleep per hour depicted over a circadian day for
selected genotypes from the same analysis as in (A). Control shown in black.
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Chapter 5.

Concluding remarks about the role of the scaling factor DIMM in
LEAP cell physiology
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THESIS SUMMARY
This thesis presents two approaches to understanding the mechanism that DIMM
uses to instruct cells to produce LDCVs, scale up RSP components and develop most or
all competencies required of a NE cell except for selection of neuropeptide cargo. In
Chapter 2, I contributed molecular and bioinformatic efforts to a larger, multidisciplinary
study. This study aimed to understand how DIMM functions by trying to identify a few
crucial DIMM targets and to confirm the fidelity of these targets by multiple assays. The
contribution of these individual gene targets to DIMM-dependent physiology was
assessed by cellular, molecular and proteomic assays. This study provided the first
specific clues about how DIMM functions in a molecular context. In Chapter 3, I took a
genome-wide approach to understanding the mechanism of DIMM function. I first
attempted to identify all direct genomic targets of DIMM by ChIP-chip. In order to
correlate genome binding to gene activation, I profiled gene expression in LEAP cells by
RNA-Seq. I then merged these two data sets by identifying ChIP-chip targets that were
enriched in LEAP cells. The integration of these two data sets allowed me to obtain the
most direct measure of DIMM direct gene targets. In Chapter 4, I carried a pilot genetic
screen for sleep behavioral defects caused by RNAi-based knockdown of DIMM target
gene expression. These results show preliminary effects on sleep that need to be further
investigated. In sum I produced a body of information detailing precisely how DIMM
operates in LEAP cells by identifying the genes that it regulates, their expression levels
and preliminarily, some functional consequences of their knockdown. Here I discuss the
overall scope of the work, including what I see as limitations and caveats, as well as a
summary of the major conclusions and my opinions on potentially useful future
directions.
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Section on Limitations.
Limitations of tagged DIMM::MYC ChIP-chip.
In Chapter 3, I carried out tagged ChIP-chip to identify direct DIMM binding
targets. This approach is a modification of traditional ChIP-chip, which is carried out with
native antibodies against the transcription factor of interest to immunoprecipitate DNAprotein adducts after crosslinking. I resorted to tagged ChIP-chip after originally
attempting ChIP with an anti-DIMM antibody that was developed in the laboratory, and
which has shown specificity in tissue staining and Western blots. Unfortunately, this
“native” antibody did not perform well in ChIP-chip in my hands. According to my reading
of the literature, this is not an uncommon occurrence, as ChIP antibodies must be able
to capture fixed epitopes in solution. I therefore adapted my approach by using the
GAL4-UAS system to express a single copy of a DIMM transgene tagged at the Cterminal with 6 copies of the human hexapeptide MYC tag. I used c929-GAL4 in
combination with the TARGET system in order to achieve precise, spatiotemporally
controlled induction of DIMM::MYC only in DIMM+ adult neurons (McGuire et al. 2003).
Application of affinity-tagged transgenes is a frequently-used strategy for carrying
out ChIP-chip in vivo (Kolodziej et al. 2009; Mazzoni et al. 2011). Tagged ChIP-chip is
used when a ChIP-grade antibody is not available or when a native antibody recognizes
several isoforms of a transcription factor, or also when it recognizes heterologous
molecules (Harada and Nepveu 2012). Nevertheless, as with any approach, including
native antibody ChIP-chip, there are drawbacks to tagged ChIP-chip. One major
potential source of error (false positives) is genome-binding artifacts arising from
overexpression of the transcription factor being studied. The hypothesis here is that
increasing expression levels of the transcription factor under study, beyond those found
in normal cells, leads to increased competition with other transcription factors for similar
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binding sites in the genome. This, in turn, could cause promiscuous binding to occur at
those loci not normally bound by the transcription factor in question. While this is a valid
point, several experiment-specific conditions need to be examined. The main issues are
those of space and time where the ChIP-chip transgene is induced. Is transgene
induction global, e.g., in the whole brain, or is it more limited, as I performed my study in
Chapter 3? Second, is the transgene induced from the birth of the animal, when
chromatin structure is being established, or is the transgene induced in fully
differentiated, adult cells, as in Chapter 3? In the latter example, the animal develops
chromatin boundaries normally, and its cells express normal levels of transcription
factors, until the transcription factor transgene is turned on in adult, post-mitotic cells.
Overexpression artifacts are more likely to happen with broad overexpression that
begins at birth and is maintained for the life of the animal. In order to avoid such artifacts,
I selectively induced DIMM::MYC in adult cells that normally express DIMM.
Another issue is the potential for off-target binding by a transcription factor that is
expressed at supra-physiological levels. For example, it may compete with other similar
transcription factors (in this case, other members of the Atonal superfamily of bHLHs) for
related target sites. In theory, extraneous binding would be weaker than endogenous
binding because affinity for sites normally bound by other bHLHs is presumably lower
than the affinity for the sites that the particular bHLH under study binds on its own. False
positives could also occur by binding to sites that match the native binding site but are
normally not bound by any transcription factors. Since bHLHs are known to bind six-base
pair long E-boxes (Powell and Jarman 2008), such sequences occur throughout the
genome in all parts of a gene, as well as intergenically at a rate of approximately once
every 2 kB. It is possible that some of these sites are found in open chromatin due to
stochasticity or unrelated transcription. Hence, an overexpressed transcription factor
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could bind to such sites more frequently than the same transcription factor at physiologic
levels. Finally, it is possible that the affinity tag that is placed at the N or C-terminal of a
transcription factor could interfere with the native function of the transcription factor in
question, or it could cause some neomorphic interactions. The UAS-DIMM::MYC
transgene used in Chapter 3 is capable of rescuing the dimm null mutants (Hewes et al.
2003). Therefore, the possibility that the MYC hexapeptide interferes with the normal
function of DIMM is less likely, due to the successful transgene rescue of the mutant.
A recent study examined results obtained from tagged ChIP versus native
antibody ChIP against the bHLH Olig2 at great length (Mazzoni et al. 2011).
Comparisons between native antibody and tagged ChIP-seq showed that endogenous
Olig2 and inducible Olig2-V5 ChIP-seq experiments were in agreement (Mazzoni et al.
2011). Furthermore, the binding-site distribution found in both experiments was also
highly concordant (Mazzoni et al. 2011). Comparing the read counts at enriched peaks
showed that only 0.2% and 1.1% were differently enriched in the native Olig2 and Olig2V5 ChIP experiments, respectively (Mazzoni et al. 2011). This is the first study to
systematically compare tagged ChIP and native ChIP results. The authors used a
doxycycline-inducible system in differentiating embryonic stem cells and generated 24
tagged lines. Interestingly, the authors observed that the efficiency and homogeneity of
transgene induction declined in postmitotic neurons (Mazzoni et al. 2011). My DIMM
ChIP-chip study (Chapter 3) likely does not suffer from the decreased postmitotic
efficiency because ChIP-chip was carried out in vivo, in cells that were already
expressing normal levels of DIMM. Therefore, the chromatin state of DIMM-positive cells
already allowed for DIMM expression and DIMM target expression, with DIMM cell
specification and progenitor delineation having occurred normally during DIMM::MYCunaffected development. Furthermore, DIMM is normally expressed only in postmitotic
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neurons, with DIMM expression not commencing until the neuroblast daughter cell exits
the cell cycle in the embryo (Allan et al. 2005; Hewes et al. 2003). Nevertheless, even
though the experimental setup that I used in Chapter 3 differs from that of Mazzoni et al.
(2011), both sets of experiments were carried out on tagged transcription factors that
were induced from transgenes. Mazzoni et al. (2011) were fortunate to have ChIP-grade
native antibodies available in addition to the tagged transgenes. The authors were
therefore able to compare tagged ChIP-seq results directly to native antibody ChIP-seq
results and observed a remarkable overlap in results.
The above referenced study is an example of an excellent validation study that
demonstrates the utility of tagged ChIP in identifying transcription factor binding
(Mazzoni et al. 2011). Nevertheless, each system is different, so proper scrutiny would
require that each tagged ChIP experiment be verified by native antibody ChIP. In most
cases, this is not possible, because tagged ChIP is usually employed because native
antibody ChIP failed or a native antibody is not available. In the case of DIMM, there
currently is no ChIP-grade native antibody available. Therefore, DIMM::MYC ChIP-chip
results cannot be compared against DIMM native antibody ChIP-chip. It is possible that
some of the binding peaks identified by DIMM ChIP-chip could represent overexpression
artifacts and not true DIMM binding sites. This possibility cannot be completely excluded,
no matter how careful the experimental design is.
Even with native antibody ChIP-chip, there is no guarantee that all identified
binding sites represent true events. In most cases, authors test the performance of a
certain number of binding sites in transcription factor luciferase reporter assays, such as
the one employed in Chapter 3. This in vitro assay directly tests the ability of an
activating transcription factor to activate luciferase expression from an enhancer
fragment located on an episome. An alternative technique is the electrophoretic mobility
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shift (EMSA) assay, which is even more devoid of a cellular context and can have a high
rate of false positives. Ultimately, gene expression studies are another way to deduce
the validity of ChIP-chip results. Optimally, a gene expression profile of the cell type in
which the ChIP-chip transgene was induced should be obtained. Additionally, it is
beneficial to have a loss-of-function gene expression profile, obtained from the cell type
of interest lacking expression of the transcription factor under study. In Chapter 3, I
presented the LEAP cell transcriptome but we currently do not have a DIMM loss-offunction LEAP cell transcriptome. The normal transcriptome is useful in assessing the
correlation of ChIP-chip peaks with gene expression. As outlined in Chapter 3, the basic
assumption is that DIMM acts as an activator of gene expression. Therefore, DIMM
binding in the proximity of a gene should correlate with the enrichment of that gene in
LEAP cells.
FACS sorted cells may be damaged
Preparation for FACS sorting requires that cells be disaggregated from each
other and dissociated into single cells or clumps of a few cells (Givan 2011). During
FACS, cells are exposed to mechanical damage from high pressures and speeds. As a
consequence, all information about tissue architecture and cell distribution is lost after
FACS sorting (Givan 2011). Strictly speaking, such information is not required for gene
expression profiling or ChIP-chip studies. These studies do not examine the morphology
of cells, but rather their RNA or nuclear contents. Nevertheless, dissociation of cells in
preparation for FACS can damage cells even before FACS is started. When fragile cells
are put through a FACS machine that generates high pressures and speeds, the cells of
interest can be further damaged. FACS can produce strong shearing forces, making it
tricky to sort more fragile, adult neurons (Hempel et al. 2007). Whether or not this affects
gene expression depends on the tissue and cell type, dissociation method, type and
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speed of FACS sorting and other factors. Cell viability after FACS sorting can be
checked by various vitality dyes that enter damaged cells that have initiated apoptosis. In
order to assess cell vitality, I used a vital dye in Chapter 3, which showed that the
majority of LEAP cells are alive after sorting. Although cells may be intact mechanically,
it is still possible that they are quite altered due to FACS sorting. The key parameter here
is the amount of time between tissue harvesting and the sorting endpoint, which is RNA
capture in cell lysis buffer. This last step essentially freezes the cellular RNA contents in
time by lysing cells and neutralizing RNase activities. In my experiments, I tried to keep
this time as short as possible, to minimize any cell damage effects of cell sorting.
The major argument I can offer against the possibility that the quality of the RNAseq results I obtained were compromised by the FACS methods is that the DIMMpositive collection of cells produced the heavy enrichment of DIMM and neuropeptides
that was expected from our prior understanding of DIMM cell biology. For example, there
are certain neuropeptides that are expressed exclusively in DIMM-positive LEAP
neurons, whereas others are expressed in DIMM-negative ones exclusively, and yet
others in both sets (Park et al. 2008). My results were highly concordant with these
three general categories. Hence I submit that the possibility for a biasing of my results
(due to disruption of gene expression by cell isolation) appears low.
Section on Major Conclusions
A delimited and defined number of transcription factors downstream of DIMM
In Chapter 3, I showed that only a few transcription factors are found amongst
DIMM targets. One transcription factor family appeared to be overrepresented: members
of the Atf/CREB family of bZIP genes. The fact that several bZIP genes are DIMM
targets is intriguing in light of the fact that DIMM only activates six transcription factors,
and those six come from three transcription factor families. There are an estimated 451
184

Chapter 5
sequence-specific transcription factors in Drosophila (The Drosophila Transcription
Factor Database FlyTF.org, v1.0). Of 451 transcription factors, there are only 16 bZIP
genes and 4 of the 16 bZIPs are DIMM targets. Compared to the relatively small bZIP
gene family, other transcription factor families contain many more members: bHLHs (53
members), homeodomain factors (73 members) and zinc finger transcription factors (91
members). The fact that four of six DIMM-targeted transcription factors are bZIPs is likely
telling of DIMM function. ATF/CREB bZIP factors control a wide variety of physiologic
processes, but what they share in common is transcriptional control of stress-response
genes (Persengiev and Green 2003).
One member of the mammalian ATF/CREB family, Atf2 has been shown to
interact with three beta cell enriched transcription factors to cause synergistic activation
of the insulin promoter (Han et al. 2011). This is interesting in light of the fact that data
presented in this thesis strongly argue against DIMM acting as a transcriptional activator
of neuropeptide expression. Drawing parallels to Atf2 in the mammalian beta cell, it is
possible that some of the ATF/CREB transcription factors that DIMM activates could
contribute to the transcriptional activation of individual neuropeptide genes. Therefore,
while DIMM does not activate neuropeptides, some of its downstream transcription factor
targets could do so combinatorially with other factors. Another mammalian ATF/CREB
factor, Atf-1, acts as a potent repressor of cyclic AMP-responsive element (CRE)mediated transcription. Atf-1, also known as Inducible cAMP early repressor (ICER)
plays an important role in the mammalian neuroendocrine and circadian systems, where
it regulates transcription of the neuropeptide melatonin (Foulkes et al. 1996; Foulkes et
al. 1997). ICER also coordinates reaction to hypothalamic-pituitary-adrenal axis
stimulation by inhibiting Corticotropin Releasing Hormone (CRH) transcription (Della
Fazia et al. 1998; Borlikova and Endo 2009). The fact that several mammalian and fly
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ATF/CREB factors play roles in the (neuro)endocrine system provide more support for
the role of DIMM as the super-organizer of such factors, and thereby the secretory
capacity of a cell.
One view of scaling factor action is that such factors do not activate many
transcription factors. If a scaling factor activated many downstream transcription factors,
its effects would depend on the timing and ability of the downstream transcription factors
to exert precise and coordinated effects on their genomic targets. This would delay
action of the master scaling factor itself and would therefore not be a very effective way
to exert its function. Instead, a scaling factor can act more immediately by activating
‘terminal’ genes needed for specific functions in a subcellular compartment, such as
LDCVs. In addition to these “terminal” genes, a scaling factor would activate only a few
key transcription factors that are also responsible for the function of a particular
subcellular compartment.
If DIMM had to control a large number of downstream transcription factors, its
function would require a coordinated effort of multiple downstream DNA-binding activities
that would have to produce a timely effect on the transcriptome of the cell. In contrast, I
propose that if DIMM activates a few downstream factors and many direct RSP
participants, this would allow for a more dynamic and direct function in the RSP. Some of
the downstream transcription factors that DIMM activates are also known transcriptional
repressors. This would be another point of regulation of the transcriptome. Instead of
acting directly as a transcriptional repressor, DIMM could activate specific transcriptional
repressors that would then inhibit certain pathways or genes, whose function might
directly interfere with the expansion and operation of a robust RSP. The study of
Hamanaka et al. (2010) showed that DIMM promoted the peptidergic cell fate at the
expense of the classic neurotransmitter cell fate. The molecular arm of this repression
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was never identified and work presented in Chapter 3 provides the first clues as to how
this might be achieved. Furthermore, it is possible that DIMM activates several
transcriptional repressors that function in negative feedback loops, similar to some
members of the clock system (Nitabach and Taghert 2008). Two of the six transcription
factors targeted by DIMM are already known to participate in negative feedback loops
(Matsumoto et al. 2007; Kadener et al. 2007).
Neuropeptides are not downstream of DIMM
Analysis of DIMM targets in Chapter 3 shows that neuropeptides are not direct
DIMM targets. Allan et al. (2005) had put forward the hypothesis that DIMM performs two
related functions in individual DIMM cells: that DIMM directly activates its exclusive gene
targets (like PHM) and that DIMM cooperates with different sets of other transcription
factors to produce codes specific to activate different neuropeptide genes. Hamanaka et
al. (2010) proposed an alternative hypothesis – that DIMM does not participate in
neuropeptide (cargo) gene activation, but only in the support of the “peptidergic
secretory machinery.” My systematic analysis now fully supports and validates the latter
hypothesis. Work in Chapter 3 is one of the first demonstrations that scaling factors such
as DIMM act on whole subcellular compartments instead of on the specific cargo inside
those compartments. This is well in agreement with the idea of scaling factor action.
Scaling factors are thought to act on whole subcellular compartments, regardless of the
particular cell subtype. The idea is that many heterogeneous types of cells are found
even within a single tissue. For example, DIMM-positive cells express at least 17
different neuropeptides, and likely more (Park et al. 2008). Therefore, LEAP cells are
highly heterogeneous with respect to their peptidergic identity, but they share the ability
to make, store and release large amounts of neuropeptides. DIMM ensures this ability,
but does not act as the master selector of peptidergic identity. Instead, there are likely
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several other transcription factors that act combinatorially to select appropriate
neuropeptides for expression in the dedicated cell type. This ensures that all LEAP cells
have the cellular capacity for neuropeptide secretion, and can appropriately select the
correct neuropeptide(s) for expression, and ultimately, for their dedicated NE function.
DIMM activates the major neuropeptide biosynthetic enzymes
Results from Chapter 3 also demonstrated that DIMM activates all major
neuropeptide biosynthetic enzymes. Although this finding is somewhat intuitive (meaning
it would have been difficult to explain if it had not been true), demonstrating it, and
demonstrating the extent to which it is true among all possible genes encoding modifying
enzymes remains a valuable contribution. In the case of peptidergic neurons, the
biosynthetic and processing enzymes are located in the trans-Golgi and also packaged
within immature LDCVs, where they operate directly on peptide precursors. Hamanaka
et al. (2010) elegantly demonstrated DIMM’s capacity to instruct cells to make ectopic
LDCVs. DIMM, along with Mist1, is the only known transcription factor able to scale up
LDCVs inside a cell. Based on Chapter 3 results, one can predict that the ectopic LDCVs
produced inside photoreceptors contain all major neuropeptide biosynthetic enzymes
(Hamanaka et al. 2010). The number of known or putative enzymes controlled by DIMM
is five, and includes both ones whose roles in neuropeptide biosynthesis are wellestablished (like Prohomone convertase 2) as well as ones not previously described as
such (e.g., slamdance; Zhang et al. 2002).
Unexpected roles of DIMM targets: endocytosis and RNA regulation
Amongst unexpected findings in Chapter 3, the inclusion of genes involved in
endocytosis and RNA metabolism as direct DIMM targets were particularly novel. The
endocytosis genes are intriguing because they are the first link between DIMM and
processes that could be occurring after massive neuropeptide release (suggested to
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normally occur in LEAP cells). Changes occurring at the cell membrane during
prolonged and copious release of neuropeptides are not trivial as the cellular contents
and architecture are rapidly changing. Such a cell likely needs to replenish numerous
structural components, as well as major signaling factors, and orchestrate a highly
choreographed re-capture of LDCV membrane from the plasma membrane for recycling.
From work on classic neurons, it is known that endocytosis is one way of replenishing
critical components that are lost during synaptic transmission (Südhof 2007). Following
exocytosis, synaptic terminals must rapidly replenish their vesicle pool by locally
recycling synaptic vesicles (Zhang 2003). Recent work has shown that in many
synapses, exocytosis of neurotransmitter is coupled to endocytosis, and that synapses
have evolved a specialized apparatus of scaffolding proteins to comply with these
demands (Haucke et al. 2011). Exocytosed synaptic vesicle membrane proteins and
lipids are recycled at the periactive zone that surrounds the release site, in order to
restore functional synaptic vesicle pools for reuse and to ensure long-term functionality
of the synapse (Haucke et al. 2011). It is therefore entirely possible that cellular sites of
NE cargo release have similar requirements for the replenishment of basic building
blocks necessary for their type of neurotransmission. DIMM could play a role in this
process by directing transcription of proteins involved in endocytosis of specific cargo,
which may be particularly important for the proper functioning of LEAP cells. By virtue of
this significant target list, my work is the first to call attention to the fundamental
importance of LDCV endocytosis in the biology of peptidergic neurons.
RNA regulation is another process that was not previously implicated to be
included in DIMM action mechanism. Several RNA-regulatory factors were identified as
major DIMM targets in Chapter 3. How regulation of various RNA species affects LEAP
cell physiology is entirely unknown at this point. There are several examples of bHLH
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transcription factors activating RNA-binding proteins with key roles in the processes
controlled by the bHLH in question. One such example is the bHLH MyoD and its RNAbinding protein target Seb4/RBM24 (Li et al. 2010). MyoD activates RBM24 in the
developing Xenopus embryos and loss of RBM24 produces a phenotype similar to a
MyoD dominant negative mutant (Li et al. 2010). Therefore, the MyoD target gene
RBM24 appears to be required for expression of myogenic genes in the frog embryo (Li
et al. 2010). Another example comes from the mammalian bHLH NeuroD and its RNAbinding protein target SRp38 (Liu and Harland 2005). NeuroD activates SRp38 and
SRp38 inhibits neuronal differentiation at a step between neurogenin and neuroD activity
(Liu and Harland 2005). SRp38 inhibits neural differentiation in the Xenopus embryo but
it does not affect neural induction or competence (Liu and Harland 2005). SRp38 is a
known mitotic splicing repressor, but it may also act by regulating ribosome biogenesis,
via its binding to the 28S rRNA (Liu and Harland 2005). The examples of RBM24 and
SRp38 illustrate that RNA-binding proteins that are transcriptionally activated by certain
bHLHs may play important roles in biologic processes controlled by the bHLH in
question. What is interesting about DIMM-targeted RNA-binding proteins is the fact that
LEAP cells are a mature, post-mitotic lineage. Therefore, the RNA-binding proteins that
DIMM targets do not function in the context of a developing, highly mitotic lineage.
Nevertheless, the intracellular environment in NE cells might be similarly dynamic
because NE cells are required to integrate many environmental stimuli and to produce
long-lasting effects on the whole organism. It is possible that due to the highly complex
nature of LDCV formation, storage, traffic and release, particular RNAs must be
precisely modified with respect to their half-lives, biochemical modifications, translation
and localization.
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The value of establishing all major gene targets for a regulatory transcription
factor
Establishing a particular transcription factor’s gene regulatory interactome and
interpreting these results in the context of a cell-specific transcriptome are important for
various reasons. First, this will help us understand how a particular transcription factor
acts inside a cell in order to accomplish its various functions. Specifically, for a scaling
factor, this will allow us to understand how whole subcellular compartments are
constructed inside of cells. Second, interactome / transcriptome identification is helpful
because we currently lack complete models of transcription factor action in specific cell
types, as opposed to whole tissues. Publicly supported group projects such as
modENCODE and ENCODE have understandably focused on profiling whole tissues.
Cell-type specific models of transcription factor actions are useful especially in
evolutionary contexts: do Drosophilids use more or less complicated gene regulatory
hierarchies to accomplish similar tasks as mammals? Does a fly scaling factor
accomplish the same scaling effect as a homologous mammalian scaling factor by using
the same types of tools, or by using completely different tools? If so, do both types of
scaling factors arrive at their goal by completely different methods? Or is the gene
regulatory logic required for scaling conserved between mammals and flies? Although
these questions might seem esoteric, they have real life applications. For example, beta
cells have LDCVs and a robust RSP. Attempts at understanding beta cell biology have
been ongoing for decades, but we are still unable to effectively repair a defective RSP
inside these cells. Diabetes is rapidly escalating as a 21st century epidemic, yet, we do
not know understand in great detail how beta cells are constructed to make insulin.
Section on Future Directions.
Elucidating LEAP cell LDCV content and uniformity by ultrastructural methods
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Transmitters are stored in vesicles and granules that have transmitter-specific
morphological characteristics. For example, glutamate-filled and acetylcholinecontaining vesicles are round, small (~35 nm in diameter) and display a clear core
(Watson and Schürmann 2002; Honda and Semba 1995). GABA-containing vesicles are
often small and clear, but flattened (Fabian-Fine et al. 2000; Hamori et al. 1990). Amine
containing granules are slightly larger and have a characteristic dense core (Shkolnik
and Schwartz 1980). Peptide-containing granules are significantly larger (80-200 nm)
and also display a dense core (Borgonovo et al. 2006; Crivellato et al. 2005; Crivellato et
al. 2006; Edwards 1998). Overall, LDCVs tend to be at least twice the size of small
synaptic vesicles (Bruns et al. 2000). Given the association of DIMM with the biology of
peptide LDCVs (Hamanaka et al. 2010), it is natural to inquire about the relationships
between the individual genes that DIMM activates and the production, stabilization,
trafficking, accumulation, release and or endocytosis of LDCVs. If DIMM instructs cells
how to scale up the LDCV compartment, an obvious question pertains to the nature of
the LDCVs formed. If DIMM acts through a single mechanism, the implicit assumption is
that it will instruct the cells to produce a single type of LDCV. Since LDCVs are a
subcellular structure, they can only be effectively visualized by electron microscopy
(EM). It could therefore be useful to assess the consequences of DIMM action at the
ultrastructural level by obtaining EM images of purified LEAP cells. The number, size
and characteristics of LDCVs could be assessed in detail from EM images. If the
prediction is true, LEAP cells should have a fairly homogenous pool of LDCVs that are
produced in response to DIMM action. An interesting correlate is that peptide-containing
granules in non-DIMM cells may have a distinct category of LDCVs (morphologically,
biochemically, physiologically distinct). On the other hand, LEAP cell LDCVs could be
heterogeneous if their underlying peptide cargo has important consequences on the
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size, shape and characteristics of the LDCVs that house the cargo. Just such a
relationship between cargo content and LDCV morphology has been proposed for the
case of granules containing the Atrial Natriuretic Factor (Baertschi et al. 2001).
Identifying DIMM loss-of-function transcriptome
In Chapter 3, I identified the normal LEAP cell transcriptome. While this is a
useful first step in assigning ChIP-chip peaks to genes, its value will be even grater once
it can be compared to the gene expression profile of LEAP cells that have acutely lost
DIMM expression. This loss-of-function gene expression profile would be a snapshot of
changes in transcript levels that occur with loss of DIMM support and help interpret the
full list of DIMM targets identified in Chapter 3. The loss-of-function transcriptome would
allow one to check whether or not LEAP cells lose expression of identified DIMM target
genes when they lose DIMM expression. Furthermore, it is likely that numerous other
genes will have perturbed levels, as an indirect / downstream consequence of DIMM
loss. Changes in the expression of these genes would tell us about what downstream
processes DIMM controls. This would be helpful in case that DIMM acts not only as a
scaling factor, but also in other, as of yet, unknown ways. Furthermore, the DIMM lossof-function gene expression would be helpful in identifying any genes that DIMM might
repress. In this case, such genes would be expected to be upregulated upon DIMM loss.
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